site aa pred_sec pred_expbur pred_accessibility pdb_asym_id hetero nucleotide compound metal otherpoly homo precipitant A C D E F G H I K L M N P Q R S T V W Y feature_table variant 1 M 0 0 0 0 0 0 0 0 0 31 69 0 0 0 0 0 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 2 R 17 0 0 16 0 0 15 0 16 0 0 0 0 0 26 10 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 3 Q 0 0 12 0 0 11 0 0 0 0 0 0 13 8 31 0 12 13 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 4 T 12 0 13 0 0 0 0 0 0 12 0 11 8 0 0 12 32 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 5 L 0 0 0 0 0 9 0 21 0 44 18 0 0 0 0 0 0 8 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 6 P 0 0 0 0 7 0 0 7 12 7 0 0 60 0 0 7 0 0 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 7 C 7 60 4 0 0 0 0 0 0 4 0 0 12 0 0 0 5 4 0 3 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 8 I 4 0 0 0 4 0 5 22 0 21 8 0 0 9 0 0 11 9 7 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 9 Y 12 0 6 4 15 0 0 0 0 21 0 0 3 3 7 3 0 6 0 19 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 10 F 0 3 3 0 30 3 0 4 0 29 6 0 3 0 0 2 0 10 5 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 11 W 10 0 0 0 13 2 0 3 4 16 0 0 4 3 0 0 5 3 23 12 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 12 G 11 0 0 1 0 39 3 4 0 10 0 0 5 3 0 14 2 6 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 13 G 10 2 0 0 3 34 5 0 2 5 0 6 4 4 0 5 8 8 2 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 14 L 3 2 0 1 2 5 0 8 0 46 9 0 2 0 0 2 0 12 0 5 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 15 L 10 10 2 2 6 1 0 10 0 44 0 0 0 0 3 5 4 3 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 16 P 12 0 0 0 0 3 0 0 2 4 1 1 58 0 2 6 2 5 0 3 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 17 F 7 3 6 2 34 4 0 0 0 16 2 0 3 0 3 6 2 4 0 6 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 18 G T e 79.8 2o6q_A 12 1 1 2 0 52 2 1 0 4 0 3 1 5 0 13 0 2 1 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 19 M b 13.1 2o6q_A 5 8 0 0 1 7 1 7 2 13 14 0 8 2 7 6 8 9 0 0 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 20 L e 98.9 4kt1_A 14 0 1 4 6 5 0 4 3 37 3 0 2 6 2 3 3 7 0 1 SIGNAL::DISORDER:predicted by DISOPRED:SIGNAL: 21 C e 21.3 4kt1_A 12 36 2 0 1 4 2 3 2 6 1 0 2 0 2 5 11 7 1 0 SIGNAL::SIGNAL: 22 A e 25.9 4kt1_A 14 4 3 0 2 6 1 6 3 6 1 0 22 2 4 12 4 8 0 1 SIGNAL::SIGNAL: 23 S T e 79.5 4kt1_A 14 3 4 3 5 4 1 0 0 2 1 4 13 0 3 32 7 2 0 1 SIGNAL::SIGNAL: 24 S T e 44.2 4kt1_A 10 17 3 7 0 6 2 1 4 2 0 2 5 1 3 26 4 4 0 1 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 25 T b 8.7 4kt1_A 5 13 3 3 0 5 0 2 5 11 0 1 22 6 2 4 11 5 3 0 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 26 T e 114.9 2a0z_A 9 11 3 3 4 10 1 3 1 2 0 4 2 2 6 15 17 7 0 1 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 27 K e 77.8 2a0z_A LIMS1_HUMAN:LIM and senescent cell antigen-like-containing dom.. PGS2_BOVIN:Decorin[305 aa] PEG 5 2 4 10 1 7 2 2 12 4 2 3 9 12 9 4 4 8 0 0 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 28 C b 18.7 2a0z_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. PEG 2 82 1 0 0 0 0 4 0 1 1 0 1 2 0 2 0 3 0 1 DISULFID::DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DISULFID::DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 29 T E e 54.5 2a0z_A LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:LIMS1_HUMAN:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Adhesion G protein-coupled receptor L3[263 aa]:LIM and senescent cell antigen-like-containing dom.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. PGS2_BOVIN:Decorin[305 aa] SO4 4 1 4 2 1 3 4 1 3 5 0 2 2 4 10 19 24 6 0 7 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 30 V e 101.3 7c76_A VWF_HUMAN:Von Willebrand factor (vWF) [Contains: Von Willebr..:Von Willebrand factor[208 aa]:VON WILLEBRAND FACTOR[202 aa]:VON WILLEBRAND FACTOR[199 aa]:VON WILLEBRAND FACTOR[197 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4 3 34 1 5 5 2 0 9 3 9 3 1 1 1 3 3 1 14 0 2 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 31 S e 49.2 7c76_A VWF_HUMAN:LPHN3_MOUSE:AGRL3_MOUSE:LIMS1_HUMAN:von Willebrand Factor[199 aa]:VON WILLEBRAND FACTOR[202 aa]:Latrophilin-3[267 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:LIM and senescent cell antigen-like-containing dom.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4 7 2 8 5 2 2 4 1 1 3 0 1 17 5 7 23 4 4 0 1 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 32 H S e 85.9 7c76_A VWF_HUMAN:ROBO1_HUMAN:AGRL3_MOUSE:LIMS1_HUMAN:von Willebrand Factor[199 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:VON WILLEBRAND FACTOR[202 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:LIM and senescent cell antigen-like-containing dom.. NAG TRS 6 0 6 6 0 11 10 1 5 9 1 8 3 6 11 5 3 2 0 5 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 33 E S e 47.7 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TRS 1 0 6 24 1 6 1 3 5 6 1 8 2 9 16 2 4 4 1 0 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 34 V E e 42.7 7c76_A VWF_HUMAN:ROBO1_HUMAN:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:von Willebrand Factor[199 aa]:Von Willebrand factor[208 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:VON WILLEBRAND FACTOR[199 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:Adhesion G protein-coupled receptor L3[263 aa] TRS 5 1 2 6 6 1 1 13 1 11 2 1 2 2 2 7 11 25 0 1 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 35 A E b 1.8 7c76_A 14 4 0 1 3 8 0 8 2 13 1 1 2 0 2 4 2 33 0 3 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 36 D E e 51.9 7c76_A VWF_HUMAN:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:von Willebrand Factor[199 aa]:Von Willebrand factor (vWF) [Contains: Von Willebr..:Von Willebrand factor[208 aa]:VON WILLEBRAND FACTOR[202 aa]:VON WILLEBRAND FACTOR[199 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Adhesion G protein-coupled receptor L3[263 aa] NAG PGS2_BOVIN:SLIT2_HUMAN:Decorin[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa] 2 0 44 6 2 2 2 1 2 3 0 11 0 6 2 7 1 1 0 6 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 37 C b 6.7 7c76_A 1 77 0 0 1 0 0 2 1 10 1 1 0 0 0 0 1 2 0 1 DISULFID::DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DISULFID::DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 38 S T b 14.8 7c76_A VWF_HUMAN:ROBO1_HUMAN:LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:A4IFT3_BOVIN:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:Von Willebrand factor (vWF) [Contains: Von Willebr..:ROUNDABOUT HOMOLOG 1[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[127 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:VON WILLEBRAND FACTOR[202 aa]:VON WILLEBRAND FACTOR[199 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:Adhesion G protein-coupled receptor L3[263 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PGS2_BOVIN:TLR5_HUMAN:Decorin[305 aa]:Toll-like receptor 5[797 aa] 5 1 6 4 0 4 2 2 2 2 3 9 1 5 5 40 6 3 0 0 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 39 H T e 68.6 7c76_A LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:A4IFT3_BOVIN:Q81JD7_BACAN:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:BclA protein[136 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa]:Adhesion G protein-coupled receptor L3[263 aa] 46-MER:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') :RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG PGS2_BOVIN:SLIT2_HUMAN:Decorin[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa] SO4 3 0 13 11 3 15 12 0 5 1 0 12 0 2 7 11 0 1 1 3 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 40 L S e 58.4 7c76_A LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Adhesion G protein-coupled receptor L3[263 aa] NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. PGS2_BOVIN:TLR5_HUMAN:Decorin[305 aa]:Toll-like receptor 5[797 aa] 6 2 0 1 0 1 1 2 7 25 2 14 1 5 23 2 4 2 1 1 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 41 K e 66.0 7c76_A A8JH98_CHLRE:Phosphopyruvate hydratase[476 aa] 46-MER:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') :RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4:EDO 2 0 8 7 2 23 1 0 14 0 1 16 1 9 7 5 2 0 0 1 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 42 L e 27.0 7c76_A NAG LRC26_HUMAN:Leucine-rich repeat-containing protein 26[242 aa] SO4:EDO 1 0 0 1 6 1 0 7 1 71 2 0 2 0 0 0 0 4 1 1 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 43 T S e 54.5 7c76_A UNC5D_RAT:A8JH98_CHLRE:NETRIN RECEPTOR UNC5D[259 aa]:Phosphopyruvate hydratase[476 aa] DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LRC26_HUMAN:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] SO4:EDO 7 1 2 3 1 3 2 2 5 5 0 3 3 5 6 16 31 4 0 2 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 44 Q S e 33.2 7c76_A A8JH98_CHLRE:Phosphopyruvate hydratase[476 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LRC26_HUMAN:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] SO4 13 1 3 21 1 4 3 1 5 2 0 2 1 9 4 17 6 3 0 1 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 45 V b 5.3 7c76_A A8JH98_CHLRE:Phosphopyruvate hydratase[476 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. LRC26_HUMAN:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] EDO 2 1 0 0 4 0 0 29 1 16 2 0 1 0 0 1 3 37 0 3 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 46 P b 17.1 7c76_A A8JH98_CHLRE:Phosphopyruvate hydratase[476 aa] GOL:EDO 2 0 1 1 0 1 0 1 1 4 0 1 85 0 0 2 2 1 0 0 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 47 D S e 64.8 7c76_A A8JH98_CHLRE:Phosphopyruvate hydratase[476 aa] NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LRC26_HUMAN:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] GOL:EDO 9 1 15 9 1 6 1 1 8 2 0 2 9 4 6 14 7 4 0 1 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 48 D e 74.7 7c76_A NAG LRC26_HUMAN:Leucine-rich repeat-containing protein 26[242 aa] GOL:EDO 4 1 23 8 0 18 1 1 1 2 0 12 7 2 3 10 4 3 0 1 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 49 L S b 14.6 7c76_A alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. LRC26_HUMAN:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] GOL:EDO 2 1 0 0 8 3 0 31 1 44 1 0 0 0 1 1 1 6 1 0 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 50 P e 51.9 7c76_A 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 3 1 3 1 1 7 0 1 3 3 0 1 60 2 1 11 2 0 1 0 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 51 T T e 46.8 7c76_A FUL:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:LRC26_HUMAN:Toll-like receptor 8[747 aa]:Leucine-rich repeat-containing protein 26[242 aa] 10 1 2 5 1 3 1 1 5 5 1 4 12 2 6 17 18 4 1 0 DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRNT":TOPO_DOM:/note="Lumenal" 52 N T e 65.5 7c76_A NAG CA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:Toll-like receptor 8[747 aa]:Volume-regulated anion channel subunit LRRC8A[702 ..:Volume-regulated anion channel subunit LRRC8A[706 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[729 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. 4 0 16 5 2 6 4 0 4 1 0 28 1 3 4 15 4 0 1 3 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 53 I b 2.9 7c76_A 5 1 0 1 1 0 0 8 0 38 1 1 0 0 0 4 25 15 0 0 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 54 T b 18.8 7c76_A IGG1_HUMAN:IGF1_HUMAN:Immunoglobulin gamma-1 heavy chain[208 aa]:Isoform 3 of Insulin-like growth factor I[65 aa] CA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:Volume-regulated anion channel subunit LRRC8A[706 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. TRS:SO4 4 1 1 11 0 1 1 2 7 4 1 1 0 9 14 6 25 10 0 2 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 55 V E e 29.3 7c76_A CADH1_MOUSE:ROBO1_HUMAN:ERL1_ARATH:LIMS1_HUMAN:LRC8A_MOUSE:C562_ECOLX:Epithelial-cadherin[105 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:flg22[21 aa]:LRR receptor-like serine/threonine-protein kinase ..:LIM and senescent cell antigen-like-containing dom..:Volume-regulated anion channel subunit LRRC8A,Solu.. CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. PGS1_BOVIN:LRC8A_MOUSE:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:Volume-regulated anion channel subunit LRRC8A[718 .. SO4 4 1 2 10 2 3 4 6 4 8 2 5 0 3 8 9 10 12 0 6 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 56 L E b 7.9 7c76_A F2YBL9_ANOGA:Anopheles Plasmodium-responsive Leucine-rich repea.. 1 0 0 0 2 0 0 10 0 79 2 0 0 0 1 0 0 4 0 0 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 57 N E e 31.5 7c76_A VWF_HUMAN:CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:ROBO1_HUMAN:LY96_MOUSE:LY96_HUMAN:LYSC_CHICK:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:ERL1_ARATH:IGG1_HUMAN:LIMS1_HUMAN:von Willebrand Factor[199 aa]:E-CADHERIN[105 aa]:Von Willebrand factor (vWF) [Contains: Von Willebr..:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[126 aa]:Lysozyme C[124 aa]:Lysozyme C[127 aa]:Lysozyme C[125 aa]:VON WILLEBRAND FACTOR[202 aa]:VON WILLEBRAND FACTOR[199 aa]:flg22[21 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:LRR receptor-like serine/threonine-protein kinase ..:Adhesion G protein-coupled receptor L3[263 aa]:Immunoglobulin gamma-1 heavy chain[208 aa]:LIM and senescent cell antigen-like-containing dom..:Cadherin-1[213 aa]:NbRoco2[116 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. PGS1_BOVIN:SLIT2_HUMAN:F2YBL9_ANOGA:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Anopheles Plasmodium-responsive Leucine-rich repea.. SO4:EDO 1 1 25 4 5 3 3 3 2 5 1 17 0 3 7 9 1 2 1 8 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 58 L b 1.1 7c76_A F2YBL9_ANOGA:Anopheles Plasmodium-responsive Leucine-rich repea.. 1 1 0 0 4 0 0 6 0 81 2 0 0 0 1 0 0 4 0 1 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 59 T b 11.0 7c76_A CAD1_HUMAN:VWF_HUMAN:CADH1_HUMAN:CADH1_MOUSE:LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:Q7Q5N3_ANOGA:A4IFT3_BOVIN:Q81JD7_BACAN:SPZ_DROME:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:ERL1_ARATH:IGG1_HUMAN:CIF2_ARATH:LIMS1_HUMAN:IDA_ARATH:IDL1_ARATH:E-CADHERIN[105 aa]:Von Willebrand factor (vWF) [Contains: Von Willebr..:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[126 aa]:Lysozyme C[124 aa]:Lysozyme C[127 aa]:Lysozyme C[125 aa]:Leucine-rich Immune Molecule 1[482 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:BclA protein[136 aa]:VON WILLEBRAND FACTOR[199 aa]:VON WILLEBRAND FACTOR[197 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:flg22[21 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Lymphocyte antigen 96[137 aa]:LRR receptor-like serine/threonine-protein kinase ..:Adhesion G protein-coupled receptor L3[263 aa]:Immunoglobulin gamma-1 heavy chain[208 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:LIM and senescent cell antigen-like-containing dom..:Lymphocyte antigen 96[136 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:synthetic nanobody Sb4[124 aa]:Cadherin-1[213 aa]:NbRoco2[116 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. PGS2_BOVIN:PGS1_BOVIN:SLIT2_HUMAN:F2YBL9_ANOGA:Decorin[305 aa]:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Anopheles Plasmodium-responsive Leucine-rich repea.. SO4 5 0 6 4 1 4 3 1 2 2 0 3 2 12 6 36 6 3 0 4 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 60 H S e 41.4 7c76_A ROBO1_HUMAN:LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:Q7Q5N3_ANOGA:A4IFT3_BOVIN:Q81JD7_BACAN:RSPO1_HUMAN:SPZ_DROME:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:ERL1_ARATH:IGG1_HUMAN:LIMS1_HUMAN:IDL1_ARATH:PP1G_HUMAN:PP1A_HUMAN:ROUNDABOUT HOMOLOG 1[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Leucine-rich Immune Molecule 1[482 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:BclA protein[136 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[63 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:LRR receptor-like serine/threonine-protein kinase ..:Adhesion G protein-coupled receptor L3[263 aa]:Immunoglobulin gamma-1 heavy chain[208 aa]:LIM and senescent cell antigen-like-containing dom..:Protein IDA-LIKE 1[14 aa]:synthetic nanobody Sb4[124 aa]:Serine/threonine-protein phosphatase PP1-gamma cat..:Serine/threonine-protein phosphatase PP1-alpha cat..:VHH10[119 aa]:NbRoco2[116 aa] 46-MER:DNA (5'-D(*CP*AP*TP*GP*AP*CP*GP*TP*TP*CP*CP*T)-3')..:DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') :DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') :RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG CL:NI 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PGS2_BOVIN:F2YBL9_ANOGA:Q8KC98_CHLTE:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:Decorin[305 aa]:Anopheles Plasmodium-responsive Leucine-rich repea..:Rab family protein[440 aa]:Volume-regulated anion channel subunit LRRC8A[707 ..:Volume-regulated anion channel subunit LRRC8A[725 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[732 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. SO4:EDO:MLI 4 0 10 5 6 8 14 0 4 1 2 17 0 5 6 7 1 0 1 8 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 61 N S b 6.1 7c76_A 46-MER:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) F2YBL9_ANOGA:Anopheles Plasmodium-responsive Leucine-rich repea.. EDO:SO4:GOL:MLI 0 2 0 0 0 2 0 0 0 2 0 86 0 0 1 2 4 0 0 0 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 62 Q e 28.1 7c76_A SPZ_DROME:SERK2_ARATH:UNC5D_RAT:PROTEIN SPAETZLE C-106[68 aa]:Protein spaetzle C-106[66 aa]:Protein spaetzle C-106[65 aa]:Somatic embryogenesis receptor kinase 2[185 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[262 aa]:synthetic nanobody Sb2[120 aa]:synthetic nanobody Sb3[120 aa] 46-MER:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') :RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR5_HUMAN:F2YBL9_ANOGA:LRC26_HUMAN:Toll-like receptor 5[797 aa]:Anopheles Plasmodium-responsive Leucine-rich repea..:Leucine-rich repeat-containing protein 26[262 aa] SO4:GOL:EDO 2 1 3 6 3 3 6 0 12 3 3 9 3 18 14 8 1 1 0 2 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 63 L b 0.6 7c76_A F2YBL9_ANOGA:Anopheles Plasmodium-responsive Leucine-rich repea.. SO4 1 0 0 0 7 0 0 44 0 41 1 0 0 0 0 1 0 3 0 1 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 64 R e 32.4 7c76_A SPZ_DROME:UNC5D_RAT:PROTEIN SPAETZLE C-106[68 aa]:Protein spaetzle C-106[66 aa]:Protein spaetzle C-106[65 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[262 aa]:synthetic nanobody Sb3[120 aa] 46-MER:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') :RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. F2YBL9_ANOGA:LRC26_HUMAN:Anopheles Plasmodium-responsive Leucine-rich repea..:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] SO4:GOL 4 0 4 8 1 3 3 2 7 2 0 4 3 6 13 18 17 3 0 1 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 65 R e 58.1 7c76_A Synthetic nanobody Sb1[114 aa] DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') :RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG F2YBL9_ANOGA:Anopheles Plasmodium-responsive Leucine-rich repea.. SO4 6 1 3 9 1 17 5 1 8 2 2 5 0 3 12 11 9 5 0 1 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 66 L b 2.2 7c76_A Synthetic nanobody Sb1[114 aa] F2YBL9_ANOGA:Anopheles Plasmodium-responsive Leucine-rich repea.. SO4 2 0 2 2 1 1 0 27 2 41 1 2 2 2 0 2 3 10 0 1 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 67 P e 30.2 7c76_A A8JH98_CHLRE:Phosphopyruvate hydratase[476 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. F2YBL9_ANOGA:LRC26_HUMAN:Anopheles Plasmodium-responsive Leucine-rich repea..:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] SO4:TRS 4 0 3 3 1 4 3 6 6 9 0 3 38 4 4 6 3 1 1 1 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 68 A S b 9.8 7c76_A Synthetic nanobody Sb1[114 aa] NAG Q96FE5_HUMAN:LRC26_HUMAN:Leucine rich repeat neuronal 6A[472 aa]:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] SO4:TRS 12 0 5 9 1 3 2 2 6 2 1 7 22 3 2 11 4 3 0 4 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 69 A G e 67.9 7c76_A A8JH98_CHLRE:Phosphopyruvate hydratase[476 aa] NAG F2YBL9_ANOGA:LRC26_HUMAN:Anopheles Plasmodium-responsive Leucine-rich repea..:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[242 aa] EDO:TRS 12 1 6 8 2 20 3 1 3 3 1 9 3 2 4 14 3 2 2 2 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 70 N G e 43.0 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. F2YBL9_ANOGA:Anopheles Plasmodium-responsive Leucine-rich repea.. GOL:EDO 15 1 15 6 4 2 1 5 1 4 1 10 2 3 4 13 6 6 0 1 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 71 F G b 1.4 7c76_A Synthetic nanobody Sb1[114 aa] F2YBL9_ANOGA:Anopheles Plasmodium-responsive Leucine-rich repea.. 2 0 1 0 49 1 0 7 0 24 2 2 2 0 0 0 1 4 0 3 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 72 T S e 54.5 7c76_A NAG PT 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. LRC26_HUMAN:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] PO4 13 2 3 4 2 13 2 3 7 3 1 3 2 5 5 20 8 3 1 2 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 73 R S e 43.9 7c76_A NAG CL alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. F2YBL9_ANOGA:LRC26_HUMAN:Anopheles Plasmodium-responsive Leucine-rich repea..:Leucine-rich repeat-containing protein 26[242 aa] GOL 3 1 3 4 2 17 5 1 6 4 0 19 3 3 14 7 3 2 0 2 REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 1":TOPO_DOM:/note="Lumenal" 74 Y b 2.6 7c76_A LRC8C_MOUSE:Volume-regulated anion channel subunit LRRC8C[704 .. NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 6 3 0 2 10 1 1 5 0 47 4 0 1 1 1 1 1 3 2 9 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 75 S e 42.2 7c76_A LRC8C_MOUSE:Volume-regulated anion channel subunit LRRC8C[704 .. NAG CL alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:Toll-like receptor 8[747 aa]:Volume-regulated anion channel subunit LRRC8A[702 ..:Volume-regulated anion channel subunit LRRC8A[706 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. GOL 2 1 1 4 1 4 4 2 10 1 3 5 12 3 5 21 16 4 0 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 76 Q S e 33.7 7c76_A RSMB_SCHPO:Small nuclear ribonucleoprotein-associated protein.. NAG CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:Toll-like receptor 8[747 aa] GOL 6 0 5 6 2 6 6 0 7 3 0 18 1 14 6 13 3 0 1 1 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 77 L b 0.0 7c76_A CL 1 0 1 0 1 0 0 2 0 86 2 0 0 0 0 0 1 5 0 0 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 78 T e 27.3 7c76_A ERL1_ARATH:Q6J4H1_CHLRE:RASM_HUMAN:flg22[21 aa]:LRR receptor-like serine/threonine-protein kinase ..:CPC1[1558 aa]:Ras-related protein M-Ras[175 aa] NAG PGS1_BOVIN:CHAD_HUMAN:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:Chondroadherin[324 aa]:Volume-regulated anion channel subunit LRRC8A[706 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. TRS:PEG:SO4 2 0 1 16 0 2 3 3 6 4 1 2 0 17 11 3 19 7 0 2 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 79 S E b 19.5 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:ROBO1_HUMAN:LYSC_CHICK:VWF_HUMAN:LY96_MOUSE:ERL1_ARATH:AGRL3_MOUSE:LIMS1_HUMAN:IGF1_HUMAN:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:Lysozyme C[126 aa]:Lysozyme C[124 aa]:Lysozyme C[127 aa]:Lysozyme C[125 aa]:VON WILLEBRAND FACTOR[199 aa]:Lymphocyte antigen 96[136 aa]:LRR receptor-like serine/threonine-protein kinase ..:Adhesion G protein-coupled receptor L3[263 aa]:LIM and senescent cell antigen-like-containing dom..:Isoform 3 of Insulin-like growth factor I[65 aa]:Cadherin-1[213 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. PGS1_BOVIN:SLIT2_HUMAN:CHAD_HUMAN:LRC8A_MOUSE:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Chondroadherin[324 aa]:Chondroadherin[325 aa]:Chondroadherin[323 aa]:Volume-regulated anion channel subunit LRRC8A[718 .. PEG 5 2 4 9 5 2 4 4 6 6 2 3 0 3 5 11 9 11 3 7 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 80 L E b 3.4 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Cadherin-1[213 aa] 0 0 0 1 3 0 0 10 0 77 1 0 1 0 0 1 1 5 0 0 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 81 D E b 16.7 7c76_A CAD1_HUMAN:VWF_HUMAN:CADH1_HUMAN:CADH1_MOUSE:LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:RU2B_SCHPO:Q81JD7_BACAN:SPZ_DROME:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:CIF2_ARATH:LIMS1_HUMAN:E-CADHERIN[105 aa]:Von Willebrand factor (vWF) [Contains: Von Willebr..:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[126 aa]:Lysozyme C[124 aa]:Lysozyme C[127 aa]:Lysozyme C[125 aa]:Probable U2 small nuclear ribonucleoprotein B'' [8..:BclA protein[136 aa]:PROTEIN SPAETZLE C-106[66 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:flg22[21 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:Adhesion G protein-coupled receptor L3[263 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:LIM and senescent cell antigen-like-containing dom..:Cadherin-1[213 aa]:NbRoco2[116 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. SLIT2_HUMAN:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa] SO4 1 1 41 4 2 1 4 3 3 1 2 12 1 3 6 5 1 2 3 5 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 82 V b 2.0 7c76_A SO4 2 1 0 0 1 1 0 8 0 64 5 0 0 1 1 2 1 11 0 0 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 83 G b 0.0 7c76_A LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:A4IFT3_BOVIN:Q81JD7_BACAN:VWF_HUMAN:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:IGG1_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[126 aa]:Lysozyme C[124 aa]:Lysozyme C[127 aa]:Lysozyme C[125 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:BclA protein[136 aa]:VON WILLEBRAND FACTOR[197 aa]:flg22[21 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:Adhesion G protein-coupled receptor L3[263 aa]:Immunoglobulin gamma-1 heavy chain[208 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:synthetic nanobody Sb4[124 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. PGS2_BOVIN:SLIT2_HUMAN:F2YBL9_ANOGA:Decorin[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Anopheles Plasmodium-responsive Leucine-rich repea.. SO4:GOL:CIT:ACT 5 1 5 3 1 12 5 2 6 1 1 4 0 7 3 35 4 3 0 2 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 84 F S e 41.6 7c76_A CADH1_HUMAN:LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:RU2B_SCHPO:Q7Q5N3_ANOGA:A4IFT3_BOVIN:Q81JD7_BACAN:AGRL3_MOUSE:IGG1_HUMAN:LIMS1_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:PP1G_HUMAN:Epithelial-cadherin[105 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[127 aa]:Probable U2 small nuclear ribonucleoprotein B'' [8..:Leucine-rich Immune Molecule 1[482 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:BclA protein[136 aa]:flg22[21 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:Immunoglobulin gamma-1 heavy chain[208 aa]:LIM and senescent cell antigen-like-containing dom..:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:Peptide hormone IDL3[12 aa]:synthetic nanobody Sb4[124 aa]:Serine/threonine-protein phosphatase PP1-gamma cat.. 46-MER:DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') :RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG NI:CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. PGS2_BOVIN:F2YBL9_ANOGA:Q8KC98_CHLTE:LRC8A_HUMAN:LRC8A_MOUSE:LRC26_HUMAN:C562_ECOLX:Decorin[305 aa]:Anopheles Plasmodium-responsive Leucine-rich repea..:Rab family protein[440 aa]:Volume-regulated anion channel subunit LRRC8A[707 ..:Volume-regulated anion channel subunit LRRC8A[725 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[732 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. SO4:EPE:ACT:EDO:GOL:MLI 1 0 5 8 7 11 11 2 4 2 1 14 0 3 8 8 2 2 2 9 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 85 N S b 3.0 7c76_A 46-MER:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) TLR5_HUMAN:Toll-like receptor 5[797 aa] SO4:EPE:EDO:GOL 0 4 1 0 1 1 0 0 1 2 0 81 0 1 1 3 2 0 0 0 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 86 T e 46.1 7c76_A AGRL3_MOUSE:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:synthetic nanobody Sb3[120 aa] 46-MER:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. CD180_HUMAN:A6QNK7_BOVIN:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:CD180 antigen[601 aa]:CD180 molecule[599 aa]:CD180 molecule[592 aa]:CD180 molecule[397 aa]:CD180 molecule[593 aa]:Volume-regulated anion channel subunit LRRC8A[725 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. EPE:EDO:GOL:MLI 4 4 2 7 2 2 4 2 10 7 4 11 2 10 8 10 5 2 1 3 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 87 I b 0.0 7c76_A DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') 1 0 0 1 7 1 1 36 0 37 1 2 2 0 2 1 3 6 0 0 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 88 S S e 67.2 7c76_A A8JH98_CHLRE:synthetic nanobody Sb3[120 aa]:Phosphopyruvate hydratase[476 aa] 46-MER:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:Toll-like receptor 8[751 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[708 aa] PO4:GOL 5 1 2 8 1 5 2 1 5 2 1 6 3 4 10 26 13 3 0 2 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 89 K S e 75.5 7c76_A LY86_HUMAN:A4IFT3_BOVIN:UNC5D_RAT:A8JH98_CHLRE:Lymphocyte antigen 86[139 aa]:LY86 protein[136 aa]:LY86 protein[138 aa]:LY86 protein[135 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[262 aa]:light chain (anti-TLR3)[107 aa]:Phosphopyruvate hydratase[476 aa] RNA (80-MER):RNA (46-MER) NAG PO4 6 2 4 11 2 16 3 2 11 2 1 3 1 6 4 12 8 3 1 3 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 90 L b 10.7 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 2 0 2 3 2 2 1 32 1 31 2 0 2 1 1 3 2 11 1 1 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 91 E e 25.6 7c76_A LY86_HUMAN:A4IFT3_BOVIN:UNC5D_RAT:Lymphocyte antigen 86[139 aa]:LY86 protein[136 aa]:LY86 protein[138 aa]:LY86 protein[135 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[262 aa]:Synthetic nanobody Sb1[114 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LRC26_HUMAN:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa] SO4 5 1 8 18 3 4 6 7 2 6 1 2 15 5 3 6 5 3 0 1 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 92 P G e 31.0 7c76_A LY86_HUMAN:A4IFT3_BOVIN:Lymphocyte antigen 86[139 aa]:LY86 protein[136 aa]:LY86 protein[138 aa]:LY86 protein[135 aa]:Synthetic nanobody Sb1[114 aa] Q96FE5_HUMAN:LRC26_HUMAN:Leucine rich repeat neuronal 6A[471 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] SO4 7 0 7 6 1 4 2 2 5 4 0 4 44 1 3 5 2 2 1 1 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 93 E G e 49.2 7c76_A UNC5D_RAT:NETRIN RECEPTOR UNC5D[259 aa] Q96FE5_HUMAN:LRC26_HUMAN:Leucine rich repeat neuronal 6A[472 aa]:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] SO4:GOL 4 1 13 12 1 16 1 2 9 2 1 6 3 6 7 9 2 3 0 4 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 94 L G b 4.5 7c76_A Synthetic nanobody Sb1[114 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL 25 1 2 4 5 2 1 7 1 15 4 1 2 1 0 10 8 8 1 1 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 95 C G b 8.7 7c76_A Synthetic nanobody Sb1[114 aa] PEG:GOL:SO4 3 10 1 0 32 5 0 8 0 22 2 1 4 1 0 2 2 6 1 1 MUTAGEN:/note="C->A: Reduced response to ds-RNA.":REPEAT:/note="LRR 2":DISULFID::TOPO_DOM:/note="Lumenal":MUTAGEN:/note="C->A: Reduced response to ds-RNA.":REPEAT:/note="LRR 2":DISULFID::TOPO_DOM:/note="Lumenal" 96 Q G e 38.8 7c76_A Synthetic nanobody Sb1[114 aa] DNA (5'-D(*CP*AP*TP*GP*AP*CP*GP*TP*TP*CP*CP*T)-3')..:DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') :DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') RX8:9K9:ACK:23G ZN Q96FE5_HUMAN:B3Y653_MACMU:G7NS93_MACMU:LRC26_HUMAN:Leucine rich repeat neuronal 6A[472 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] SO4:PEG:GOL 6 1 6 6 3 11 2 1 5 5 1 4 1 13 10 12 8 2 1 3 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 97 K G e 43.9 7c76_A Synthetic nanobody Sb1[114 aa] NAG:IDQ NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. B3Y653_MACMU:G7NS93_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa] PEG:GOL:SO4 3 0 4 6 2 17 5 1 10 2 2 16 4 3 7 11 2 2 3 1 REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 2":TOPO_DOM:/note="Lumenal" 98 L b 0.6 7c76_A 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B3Y653_MACMU:G7NS93_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa] PEG:GOL:SO4 4 5 0 1 4 1 1 7 0 57 4 1 0 2 0 2 2 7 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 99 P T e 51.9 7c76_A Synthetic nanobody Sb1[114 aa] NAG NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B3Y653_MACMU:G7NS93_MACMU:LRC8A_MOUSE:LRC8A_HUMAN:Toll-like receptor 7[776 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Volume-regulated anion channel subunit LRRC8A[718 ..:Toll-like receptor 7[771 aa]:Volume-regulated anion channel subunit LRRC8A[729 ..:Volume-regulated anion channel subunit LRRC8A[730 .. PEG:SO4:GOL 3 0 4 3 3 5 4 1 8 2 0 5 25 4 5 13 6 6 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 100 M T e 39.1 7c76_A LRC8C_MOUSE:Volume-regulated anion channel subunit LRRC8C[704 .. DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:Q2EEY0_HORSE:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:Toll-like receptor 8[747 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Volume-regulated anion channel subunit LRRC8A[702 ..:Volume-regulated anion channel subunit LRRC8A[706 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[729 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A,Solu..:Volume-regulated anion channel subunit LRRC8A[407 .. GOL 4 1 2 7 1 5 6 0 10 6 5 17 1 6 7 12 4 2 1 2 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 101 L b 1.1 7c76_A B3Y653_MACMU:G7NS93_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa] SO4 2 0 1 0 2 0 0 3 3 73 2 0 2 0 0 3 3 5 0 0 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 102 K e 37.3 7c76_A VWF_HUMAN:SPZ_DROME:ERL1_ARATH:LIMS1_HUMAN:Q6J4H1_CHLRE:IGF1_HUMAN:von Willebrand Factor[199 aa]:Von Willebrand factor[208 aa]:VON WILLEBRAND FACTOR[202 aa]:VON WILLEBRAND FACTOR[199 aa]:VON WILLEBRAND FACTOR[197 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:LRR receptor-like serine/threonine-protein kinase ..:LIM and senescent cell antigen-like-containing dom..:CPC1[1558 aa]:Isoform 3 of Insulin-like growth factor I[65 aa] DNA (5'-D(*CP*AP*TP*GP*AP*CP*GP*TP*TP*CP*CP*T)-3')..:DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') :DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SLIT2_HUMAN:TLR8_HUMAN:Q2EEY0_HORSE:LGR4_XENTR:B3Y653_MACMU:CHAD_HUMAN:G7NS93_MACMU:LRC8A_HUMAN:LRC8A_MOUSE:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 7[776 aa]:Toll-like receptor 7[772 aa]:Chondroadherin[324 aa]:Chondroadherin[323 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Volume-regulated anion channel subunit LRRC8A[706 ..:Toll-like receptor 7[771 aa]:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[730 .. SO4:PEG 2 1 3 16 1 5 3 2 17 2 2 3 2 12 15 4 8 2 0 1 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 103 V E e 31.3 7c76_A CAD1_HUMAN:VWF_HUMAN:CADH1_HUMAN:LYSC_CHICK:SPZ_DROME:LPHN3_MOUSE:LPHN3_HUMAN:ERL1_ARATH:IGG1_HUMAN:CIF2_ARATH:RASM_HUMAN:E-CADHERIN[105 aa]:Von Willebrand factor[208 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Lysozyme C[126 aa]:Lysozyme C[124 aa]:Lysozyme C[127 aa]:Lysozyme C[125 aa]:OS1 peptide[11 aa]:PROTEIN SPAETZLE C-106[66 aa]:VON WILLEBRAND FACTOR[202 aa]:VON WILLEBRAND FACTOR[199 aa]:VON WILLEBRAND FACTOR[197 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:flg22[21 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:LRR receptor-like serine/threonine-protein kinase ..:Immunoglobulin gamma-1 heavy chain[208 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Ras-related protein M-Ras[174 aa]:Cadherin-1[213 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3').. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. PGS1_BOVIN:SLIT2_HUMAN:Q8KC98_CHLTE:CHAD_HUMAN:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Rab family protein[440 aa]:Chondroadherin[324 aa]:Chondroadherin[325 aa]:Chondroadherin[323 aa] PEG 3 3 2 8 4 1 4 6 6 9 3 2 0 3 5 8 10 12 2 7 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 104 L E b 3.9 7c76_A 4 0 0 0 2 0 0 6 2 72 3 2 0 0 0 0 0 6 0 0 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 105 N E b 9.1 7c76_A CADH1_MOUSE:CADH1_HUMAN:LYSC_CHICK:RU2B_SCHPO:SPZ_DROME:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:IGG1_HUMAN:CIF2_ARATH:LIMS1_HUMAN:Epithelial-cadherin[105 aa]:Lysozyme C[126 aa]:Lysozyme C[124 aa]:Lysozyme C[127 aa]:Lysozyme C[125 aa]:Probable U2 small nuclear ribonucleoprotein B'' [8..:PROTEIN SPAETZLE C-106[66 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Immunoglobulin gamma-1 heavy chain[208 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:LIM and senescent cell antigen-like-containing dom..:Cadherin-1[213 aa]:NbRoco2[116 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3').. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. PGS2_BOVIN:PGS1_BOVIN:SLIT2_HUMAN:Q8KC98_CHLTE:Decorin[305 aa]:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Rab family protein[440 aa] PEG:SO4:GOL:CIT:EDO 2 1 23 3 4 2 3 3 4 2 2 18 2 1 7 7 4 4 1 8 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 106 L b 3.9 7c76_A 2 4 0 0 4 0 0 7 0 64 6 0 0 0 0 0 0 9 0 0 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 107 Q T e 25.5 7c76_A ROBO1_HUMAN:LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:Q7Q5N3_ANOGA:A4IFT3_BOVIN:Q81JD7_BACAN:SPZ_DROME:RSPO1_HUMAN:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:LIMS1_HUMAN:ROUNDABOUT HOMOLOG 1[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[126 aa]:Lysozyme C[124 aa]:Lysozyme C[127 aa]:Lysozyme C[125 aa]:Leucine-rich Immune Molecule 1[482 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:BclA protein[136 aa]:PROTEIN SPAETZLE C-106[66 aa]:PROTEIN SPAETZLE C-106[68 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[66 aa]:Protein spaetzle C-106[63 aa]:Protein spaetzle C-106[65 aa]:flg22[21 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:Adhesion G protein-coupled receptor L3[263 aa]:LIM and senescent cell antigen-like-containing dom.. NAG alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SLIT2_HUMAN:Q8KC98_CHLTE:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Rab family protein[440 aa] PEG:SO4:GOL:CIT:ACT:PO4 6 1 8 5 2 3 2 2 5 1 1 8 2 10 3 32 4 2 2 3 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 108 H T e 38.7 7c76_A CADH1_HUMAN:LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:Q7Q5N3_ANOGA:Q81JD7_BACAN:LY96_MOUSE:SPZ_DROME:RSPO1_HUMAN:SERK2_ARATH:LPHN3_HUMAN:AGRL3_MOUSE:IGG1_HUMAN:LIMS1_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:PP1A_HUMAN:Epithelial-cadherin[105 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[127 aa]:Leucine-rich Immune Molecule 1[482 aa]:BclA protein[136 aa]:Lymphocyte antigen 96[135 aa]:PROTEIN SPAETZLE C-106[68 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[66 aa]:Protein spaetzle C-106[65 aa]:flg22[21 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:Somatic embryogenesis receptor kinase 2[185 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:Adhesion G protein-coupled receptor L3[263 aa]:Immunoglobulin gamma-1 heavy chain[208 aa]:LIM and senescent cell antigen-like-containing dom..:Lymphocyte antigen 96[136 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:synthetic nanobody Sb4[124 aa]:Serine/threonine-protein phosphatase PP1-alpha cat..:VHH10[119 aa] 46-MER:DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*..:DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG PT 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. PGS2_BOVIN:PGS1_BOVIN:Q8KC98_CHLTE:LRC8A_MOUSE:LRC8A_HUMAN:LRC26_HUMAN:C562_ECOLX:Decorin[305 aa]:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:Rab family protein[440 aa]:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Leucine-rich repeat-containing protein 26[262 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. SO4:GOL:PEG:CIT:EPE:ACT:MLI:PO4:EDO 2 1 6 5 2 10 19 0 5 2 1 15 0 4 7 8 2 1 1 8 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 109 N b 0.0 7c76_A UNC5D_RAT:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa] PEG:EPE:GOL:EDO 1 1 1 0 0 0 1 2 3 2 0 76 2 0 3 1 2 2 0 0 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 110 E e 43.7 7c76_A LY86_HUMAN:F1LW30_RAT:UNC5D_RAT:Lymphocyte antigen 86[139 aa]:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[106 aa]:synthetic nanobody Sb3[120 aa] 46-MER:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) CL LRC8A_HUMAN:LRC8A_MOUSE:LRC26_HUMAN:C562_ECOLX:Volume-regulated anion channel subunit LRRC8A[707 ..:Volume-regulated anion channel subunit LRRC8A[725 ..:Volume-regulated anion channel subunit LRRC8A[732 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Leucine-rich repeat-containing protein 26[242 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. PEG:EPE:SO4:GOL:EDO 7 1 4 9 3 4 3 1 13 3 1 16 5 11 9 6 2 0 1 2 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 111 L b 10.7 7c76_A LY86_HUMAN:A4IFT3_BOVIN:Lymphocyte antigen 86[139 aa]:LY86 protein[136 aa]:LY86 protein[138 aa]:LY86 protein[135 aa] NAG 0 0 0 0 11 0 0 20 4 45 3 0 4 0 0 3 4 4 0 0 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 112 S e 45.3 7c76_A LY86_HUMAN:A4IFT3_BOVIN:F1LW30_RAT:UNC5D_RAT:TGFB1_HUMAN:Lymphocyte antigen 86[139 aa]:LY86 protein[136 aa]:LY86 protein[138 aa]:LY86 protein[135 aa]:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[106 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[109 aa] 46-MER:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER) SO4 7 2 2 5 1 5 3 3 5 4 2 7 3 10 8 15 11 5 0 2 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 113 Q S e 74.0 7c76_A LY86_HUMAN:A4IFT3_BOVIN:UNC5D_RAT:Lymphocyte antigen 86[139 aa]:LY86 protein[136 aa]:LY86 protein[138 aa]:LY86 protein[135 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[262 aa]:Synthetic nanobody Sb1[114 aa] NAG Q96FE5_HUMAN:TLR8_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Toll-like receptor 8[754 aa]:Toll-like receptor 8[749 aa] SO4 4 3 6 8 3 15 4 2 8 4 2 2 2 14 5 6 4 3 0 3 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 114 L b 11.2 7c76_A Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[471 aa] SO4 3 0 0 2 5 2 4 18 2 33 3 2 5 2 2 4 2 8 3 0 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 115 S e 44.5 7c76_A Fab12 light chain[210 aa]:light chain (anti-TLR3)[107 aa] NAG Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa] SO4 7 0 5 4 1 4 3 8 3 4 0 3 34 3 3 11 4 1 0 2 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 116 D G e 25.3 7c76_A THRB_HUMAN:LY86_HUMAN:Prothrombin[250 aa]:Lymphocyte antigen 86[139 aa]:Fab12 light chain[210 aa]:Fab12 heavy chain[224 aa]:light chain (anti-TLR3)[107 aa]:heavy chain (anti-TLR3)[122 aa]:Synthetic nanobody Sb1[114 aa]:mAb12[228 aa] Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa] GOL:SO4 5 0 12 11 2 3 1 2 4 5 0 9 22 3 4 7 2 3 2 1 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 117 K G e 64.2 7c76_A THRB_HUMAN:Prothrombin[250 aa]:Fab12 light chain[210 aa]:light chain (anti-TLR3)[107 aa]:Synthetic nanobody Sb1[114 aa]:mAb12[228 aa] NAG CL alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[472 aa] GOL 6 0 9 12 2 12 2 1 7 5 1 5 4 4 8 11 5 3 1 2 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 118 T G b 7.1 7c76_A NAG alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. GOL 13 1 6 3 2 4 1 6 2 10 2 5 3 3 2 13 15 7 1 1 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 119 F G b 7.2 7c76_A 2 0 0 1 46 2 1 6 2 21 1 0 2 1 1 1 2 3 2 3 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 120 A S b 12.5 7c76_A THRB_HUMAN:Prothrombin[250 aa]:Fab12 light chain[210 aa]:light chain (anti-TLR3)[107 aa]:mAb12[228 aa] CL Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[472 aa] SO4:GOL 12 2 3 5 1 10 2 2 9 4 1 3 5 7 5 17 5 3 1 3 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 121 F S e 72.7 7c76_A Fab12 light chain[210 aa]:light chain (anti-TLR3)[107 aa]:Synthetic nanobody Sb1[114 aa] NAG ZN alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. SO4:GOL 4 1 6 4 7 16 4 4 4 13 1 11 2 3 4 7 2 2 1 3 REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 3":TOPO_DOM:/note="Lumenal" 122 C b 6.7 7c76_A GOL 4 11 0 1 1 2 1 3 0 39 4 2 8 1 0 8 3 6 2 1 MUTAGEN:/note="C->A: Reduced response to ds-RNA.":DISULFID::TOPO_DOM:/note="Lumenal":MUTAGEN:/note="C->A: Reduced response to ds-RNA.":DISULFID::TOPO_DOM:/note="Lumenal" 123 T e 33.1 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa] GOL:SO4 4 0 2 4 1 6 3 1 9 3 2 4 10 6 5 18 16 6 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 124 N e 30.9 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:Volume-regulated anion channel subunit LRRC8A[702 ..:Volume-regulated anion channel subunit LRRC8A[729 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. GOL:SO4 6 1 2 2 0 3 4 1 6 2 1 32 4 3 6 20 6 1 0 1 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 125 L b 2.2 7c76_A 1 1 0 0 1 0 0 7 0 77 2 1 1 0 0 1 1 4 0 0 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 126 T b 17.5 7c76_A VWF_HUMAN:SPZ_DROME:ERL1_ARATH:LIMS1_HUMAN:Q6J4H1_CHLRE:RASM_HUMAN:IGF1_HUMAN:LRC8A_MOUSE:C562_ECOLX:von Willebrand Factor[199 aa]:Von Willebrand factor[208 aa]:VON WILLEBRAND FACTOR[202 aa]:VON WILLEBRAND FACTOR[199 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:LRR receptor-like serine/threonine-protein kinase ..:LIM and senescent cell antigen-like-containing dom..:CPC1[1558 aa]:Ras-related protein M-Ras[174 aa]:Isoform 3 of Insulin-like growth factor I[65 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3').. NAG SLIT2_HUMAN:CHAD_HUMAN:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Chondroadherin[324 aa]:Chondroadherin[325 aa]:Chondroadherin[323 aa]:Volume-regulated anion channel subunit LRRC8A[706 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[732 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A[729 ..:Volume-regulated anion channel subunit LRRC8A,Solu..:Volume-regulated anion channel subunit LRRC8A[407 .. 5 0 1 16 3 1 2 2 8 5 1 2 2 16 10 4 17 6 1 0 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 127 E E e 28.1 7c76_A VWF_HUMAN:ROBO1_HUMAN:LYSC_CHICK:SPZ_DROME:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:ERL1_ARATH:CIF2_ARATH:RASM_HUMAN:LRC8A_MOUSE:C562_ECOLX:von Willebrand Factor[199 aa]:Von Willebrand factor[208 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:Lysozyme C[126 aa]:Lysozyme C[124 aa]:Lysozyme C[127 aa]:Lysozyme C[125 aa]:OS1 peptide[11 aa]:PROTEIN SPAETZLE C-106[66 aa]:VON WILLEBRAND FACTOR[202 aa]:VON WILLEBRAND FACTOR[199 aa]:VON WILLEBRAND FACTOR[197 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:flg22[21 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:LRR receptor-like serine/threonine-protein kinase ..:Adhesion G protein-coupled receptor L3[263 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Ras-related protein M-Ras[175 aa]:Volume-regulated anion channel subunit LRRC8A,Solu..:NbRoco2[116 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3').. NAG PGS2_BOVIN:PGS1_BOVIN:SLIT2_HUMAN:LRC8A_MOUSE:Decorin[305 aa]:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Volume-regulated anion channel subunit LRRC8A[718 .. PEG:SO4:EDO 8 2 3 19 3 5 4 3 6 6 1 5 0 4 5 10 5 6 1 4 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 128 L E b 0.0 7c76_A SPZ_DROME:PROTEIN SPAETZLE C-106[66 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa] 2 1 4 0 5 2 0 4 0 67 3 0 0 0 2 2 2 4 0 0 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 129 H E e 23.0 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:ROBO1_HUMAN:LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:A4IFT3_BOVIN:Q81JD7_BACAN:SPZ_DROME:RSPO1_HUMAN:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:ERL1_ARATH:IGG1_HUMAN:LIMS1_HUMAN:E-CADHERIN[105 aa]:Epithelial-cadherin[105 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[126 aa]:Lysozyme C[124 aa]:Lysozyme C[127 aa]:Lysozyme C[125 aa]:OS1 peptide[11 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:BclA protein[136 aa]:PROTEIN SPAETZLE C-106[66 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:flg22[21 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:LRR receptor-like serine/threonine-protein kinase ..:Immunoglobulin gamma-1 heavy chain[208 aa]:LIM and senescent cell antigen-like-containing dom..:Lymphocyte antigen 96[136 aa]:NbRoco2[116 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') :DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. PGS2_BOVIN:PGS1_BOVIN:SLIT2_HUMAN:LGR4_XENTR:Q8KC98_CHLTE:Decorin[305 aa]:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Leucine-rich repeat-containing G-protein coupled r..:Rab family protein[440 aa] SO4:PEG:EDO:PO4 3 1 13 6 4 3 10 3 2 6 0 6 0 6 10 10 3 6 1 7 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 130 L b 5.6 7c76_A 8 2 4 2 4 1 2 8 4 50 4 0 0 0 3 0 0 5 1 2 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 131 M b 11.1 7c76_A CADH1_HUMAN:ROBO1_HUMAN:LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:A4IFT3_BOVIN:Q81JD7_BACAN:SPZ_DROME:RSPO1_HUMAN:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:LIMS1_HUMAN:Epithelial-cadherin; E-Cad/CTF1[105 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:OS1 peptide[11 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:BclA protein[136 aa]:PROTEIN SPAETZLE C-106[66 aa]:PROTEIN SPAETZLE C-106[68 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[66 aa]:Protein spaetzle C-106[63 aa]:Protein spaetzle C-106[65 aa]:flg22[21 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:LIM and senescent cell antigen-like-containing dom..:synthetic nanobody Sb4[124 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') :DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') NAG ZN alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. PGS2_BOVIN:SLIT2_HUMAN:Decorin[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa] FLC:SO4:PEG:ACT:PO4 5 2 5 2 1 5 3 5 4 10 4 10 2 5 6 18 2 7 1 2 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 132 S S b 19.5 7c76_A CADH1_HUMAN:CADH1_MOUSE:ROBO1_HUMAN:LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:Q7Q5N3_ANOGA:A4IFT3_BOVIN:Q81JD7_BACAN:SPZ_DROME:RSPO1_HUMAN:LPHN3_MOUSE:LIMS1_HUMAN:PP1G_HUMAN:PP1A_HUMAN:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[107 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[126 aa]:Leucine-rich Immune Molecule 1[482 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:BclA protein[136 aa]:PROTEIN SPAETZLE C-106[68 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[66 aa]:Protein spaetzle C-106[65 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:Latrophilin-3[267 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:LIM and senescent cell antigen-like-containing dom..:synthetic nanobody Sb4[124 aa]:Serine/threonine-protein phosphatase PP1-gamma cat..:Serine/threonine-protein phosphatase PP1-alpha cat..:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:RNA (46-MER) NAG alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. INLA_LISMO:PGS2_BOVIN:LRC8A_HUMAN:LRC8A_MOUSE:LRC26_HUMAN:C562_ECOLX:INTERNALIN A[462 aa]:Decorin[305 aa]:Volume-regulated anion channel subunit LRRC8A[707 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Leucine-rich repeat-containing protein 26[263 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. FLC:ACT:PO4:GOL 5 1 11 6 2 7 6 4 3 4 0 10 0 6 5 18 5 2 1 3 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 133 N b 0.0 7c76_A F1LW30_RAT:PROTEIN UNC5D[106 aa]:MHG-8 Fab light chain[212 aa]:MHG-8 Fab light chain[104 aa]:Anti-internalin A VHH24[121 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4:PEG 2 3 2 1 0 3 2 2 4 4 0 59 4 0 2 7 4 2 0 0 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 134 S e 41.4 7c76_A F1LW30_RAT:UNC5D_RAT:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[106 aa]:synthetic nanobody Sb3[120 aa] NAG CL beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. LRC8A_HUMAN:LRC8A_MOUSE:LRC26_HUMAN:C562_ECOLX:Volume-regulated anion channel subunit LRRC8A[707 ..:Volume-regulated anion channel subunit LRRC8A[725 ..:Volume-regulated anion channel subunit LRRC8A[732 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. SO4 6 3 2 4 2 4 4 1 11 5 2 11 5 8 9 15 5 2 0 1 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" S->P:US:-: -; 135 I b 1.2 7c76_A DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4:PEG 2 1 0 2 6 2 0 27 0 36 3 3 2 1 0 2 2 7 0 2 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 136 Q e 59.2 7c76_A F1LW30_RAT:UNC5D_RAT:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[106 aa]:MHG-8 Fab light chain[212 aa]:MHG-8 Fab light chain[104 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') NAG alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. Q96FE5_HUMAN:TLR9_MOUSE:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:Leucine rich repeat neuronal 6A[473 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Volume-regulated anion channel subunit LRRC8A[707 ..:Volume-regulated anion channel subunit LRRC8A[725 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. PEG:SO4:GOL 4 0 4 10 2 4 4 1 4 2 3 7 2 12 10 13 10 4 1 4 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 137 K e 60.8 7c76_A LY86_HUMAN:A4IFT3_BOVIN:SERK2_ARATH:A0A1W2PRB0_HUMAN:Lymphocyte antigen 86[139 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:Somatic embryogenesis receptor kinase 2[185 aa]:MHG-8 Fab light chain[212 aa]:MHG-8 Fab light chain[104 aa]:Calcium-activated potassium channel subunit alpha-..:Synthetic nanobody Sb1[114 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') NAG Q96FE5_HUMAN:TLR9_MOUSE:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa] GOL:SO4 5 1 3 7 4 11 3 2 10 4 1 2 3 4 10 13 8 5 0 3 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 138 I b 12.3 7c76_A MHG-8 Fab light chain[212 aa]:MHG-8 Fab light chain[104 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL:CIT:SO4 2 2 1 1 5 2 0 25 2 30 2 1 2 3 2 4 3 12 0 1 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 139 K e 42.9 7c76_A LY86_HUMAN:A4IFT3_BOVIN:Lymphocyte antigen 86[139 aa]:LY86 protein[136 aa]:LY86 protein[138 aa]:LY86 protein[135 aa]:Fab12 light chain[210 aa]:light chain (anti-TLR3)[107 aa]:MHG-8 Fab light chain[212 aa]:MHG-8 Fab light chain[104 aa]:mAb12[228 aa] NAG Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa] SO4:GOL 5 1 7 9 1 4 2 10 6 7 1 2 21 4 7 5 3 2 0 1 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 140 N S e 42.4 7c76_A THRB_HUMAN:LY86_HUMAN:A4IFT3_BOVIN:Prothrombin[250 aa]:Lymphocyte antigen 86[139 aa]:LY86 protein[136 aa]:LY86 protein[138 aa]:LY86 protein[135 aa]:Fab12 light chain[210 aa]:light chain (anti-TLR3)[107 aa]:mAb12[228 aa] NAG TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[659 aa] SO4:GOL:CIT 6 1 11 8 2 4 2 2 6 4 0 9 18 2 4 9 4 5 0 2 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 141 N b 13.9 7c76_A THRB_HUMAN:Prothrombin[250 aa]:Light Chain of Li81 Fab, kappa 3[214 aa]:Heavy Chain of Li81 Fab, VH3-23[221 aa]:light chain (anti-TLR3)[107 aa]:heavy chain (anti-TLR3)[122 aa]:Synthetic nanobody Sb1[114 aa] NAG CL Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa] GOL:SO4:PEG 6 2 8 6 4 12 4 2 3 6 0 13 4 3 4 13 3 3 0 3 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 142 P S b 0.8 7c76_A GOL:PEG:SO4 8 3 4 4 3 5 5 6 3 5 3 4 23 3 3 4 3 5 3 4 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 143 F S b 0.0 7c76_A PEG 6 6 0 6 6 6 0 6 6 6 6 0 6 6 6 6 6 6 6 0 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 144 V e 30.0 7c76_A THRB_HUMAN:Prothrombin[250 aa]:Fab12 heavy chain[224 aa]:Heavy Chain of Li81 Fab, VH3-23[221 aa]:heavy chain (anti-TLR3)[122 aa]:Synthetic nanobody Sb1[114 aa]:mAb12[228 aa] NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa] GOL:PEG:SO4 8 4 5 5 5 7 4 4 4 7 1 5 2 6 7 9 5 8 2 2 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 145 K S e 46.7 7c76_A THRB_HUMAN:Prothrombin[250 aa]:Fab12 light chain[210 aa]:Fab12 heavy chain[224 aa]:light chain (anti-TLR3)[107 aa]:heavy chain (anti-TLR3)[122 aa]:mAb12[228 aa] NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa] SO4:PEG 5 4 7 7 2 16 3 3 7 4 2 6 4 5 7 7 5 3 0 2 REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 4":TOPO_DOM:/note="Lumenal" 146 Q b 2.0 7c76_A 4 4 2 3 4 2 2 3 3 35 5 4 4 4 3 5 4 3 2 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 147 K T e 63.7 7c76_A NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. Q96FE5_HUMAN:LGR4_XENTR:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Leucine-rich repeat-containing G-protein coupled r..:Volume-regulated anion channel subunit LRRC8A[702 ..:Volume-regulated anion channel subunit LRRC8A[706 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[729 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A[407 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. SO4 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 0 5 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 148 N T e 43.0 7c76_A ERL1_ARATH:Q6J4H1_CHLRE:IGF1_HUMAN:LRR receptor-like serine/threonine-protein kinase ..:CPC1[1558 aa]:CPC1[1184 aa]:CPC1[1498 aa]:CPC1[1485 aa]:Isoform 3 of Insulin-like growth factor I[65 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:LGR4_XENTR:Toll-like receptor 8[747 aa]:Leucine-rich repeat-containing G-protein coupled r.. SO4 8 2 2 3 3 6 3 4 9 4 2 21 2 10 6 8 3 2 0 2 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 149 L b 0.6 7c76_A Q6J4H1_CHLRE:CPC1[1558 aa]:CPC1[1184 aa]:CPC1[1322 aa]:CPC1[1498 aa]:CPC1[1485 aa] 7 7 0 0 0 7 0 7 7 7 7 7 7 7 0 7 7 7 0 7 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 150 I e 25.7 7c76_A THRB_HUMAN:ERL1_ARATH:IGG1_HUMAN:SLB2_DEIAC:IGF1_HUMAN:Human Alpha Thrombin[259 aa]:THROMBIN BETA-CHAIN[259 aa]:LRR receptor-like serine/threonine-protein kinase ..:Immunoglobulin gamma-1 heavy chain[208 aa]:Snaclec agglucetin subunit beta-2[124 aa]:Isoform 3 of Insulin-like growth factor I[65 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3').. NAG alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. SLIT2_HUMAN:LGR4_XENTR:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Leucine-rich repeat-containing G-protein coupled r..:Volume-regulated anion channel subunit LRRC8A[702 ..:Volume-regulated anion channel subunit LRRC8A[707 ..:Volume-regulated anion channel subunit LRRC8A[725 ..:Volume-regulated anion channel subunit LRRC8A[706 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[732 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. EDO 4 1 2 8 4 3 2 8 7 13 4 3 1 4 12 5 7 7 2 3 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 151 T E e 21.4 7c76_A VWF_HUMAN:CAD1_HUMAN:THRB_HUMAN:CADH1_HUMAN:ROBO1_HUMAN:SPZ_DROME:RSPO1_HUMAN:ERL1_ARATH:AGRL3_MOUSE:IGG1_HUMAN:LIMS1_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:IGF1_HUMAN:LRC8A_MOUSE:C562_ECOLX:von Willebrand Factor[199 aa]:E-CADHERIN[105 aa]:Human Alpha Thrombin[259 aa]:Prothrombin[250 aa]:Von Willebrand factor (vWF) [Contains: Von Willebr..:Von Willebrand factor[208 aa]:Epithelial-cadherin[105 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:OS1 peptide[11 aa]:THROMBIN BETA-CHAIN[259 aa]:PROTEIN SPAETZLE C-106[66 aa]:VON WILLEBRAND FACTOR[202 aa]:VON WILLEBRAND FACTOR[199 aa]:VON WILLEBRAND FACTOR[197 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:LRR receptor-like serine/threonine-protein kinase ..:Adhesion G protein-coupled receptor L3[263 aa]:Immunoglobulin gamma-1 heavy chain[208 aa]:LIM and senescent cell antigen-like-containing dom..:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Isoform 3 of Insulin-like growth factor I[65 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') :DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3').. NAG MG:CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. PGS2_BOVIN:PGS1_BOVIN:SLIT2_HUMAN:LGR4_XENTR:CHAD_HUMAN:LRC8A_MOUSE:Decorin[305 aa]:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Leucine-rich repeat-containing G-protein coupled r..:Chondroadherin[324 aa]:Chondroadherin[325 aa]:Chondroadherin[323 aa]:Volume-regulated anion channel subunit LRRC8A[732 ..:Volume-regulated anion channel subunit LRRC8A[718 .. SO4:EDO 3 2 3 11 3 3 4 5 6 5 2 3 4 6 4 12 7 12 2 5 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 152 L E b 0.0 7c76_A SPZ_DROME:RSPO1_HUMAN:PROTEIN SPAETZLE C-106[66 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:R-spondin-1[79 aa] PGS1_BOVIN:Biglycan[303 aa]:Biglycan[305 aa] 3 3 0 1 4 4 0 6 1 61 3 0 0 0 0 1 4 8 0 0 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 153 D E b 6.2 7c76_A ROBO1_HUMAN:LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:A4IFT3_BOVIN:SPZ_DROME:RSPO1_HUMAN:LPHN3_HUMAN:ERL1_ARATH:AGRL3_MOUSE:IGG1_HUMAN:CIF2_ARATH:LIMS1_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:RASM_HUMAN:ROUNDABOUT HOMOLOG 1[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[127 aa]:OS1 peptide[11 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:PROTEIN SPAETZLE C-106[66 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:Protein spaetzle C-106[65 aa]:flg22[21 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:Latrophilin-3[247 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:LRR receptor-like serine/threonine-protein kinase ..:Adhesion G protein-coupled receptor L3[263 aa]:Immunoglobulin gamma-1 heavy chain[208 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:LIM and senescent cell antigen-like-containing dom..:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Ras-related protein M-Ras[175 aa]:Ras-related protein M-Ras[173 aa]:Ras-related protein M-Ras[169 aa]:Ras-related protein M-Ras[174 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. NAG ZN 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. PGS2_BOVIN:PGS1_BOVIN:SLIT2_HUMAN:LGR4_XENTR:Q8KC98_CHLTE:Decorin[305 aa]:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:SLIT HOMOLOG 2 PROTEIN C-PRODUCT[181 aa]:Leucine-rich repeat-containing G-protein coupled r..:Rab family protein[440 aa] SO4:GOL:EDO 2 1 29 10 2 2 3 4 4 2 4 7 4 2 3 9 2 2 2 4 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 154 L b 1.1 7c76_A Q81JD7_BACAN:BclA protein[136 aa] FLC 4 2 0 0 4 0 0 4 0 53 6 0 2 0 2 3 3 11 2 0 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 155 S T b 6.2 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:ROBO1_HUMAN:LY96_MOUSE:SPZ_DROME:RSPO1_HUMAN:LIMS1_HUMAN:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:Lymphocyte antigen 96[135 aa]:PROTEIN SPAETZLE C-106[68 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[66 aa]:Protein spaetzle C-106[65 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:Lymphocyte antigen 96[137 aa]:LIM and senescent cell antigen-like-containing dom..:Lymphocyte antigen 96[136 aa]:Cadherin-1[213 aa]:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') :DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. NAG ZN:CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. LRC26_HUMAN:Leucine-rich repeat-containing protein 26[242 aa] FLC:SO4:GOL 14 1 7 4 2 8 2 0 3 2 2 4 1 6 5 32 3 1 0 2 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 156 H T e 50.8 7c76_A LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:Q7Q5N3_ANOGA:A4IFT3_BOVIN:Q81JD7_BACAN:SPZ_DROME:RSPO1_HUMAN:BAK1_ARATH:F1LW30_RAT:UNC5D_RAT:LIMS1_HUMAN:PP1G_HUMAN:PP1A_HUMAN:IBP3_HUMAN:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[127 aa]:Leucine-rich Immune Molecule 1[482 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:BclA protein[136 aa]:PROTEIN SPAETZLE C-106[68 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[66 aa]:Protein spaetzle C-106[65 aa]:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:R-spondin-1[79 aa]:R-spondin-1[78 aa]:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[106 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:LIM and senescent cell antigen-like-containing dom..:synthetic nanobody Sb4[124 aa]:Serine/threonine-protein phosphatase PP1-gamma cat..:Serine/threonine-protein phosphatase PP1-alpha cat..:Insulin-like growth factor-binding protein 3[167 a..:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') :DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*..:DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') NAG NA alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. CD180_HUMAN:LRC8A_MOUSE:LRC26_HUMAN:CD180 antigen[601 aa]:Volume-regulated anion channel subunit LRRC8A[718 ..:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] FLC:SO4:EDO 4 1 10 6 8 10 12 2 3 7 1 10 2 3 3 5 3 1 1 8 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 157 N S b 4.2 7c76_A LYSC_CHICK:Q81JD7_BACAN:F1LW30_RAT:UNC5D_RAT:Lysozyme C[127 aa]:BclA protein[136 aa]:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[106 aa]:Anti-internalin A VHH24[121 aa] NAG NA alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. CD180_HUMAN:LRC8A_MOUSE:LRC8A_HUMAN:CD180 antigen[601 aa]:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[730 .. SO4:EDO 1 1 3 7 0 2 0 2 2 4 2 64 0 5 2 2 2 0 0 0 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 158 G b 8.3 7c76_A F1LW30_RAT:UNC5D_RAT:TGFB1_HUMAN:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[106 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[109 aa]:Anti-internalin A VHH24[121 aa] NAG NA beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. CD180_HUMAN:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:CD180 antigen[601 aa]:Volume-regulated anion channel subunit LRRC8A[707 ..:Volume-regulated anion channel subunit LRRC8A[725 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[732 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. 3 2 4 7 2 18 4 4 7 4 1 9 3 6 7 11 3 1 0 4 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 159 L b 1.1 7c76_A TLR8_HUMAN:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa] 1 0 0 3 5 0 0 16 0 54 5 2 3 1 0 0 1 6 0 1 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 160 S S e 59.4 7c76_A F1LW30_RAT:UNC5D_RAT:TGFB1_HUMAN:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[106 aa]:Transforming growth factor beta-1[111 aa]:MHG-8 Fab heavy chain[214 aa]:Transforming growth factor beta-1[109 aa]:MHG-8 Fab heavy chain[118 aa] NAG Q96FE5_HUMAN:CD180_HUMAN:A6QNK7_BOVIN:TLR8_HUMAN:LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:CD180 antigen[601 aa]:CD180 molecule[594 aa]:CD180 molecule[592 aa]:CD180 molecule[397 aa]:CD180 molecule[593 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. GOL:PO4 3 2 4 6 4 2 4 2 5 3 1 2 2 5 11 17 15 9 1 1 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 161 S S e 35.2 7c76_A Q81JD7_BACAN:BclA protein[136 aa]:MHG-8 Fab heavy chain[214 aa]:MHG-8 Fab heavy chain[118 aa] NAG Q96FE5_HUMAN:TLR8_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa] GOL:PO4 8 2 5 8 2 10 2 3 6 4 2 9 3 3 3 15 5 4 0 5 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 162 T b 1.9 7c76_A MHG-8 Fab light chain[212 aa]:MHG-8 Fab heavy chain[214 aa]:MHG-8 Fab light chain[104 aa]:MHG-8 Fab heavy chain[118 aa] SO4 6 1 2 4 2 3 1 18 2 19 1 2 2 3 4 8 10 9 0 1 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 163 K e 26.9 7c76_A TGFB1_HUMAN:heavy chain (anti-TLR3)[122 aa]:Transforming growth factor beta-1[111 aa]:MHG-8 Fab heavy chain[214 aa]:Transforming growth factor beta-1[109 aa]:MHG-8 Fab heavy chain[118 aa] Q96FE5_HUMAN:TLR8_HUMAN:Leucine rich repeat neuronal 6A[471 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa] SO4:GOL 7 2 5 8 4 6 1 7 10 4 1 4 18 4 5 8 2 3 1 2 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 164 L b 0.0 7c76_A ZN MES:SO4:GOL 5 1 4 5 2 2 2 9 3 24 1 4 14 1 4 5 3 8 2 1 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 165 G b 1.2 7c76_A Fab12 heavy chain[224 aa]:Heavy Chain of Li81 Fab, VH3-23[221 aa]:heavy chain (anti-TLR3)[122 aa]:MHG-8 Fab light chain[212 aa]:MHG-8 Fab heavy chain[214 aa]:MHG-8 Fab light chain[104 aa]:MHG-8 Fab heavy chain[118 aa] NAG Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa] MES:SO4:GOL 6 1 9 7 2 28 3 2 3 5 1 6 8 3 7 5 4 1 0 1 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 166 T S e 50.0 7c76_A Fab12 heavy chain[224 aa]:heavy chain (anti-TLR3)[122 aa]:light chain (anti-TLR3)[107 aa]:MHG-8 Fab light chain[212 aa]:MHG-8 Fab heavy chain[214 aa]:MHG-8 Fab light chain[104 aa]:MHG-8 Fab heavy chain[118 aa]:mAb12[228 aa] NAG SO4:GOL 17 2 5 5 1 4 1 4 3 7 2 3 6 1 3 15 14 4 1 0 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 167 Q S e 54.1 7c76_A Fab12 heavy chain[224 aa]:heavy chain (anti-TLR3)[122 aa]:mAb12[228 aa] NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. ACY:MES:SO4 3 1 2 4 24 6 0 6 6 20 2 2 4 3 1 5 2 3 1 3 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 168 V S e 53.3 7c76_A Fab12 heavy chain[224 aa]:heavy chain (anti-TLR3)[122 aa]:MHG-8 Fab light chain[212 aa]:MHG-8 Fab light chain[104 aa]:mAb12[228 aa] NAG Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa] ACY:MES 10 3 2 4 6 9 1 4 4 9 1 3 4 8 7 8 5 9 1 3 REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 5":TOPO_DOM:/note="Lumenal" 169 Q b 3.6 7c76_A Light Chain of Li81 Fab, kappa 3[214 aa] NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. ACY 6 0 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 0 0 6 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 170 L b 3.4 7c76_A 3 6 0 2 7 2 1 5 2 48 4 2 2 2 0 4 2 5 1 0 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 171 E T e 39.7 7c76_A THRB_HUMAN:SLB2_DEIAC:Human Alpha Thrombin[259 aa]:THROMBIN BETA-CHAIN[259 aa]:Light Chain of Li81 Fab, kappa 3[214 aa]:Snaclec agglucetin subunit beta-2[124 aa] NAG PT Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa] 3 0 2 18 2 2 3 2 9 5 0 2 16 4 6 10 7 8 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 172 N T e 48.5 7c76_A THRB_HUMAN:SLB2_DEIAC:RASM_HUMAN:Human Alpha Thrombin[259 aa]:Snaclec agglucetin subunit beta-2[124 aa]:Ras-related protein M-Ras[175 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LGR4_XENTR:LRC8A_MOUSE:LRC8A_HUMAN:C562_ECOLX:Leucine-rich repeat-containing G-protein coupled r..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A[729 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. GOL:EDO 6 3 3 3 3 4 3 4 4 3 5 17 3 3 4 20 4 3 0 5 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 173 L b 0.0 7c76_A THRB_HUMAN:Prothrombin[250 aa] 1 0 1 11 10 11 0 11 1 11 10 0 11 0 1 1 11 11 0 0 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 174 Q e 31.1 7c76_A VWF_HUMAN:THRB_HUMAN:RSPO1_HUMAN:ERL1_ARATH:CIF2_ARATH:LRC8A_MOUSE:C562_ECOLX:von Willebrand Factor[199 aa]:Human Alpha Thrombin[259 aa]:Prothrombin[250 aa]:Von Willebrand factor (vWF) [Contains: Von Willebr..:Von Willebrand factor[208 aa]:THROMBIN BETA-CHAIN[259 aa]:VON WILLEBRAND FACTOR[202 aa]:VON WILLEBRAND FACTOR[199 aa]:VON WILLEBRAND FACTOR[197 aa]:R-spondin-1[90 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:LRR receptor-like serine/threonine-protein kinase ..:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PGS1_BOVIN:TLR8_HUMAN:LGR4_XENTR:LRC8A_HUMAN:LRC8A_MOUSE:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:Toll-like receptor 8[747 aa]:Leucine-rich repeat-containing G-protein coupled r..:Volume-regulated anion channel subunit LRRC8A[702 ..:Volume-regulated anion channel subunit LRRC8A[707 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[732 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A[729 .. SO4:EDO 9 0 3 7 0 4 3 3 8 4 3 3 3 18 6 9 5 4 0 3 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 175 E E b 19.1 7c76_A VWF_HUMAN:ROBO1_HUMAN:RSPO1_HUMAN:LPHN3_HUMAN:AGRL3_MOUSE:ERL1_ARATH:IGG1_HUMAN:CIF2_ARATH:LIMS1_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:IGF1_HUMAN:von Willebrand Factor[199 aa]:Von Willebrand factor (vWF) [Contains: Von Willebr..:Von Willebrand factor[208 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:VON WILLEBRAND FACTOR[202 aa]:VON WILLEBRAND FACTOR[199 aa]:VON WILLEBRAND FACTOR[197 aa]:R-spondin-1[90 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:LRR receptor-like serine/threonine-protein kinase ..:Immunoglobulin gamma-1 heavy chain[208 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:LIM and senescent cell antigen-like-containing dom..:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Isoform 3 of Insulin-like growth factor I[65 aa] NAG MG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(2-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. PGS1_BOVIN:LGR4_XENTR:Q8KC98_CHLTE:CHAD_HUMAN:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:Leucine-rich repeat-containing G-protein coupled r..:Rab family protein[440 aa]:Chondroadherin[324 aa]:Chondroadherin[325 aa]:Chondroadherin[323 aa] SO4:EDO 5 2 5 15 2 2 6 5 10 4 2 3 3 4 4 7 8 9 2 4 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 176 L E b 1.1 7c76_A RSPO1_HUMAN:R-spondin-1[103 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa] LGR4_XENTR:Leucine-rich repeat-containing G-protein coupled r.. 9 8 0 1 9 9 0 9 0 9 9 0 9 0 0 9 9 9 0 0 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 177 L E b 16.9 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:ROBO1_HUMAN:SPZ_DROME:RSPO1_HUMAN:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:LY96_MOUSE:ERL1_ARATH:IGG1_HUMAN:CIF2_ARATH:LIMS1_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:ROUNDABOUT HOMOLOG 1[107 aa]:OS1 peptide[11 aa]:PROTEIN SPAETZLE C-106[66 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[63 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:LRR receptor-like serine/threonine-protein kinase ..:Adhesion G protein-coupled receptor L3[263 aa]:Immunoglobulin gamma-1 heavy chain[208 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:LIM and senescent cell antigen-like-containing dom..:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Cadherin-1[213 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. NAG ZN:CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(2-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. PGS1_BOVIN:LGR4_XENTR:Biglycan[303 aa]:Biglycan[304 aa]:Biglycan[305 aa]:Leucine-rich repeat-containing G-protein coupled r.. FLC:SO4:CIT 2 1 9 2 3 2 8 9 2 14 2 7 0 2 10 5 8 5 2 6 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 178 L b 0.0 7c76_A 4 2 0 0 4 1 0 10 2 55 2 0 0 2 0 4 3 6 1 2 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 179 S b 6.2 7c76_A LY96_MOUSE:LY86_HUMAN:LY96_HUMAN:SPZ_DROME:LPHN3_MOUSE:LPHN3_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:PP1A_HUMAN:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:PROTEIN SPAETZLE C-106[66 aa]:PROTEIN SPAETZLE C-106[68 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[66 aa]:Protein spaetzle C-106[63 aa]:Protein spaetzle C-106[65 aa]:flg22[21 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Serine/threonine-protein phosphatase PP1-alpha cat..:Anti-internalin A VHH24[121 aa] NAG CL:ZN beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(2-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. LRC26_HUMAN:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa] FLC:EDO 11 1 5 8 2 8 4 0 6 8 1 6 0 4 5 19 3 3 1 4 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 180 N S e 38.8 7c76_A LY86_HUMAN:LY96_HUMAN:LYSC_CHICK:A4IFT3_BOVIN:LY96_MOUSE:SPZ_DROME:RSPO1_HUMAN:F1LW30_RAT:UNC5D_RAT:TGFB1_HUMAN:PP1A_HUMAN:Lymphocyte antigen 86[139 aa]:Lymphocyte antigen 96[140 aa]:Lysozyme C[127 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:Lymphocyte antigen 96[135 aa]:PROTEIN SPAETZLE C-106[66 aa]:PROTEIN SPAETZLE C-106[68 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[64 aa]:Protein spaetzle C-106[66 aa]:Protein spaetzle C-106[63 aa]:Protein spaetzle C-106[65 aa]:flg22[21 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[106 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[109 aa]:Lymphocyte antigen 96[136 aa]:Serine/threonine-protein phosphatase PP1-alpha cat..:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') NAG NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. LRC8A_MOUSE:LRC26_HUMAN:Volume-regulated anion channel subunit LRRC8A[718 ..:Leucine-rich repeat-containing protein 26[262 aa]:Leucine-rich repeat-containing protein 26[263 aa] SO4:GOL:PO4:EDO 2 2 5 6 1 10 5 1 5 5 1 26 0 3 7 7 6 2 1 5 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 181 N S b 2.4 7c76_A LYSC_CHICK:F1LW30_RAT:UNC5D_RAT:TGFB1_HUMAN:Lysozyme C[127 aa]:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[106 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[109 aa] LRC26_HUMAN:Leucine-rich repeat-containing protein 26[242 aa] SO4 2 4 2 0 2 4 2 2 6 6 0 62 0 0 0 6 3 0 0 0 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 182 K e 47.2 7c76_A LYSC_CHICK:SPZ_DROME:F1LW30_RAT:UNC5D_RAT:TGFB1_HUMAN:Lysozyme C[127 aa]:PROTEIN SPAETZLE C-106[68 aa]:Protein spaetzle C-106[66 aa]:Protein spaetzle C-106[65 aa]:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[106 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[109 aa]:synthetic nanobody Sb4[124 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. Q96FE5_HUMAN:CD180_HUMAN:A6QNK7_BOVIN:LRC8A_HUMAN:LRC8A_MOUSE:LRC26_HUMAN:C562_ECOLX:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:CD180 antigen[601 aa]:CD180 molecule[599 aa]:CD180 molecule[594 aa]:CD180 molecule[592 aa]:CD180 molecule[397 aa]:CD180 molecule[593 aa]:Volume-regulated anion channel subunit LRRC8A[707 ..:Volume-regulated anion channel subunit LRRC8A[725 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[732 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Leucine-rich repeat-containing protein 26[263 aa]:Leucine-rich repeat-containing protein 26[242 aa]:Volume-regulated anion channel subunit LRRC8A,Solu..:Volume-regulated anion channel subunit LRRC8A[407 .. SO4:PEG 8 0 3 4 1 5 3 2 16 8 2 10 3 6 16 5 3 1 0 3 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 183 I b 0.0 7c76_A Q7Q5N3_ANOGA:Leucine-rich Immune Molecule 1[482 aa] 0 0 0 0 12 2 1 27 3 34 4 2 0 0 3 3 1 4 0 1 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 184 Q e 39.8 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[111 aa]:MHG-8 Fab heavy chain[214 aa]:Transforming growth factor beta-1[109 aa]:MHG-8 Fab heavy chain[118 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. Q96FE5_HUMAN:CD180_HUMAN:A6QNK7_BOVIN:LRC8A_HUMAN:LRC8A_MOUSE:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[470 aa]:CD180 antigen[601 aa]:CD180 molecule[599 aa]:CD180 molecule[594 aa]:CD180 molecule[592 aa]:CD180 molecule[397 aa]:CD180 molecule[593 aa]:Volume-regulated anion channel subunit LRRC8A[725 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[730 .. SO4:EDO 4 1 3 9 1 5 4 3 5 2 1 5 3 13 7 17 13 2 1 1 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 185 A E b 16.1 7c76_A MHG-8 Fab heavy chain[214 aa]:MHG-8 Fab heavy chain[118 aa] CD180_HUMAN:CD180 antigen[601 aa] SO4:EDO 11 1 2 4 4 18 3 1 4 4 2 9 3 2 3 13 7 4 1 3 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 186 L E b 0.6 7c76_A EDO:SO4 3 0 1 2 6 3 2 20 0 33 4 2 2 2 1 2 5 11 1 1 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 187 K e 38.7 7c76_A MHG-8 Fab heavy chain[214 aa]:MHG-8 Fab heavy chain[118 aa] SO4:EDO 6 1 5 6 1 4 1 9 12 3 0 2 26 4 5 7 3 2 0 2 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 188 S H e 20.3 7c76_A Fab12 heavy chain[224 aa]:heavy chain (anti-TLR3)[122 aa]:MHG-8 Fab heavy chain[214 aa]:MHG-8 Fab heavy chain[118 aa] NAG ZN beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. GOL:SO4 5 1 6 7 4 3 2 4 4 5 1 5 19 4 5 14 6 3 0 1 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 189 E H e 65.8 7c76_A Fab12 heavy chain[224 aa]:heavy chain (anti-TLR3)[122 aa]:MHG-8 Fab heavy chain[214 aa]:MHG-8 Fab heavy chain[118 aa] NAG ZN GOL:SO4 6 0 6 19 1 7 5 4 9 4 2 5 6 4 3 10 3 2 0 2 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 190 E H b 15.6 7c76_A 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 9 0 9 18 2 5 3 3 4 5 2 2 8 5 2 10 7 3 1 2 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 191 L H b 5.1 7c76_A 4 1 2 3 14 3 1 8 4 31 2 2 5 2 2 4 2 7 0 1 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 192 D G e 47.5 7c76_A Fab12 heavy chain[224 aa]:heavy chain (anti-TLR3)[122 aa]:mAb12[228 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL 8 1 16 8 1 11 3 2 5 3 2 6 3 6 8 11 3 3 0 1 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 193 I G b 1.2 7c76_A Fab12 heavy chain[224 aa]:heavy chain (anti-TLR3)[122 aa] NAG Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa] 5 1 4 2 10 6 2 16 4 19 1 4 4 2 3 4 3 7 1 1 REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 6":TOPO_DOM:/note="Lumenal" 194 F G b 0.5 7c76_A NAG 3 2 1 1 18 6 1 2 1 29 2 3 2 2 3 7 6 4 1 5 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 195 A T e 38.4 7c76_A Light Chain of Li81 Fab, kappa 3[214 aa]:mAb12[228 aa] NAG:RX8:IDQ:9K3:L07:C09:9JR:EWL:EWU:EWX beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B3Y653_MACMU:Toll-like receptor 7[772 aa] GOL 10 5 2 3 2 14 4 2 5 4 3 6 5 5 6 8 5 6 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 196 N T e 62.4 7c76_A LIMS1_HUMAN:LIM and senescent cell antigen-like-containing dom.. NAG 3 6 4 3 2 6 1 2 2 15 3 28 4 4 3 6 3 3 2 1 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":MUTAGEN:/note="N->G: Reduced expression levels; when associated with R-247.":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":MUTAGEN:/note="N->G: Reduced expression levels; when associated with R-247.":TOPO_DOM:/note="Lumenal" 197 S b 3.9 7c76_A LIMS1_HUMAN:LIM and senescent cell antigen-like-containing dom.. NAG:GMP:RX8:IDQ:6T0:9K3:L07:C09:9JR:9K9:ACK:23G:EWL:EWU:EWX:EX0 SO4 7 3 2 6 4 4 3 2 7 6 1 5 6 4 8 15 11 5 0 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 198 S E b 11.7 7c76_A LIMS1_HUMAN:LIM and senescent cell antigen-like-containing dom.. NAG NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. LRC8A_HUMAN:LRC8A_MOUSE:C562_ECOLX:Volume-regulated anion channel subunit LRRC8A[702 ..:Volume-regulated anion channel subunit LRRC8A[706 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[729 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A,Solu..:Volume-regulated anion channel subunit LRRC8A[407 .. EDO 6 2 2 7 3 3 4 2 8 3 1 11 4 6 6 22 6 2 1 2 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 199 L E b 1.1 7c76_A LIMS1_HUMAN:LIM and senescent cell antigen-like-containing dom.. NAG:9K9:ACK:23G NA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(2-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. 0 0 0 1 1 0 0 5 0 78 2 2 0 2 1 1 1 5 0 0 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 200 K S e 40.6 7c76_A RSPO1_HUMAN:ERL1_ARATH:CIF2_ARATH:LRC8A_MOUSE:C562_ECOLX:R-spondin-1[90 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:LRR receptor-like serine/threonine-protein kinase ..:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. NAG:RX8:IDQ:6T0:9K3:9JR:9K9:ACK:23G:EWL:EWU:EX0 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-.. LRC8A_HUMAN:LRC8A_MOUSE:Volume-regulated anion channel subunit LRRC8A[702 ..:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[732 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A[729 .. SO4:EDO 1 0 3 24 1 1 2 2 16 4 1 1 1 10 15 5 4 6 0 1 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 201 K E e 32.1 7c76_A RSPO1_HUMAN:LPHN3_MOUSE:LPHN3_HUMAN:AGRL3_MOUSE:CIF2_ARATH:LIMS1_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:R-spondin-1[90 aa]:R-spondin-1[103 aa]:flg22[21 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:Latrophilin-3[267 aa]:Latrophilin-3[247 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[365 aa]:ADHESION G PROTEIN-COUPLED RECEPTOR L3[368 aa]:Adhesion G protein-coupled receptor L3[263 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:LIM and senescent cell antigen-like-containing dom..:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') :DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. NAG:RX8:IDQ:6T0:9K3:9JR:EWL:EWU:EWX:EX0 CA alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PGS2_BOVIN:LGR4_XENTR:Decorin[305 aa]:Leucine-rich repeat-containing G-protein coupled r.. SO4 3 1 2 15 3 1 5 3 8 5 1 2 2 4 12 6 8 9 2 7 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 202 L E b 3.9 7c76_A GMP:RX8:IDQ:6T0:9K3:L07:C09:9JR:9K9:ACK:23G:EWL:EWU:EWX:EX0 SO4 2 1 0 0 1 0 0 4 0 83 1 1 0 1 2 0 0 3 0 1 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 203 E E b 15.1 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:LY96_MOUSE:RSPO1_HUMAN:SPZ_DROME:CIF2_ARATH:LIMS1_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 96[135 aa]:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Protein spaetzle C-106[64 aa]:flg22[21 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:LIM and senescent cell antigen-like-containing dom..:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Cadherin-1[213 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') :DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. NAG CA:CL:ZN 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(2-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-.. PGS2_BOVIN:LGR4_XENTR:CHAD_HUMAN:Decorin[305 aa]:Leucine-rich repeat-containing G-protein coupled r..:Chondroadherin[325 aa]:Chondroadherin[323 aa] FLC:SO4:EDO 2 0 35 9 2 2 6 2 3 4 0 8 0 3 8 6 2 2 1 6 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 204 L b 1.7 7c76_A SO4 3 1 2 1 2 0 1 9 1 71 2 0 0 0 1 0 1 6 0 0 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 205 S b 8.6 7c76_A LYSC_CHICK:LY96_MOUSE:SPZ_DROME:Lysozyme C[127 aa]:Lymphocyte antigen 96[135 aa]:Protein spaetzle C-106[66 aa]:flg22[21 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') NAG CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(2-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. LGR4_XENTR:Leucine-rich repeat-containing G-protein coupled r.. PO4:GOL:SO4:EDO 8 0 7 5 0 8 7 0 1 3 0 5 2 4 5 39 2 1 0 1 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 206 S S e 27.3 7c76_A LY96_HUMAN:LYSC_CHICK:LY96_MOUSE:RSPO1_HUMAN:TGFB1_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:PP1A_HUMAN:LRC8C_MOUSE:Lymphocyte antigen 96[140 aa]:Lysozyme C[127 aa]:Lymphocyte antigen 96[135 aa]:R-spondin-1[103 aa]:flg22[21 aa]:R-spondin-1[79 aa]:Lymphocyte antigen 96[137 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[109 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:synthetic nanobody Sb4[124 aa]:Serine/threonine-protein phosphatase PP1-alpha cat..:Volume-regulated anion channel subunit LRRC8C[404 ..:Volume-regulated anion channel subunit LRRC8C[704 ..:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') NAG ZN:CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. Q2EEY0_HORSE:LGR4_XENTR:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Leucine-rich repeat-containing G-protein coupled r.. GOL:PO4:SO4 4 1 6 7 3 15 7 1 7 3 2 10 1 3 8 15 3 1 0 5 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 207 N b 2.4 7c76_A VHH10[119 aa] NAG GOL 1 1 1 1 0 0 1 1 1 3 1 78 2 2 1 2 3 1 0 0 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 208 Q e 42.3 7c76_A LYSC_CHICK:F1LW30_RAT:UNC5D_RAT:TGFB1_HUMAN:Lysozyme C[127 aa]:PROTEIN UNC5D[106 aa]:NETRIN RECEPTOR UNC5D[262 aa]:NETRIN RECEPTOR UNC5D[259 aa]:NETRIN RECEPTOR UNC5D[106 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[109 aa]:Anti-internalin A VHH24[121 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LRC8A_MOUSE:LRC8A_HUMAN:C562_ECOLX:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[730 ..:Volume-regulated anion channel subunit LRRC8A,Solu.. GOL 4 1 2 6 2 3 3 0 9 3 2 11 7 18 14 6 3 3 1 2 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 209 I b 0.0 7c76_A DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. SO4 0 1 0 0 8 0 2 38 1 38 1 0 0 1 1 2 1 4 0 0 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 210 K e 61.3 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[222 aa]:Transforming growth factor beta-1[109 aa] CD180_HUMAN:LRC8A_MOUSE:LRC8A_HUMAN:CD180 antigen[601 aa]:Volume-regulated anion channel subunit LRRC8A[718 ..:Volume-regulated anion channel subunit LRRC8A[730 .. EDO:PO4 4 1 3 9 2 4 2 2 8 2 1 5 2 7 14 16 13 3 1 2 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 211 E E e 53.3 7c76_A SPZ_DROME:TGFB1_HUMAN:PROTEIN SPAETZLE C-106[66 aa]:Protein spaetzle C-106[63 aa]:Transforming growth factor beta-1[168 aa]:Transforming growth factor beta-1[222 aa]:Transforming growth factor beta-1[109 aa] CL alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. EDO:PO4:ACT 5 0 6 11 4 18 4 3 7 2 1 3 1 6 5 11 7 2 1 2 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 212 F E b 8.6 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa]:Transforming growth factor beta-1[222 aa] EDO:PO4:ACT 1 1 1 3 10 1 1 25 2 25 3 1 3 1 2 5 2 9 0 4 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 213 S b 18.0 7c76_A SPZ_DROME:TGFB1_HUMAN:Protein spaetzle C-106[65 aa]:Transforming growth factor beta-1[168 aa]:MHG-8 Fab heavy chain[214 aa]:Transforming growth factor beta-1[222 aa]:MHG-8 Fab heavy chain[118 aa] NAG EDO 3 1 3 10 2 5 5 10 4 5 1 3 16 3 5 13 3 6 0 0 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 214 P T e 86.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[222 aa] NA 7 1 5 5 1 3 1 2 6 3 1 3 43 3 3 5 4 3 0 1 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 215 G T e 35.7 7c76_A NA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4 7 1 7 6 1 23 4 2 9 5 1 7 2 3 3 9 3 4 1 2 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 216 C S b 0.0 7c76_A NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[744 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[749 aa] SO4:EDO 16 11 3 5 2 3 1 6 3 7 2 4 1 1 1 16 8 5 3 4 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 217 F G b 1.4 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[222 aa] DNA (5'-D(*TP*CP*GP*C)-3') CU8:7VF:7VC:7VL:DY3:QSM:GD0:I5N:RQY:JRI:YHG TLR8_HUMAN:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa] SO4 1 1 2 2 45 2 0 9 1 20 1 1 3 2 1 3 2 3 1 1 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 218 H G e 49.7 7c76_A DNA (5'-D(*TP*CP*GP*C)-3') NAG:CU8:DY3 TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa]:Toll-like receptor 8[733 aa] SO4 8 5 6 6 2 7 11 1 8 3 1 4 2 9 8 12 3 2 1 1 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 219 A G b 17.0 7c76_A DNA (5'-D(*TP*CP*GP*C)-3') NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa] 10 2 5 4 1 18 4 2 7 5 0 10 4 2 5 12 5 2 0 0 REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 7":TOPO_DOM:/note="Lumenal" 220 I S b 6.4 7c76_A DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') UPT TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa] 3 3 2 1 3 2 0 13 1 44 5 1 5 1 1 3 2 9 1 0 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 221 G S e 51.2 7c76_A Heavy Chain of Li81 Fab, VH3-23[221 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') NAG:UPT TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa] EDO 5 1 2 5 3 17 2 2 7 5 1 5 13 5 6 8 7 3 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 222 R E e 52.6 7c76_A RSPO1_HUMAN:CLE9_ARATH:IDL3_ARATH:R-spondin-1[90 aa]:Light Chain of Li81 Fab, kappa 3[214 aa]:Heavy Chain of Li81 Fab, VH3-23[221 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:Peptide hormone IDL3[12 aa] NAG TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa] SO4 3 0 3 6 1 4 8 2 13 3 1 11 3 5 22 9 1 3 1 2 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 223 L E b 1.7 7c76_A Light Chain of Li81 Fab, kappa 3[214 aa] NAG TLR8_HUMAN:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[744 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[749 aa] SO4 2 3 2 2 3 1 1 5 1 66 2 1 2 1 1 2 1 5 1 1 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 224 F e 21.5 7c76_A RSPO1_HUMAN:ERL1_ARATH:R-spondin-1[90 aa]:R-spondin-1[103 aa]:Light Chain of Li81 Fab, kappa 3[214 aa]:R-spondin-1[78 aa]:LRR receptor-like serine/threonine-protein kinase .. NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:Q8KC98_CHLTE:B3Y653_MACMU:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Rab family protein[440 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[749 aa] SO4 4 0 1 12 8 2 4 4 7 10 2 4 1 7 8 7 9 3 1 4 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 225 G E b 2.4 7c76_A RSPO1_HUMAN:ERL1_ARATH:CIF2_ARATH:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:IBP3_HUMAN:R-spondin-1[90 aa]:Light Chain of Li81 Fab, kappa 3[214 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa]:LRR receptor-like serine/threonine-protein kinase ..:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Insulin-like growth factor-binding protein 3[167 a.. NAG:EWX 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[749 aa] SO4 4 1 5 10 5 14 6 3 7 4 1 6 2 3 6 11 7 5 1 2 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 226 L E b 0.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[222 aa] NAG 2 3 1 1 2 1 0 3 1 69 1 2 1 1 2 1 2 5 0 2 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 227 F E b 19.1 7c76_A ERL1_ARATH:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:IBP3_HUMAN:LRR receptor-like serine/threonine-protein kinase ..:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Insulin-like growth factor-binding protein 3[167 a.. NAG:GMP:RX8:IDQ:6T0:9K3:L07:C09:9JR:9K9:ACK:23G:EWL:EWU:EWX:EX0 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. LGR4_XENTR:Q8KC98_CHLTE:Leucine-rich repeat-containing G-protein coupled r..:Rab family protein[440 aa] SO4:EDO 3 1 10 4 9 2 6 5 4 8 1 4 2 2 5 8 7 6 2 10 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 228 L b 0.0 7c76_A F1LW30_RAT:TGFB1_HUMAN:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:IDL3_ARATH:PROTEIN UNC5D[106 aa]:Transforming growth factor beta-1[222 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:Peptide hormone IDL3[12 aa] NA SO4 3 1 1 2 4 1 2 8 2 50 4 2 1 1 3 3 2 7 1 4 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 229 N b 17.0 7c76_A LY96_MOUSE:LY96_HUMAN:LRC8A_MOUSE:C562_ECOLX:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[140 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4 5 1 8 4 1 3 3 1 6 5 1 25 1 4 6 16 3 2 1 3 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 230 N S e 44.8 7c76_A RSPO1_HUMAN:F1LW30_RAT:TGFB1_HUMAN:LRC8A_MOUSE:C562_ECOLX:R-spondin-1[90 aa]:PROTEIN UNC5D[106 aa]:Transforming growth factor beta-1[109 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. GOL:SO4 4 1 10 6 4 4 5 1 3 7 1 26 3 4 3 11 2 1 0 4 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 231 V b 0.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[109 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL:EDO 2 2 2 1 4 3 1 11 4 16 2 32 1 1 1 4 3 8 1 1 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 232 Q e 55.1 7c76_A TGFB1_HUMAN:flg22[21 aa]:Transforming growth factor beta-1[109 aa] NAG alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL:SO4:EDO 4 2 6 6 1 3 4 2 11 4 1 10 2 17 7 13 3 2 0 3 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 233 L b 9.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[222 aa] EDO 3 1 2 4 7 4 2 10 3 41 2 2 3 1 1 4 3 5 1 1 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 234 G b 16.7 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[109 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL 5 1 3 5 4 18 2 5 4 6 1 8 5 3 2 13 6 4 2 2 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 235 P H e 55.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[222 aa]:28G11 Fab heavy chain[182 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. GOL:PO4 4 1 6 8 3 12 1 3 4 4 1 5 29 3 3 7 3 3 0 1 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 236 S H e 51.6 7c76_A TGFB1_HUMAN:LRC8A_MOUSE:C562_ECOLX:Transforming growth factor beta-1[222 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. NAG EDO 11 3 5 7 3 4 2 4 6 5 1 9 3 3 2 21 5 3 0 2 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 237 L H b 15.7 7c76_A TGFB1_HUMAN:LRC8A_MOUSE:C562_ECOLX:Transforming growth factor beta-1[222 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. NAG GOL 6 0 2 1 5 4 2 9 4 33 3 3 3 2 4 3 3 9 1 2 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 238 T H b 1.3 7c76_A LRC8A_MOUSE:C562_ECOLX:Volume-regulated anion channel subunit LRRC8A,Solu.. PO4 4 2 4 4 5 3 2 7 2 6 1 5 15 5 3 11 12 6 0 1 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 239 E H e 31.2 7c76_A IDL1_ARATH:IDL3_ARATH:Protein IDA-LIKE 1[14 aa]:Peptide hormone IDL3[12 aa] NAG 6 0 5 17 2 8 2 2 7 4 4 4 7 6 4 12 4 3 0 1 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 240 K H e 53.3 7c76_A NAG SO4:PO4:ACT 4 1 6 8 1 8 3 3 11 11 2 6 6 3 5 10 7 3 1 1 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 241 L H b 0.6 7c76_A IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa] NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. SO4:PO4:ACT 4 1 4 2 5 4 1 13 2 30 3 2 4 1 4 5 6 6 2 2 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 242 C H b 1.3 7c76_A NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4:PO4:ACT 5 20 3 3 10 6 2 3 2 6 0 5 9 2 3 7 5 5 0 3 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 243 L H e 47.2 7c76_A SERK1_ARATH:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:Somatic embryogenesis receptor kinase 1[185 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa] NAG SO4:EDO 8 1 4 3 6 3 3 6 4 28 2 3 5 2 4 5 3 7 2 2 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 244 E H b 14.6 7c76_A NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 8 0 9 22 4 5 3 2 6 3 0 5 3 6 3 11 5 3 2 2 REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 8":TOPO_DOM:/note="Lumenal" 245 L S b 0.6 7c76_A NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. SO4 4 3 2 2 6 2 3 8 3 37 3 2 3 3 2 5 3 7 2 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 246 A T b 16.1 7c76_A DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 9 2 7 4 7 10 2 2 5 7 2 6 8 3 4 11 3 7 0 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 247 N T e 74.5 7c76_A TGFB1_HUMAN:CIF2_ARATH:Transforming growth factor beta-1[109 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B3Y653_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[774 aa] 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":MUTAGEN:/note="N->R: Reduced response to ds-RNA. Reduced expression levels; when associated with G-196.":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":MUTAGEN:/note="N->R: Reduced response to ds-RNA. Reduced expression levels; when associated with G-196.":TOPO_DOM:/note="Lumenal" 248 T b 8.4 7c76_A DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*G)-3') NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 3 3 3 3 2 3 2 5 3 17 2 7 7 3 3 11 15 6 0 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 249 S e 38.3 7c76_A TGFB1_HUMAN:CIF2_ARATH:Transforming growth factor beta-1[109 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa] NAG:GMP:9K9 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B3Y653_MACMU:Toll-like receptor 7[776 aa] 3 2 3 3 5 5 2 2 7 5 1 9 3 4 7 29 6 1 0 2 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 250 I b 0.0 7c76_A NAG 1 3 2 1 3 2 0 17 3 44 4 2 3 1 0 3 2 7 0 2 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 251 R e 39.9 7c76_A RSPO1_HUMAN:CIF2_ARATH:R-spondin-1[90 aa]:Phytosulfokine[5 aa]:PTR-ILE-PTR-THR-GLN[5 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4:MES:PO4 4 0 5 8 2 3 4 2 10 9 2 6 4 6 18 5 7 4 0 1 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" R->G:LB/B:rs7800513: -; 252 N E e 34.5 7c76_A RSPO1_HUMAN:R-spondin-1[90 aa]:R-spondin-1[103 aa]:R-spondin-1[79 aa]:R-spondin-1[78 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. NAG:UCG:06S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(2-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. MES:PO4 3 0 9 9 3 9 3 4 6 5 2 9 2 6 7 8 5 4 2 4 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 253 L E b 0.6 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa] 2 3 2 5 4 4 0 7 2 53 2 2 0 0 2 0 3 5 0 2 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 254 S E b 3.1 7c76_A CAD1_HUMAN:CADH1_HUMAN:LY96_HUMAN:LY96_MOUSE:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 96[140 aa]:Lymphocyte antigen 96[135 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3').. NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(2-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. PGS2_BOVIN:Decorin[305 aa] SO4 3 1 10 5 2 4 4 2 2 4 3 8 5 3 4 22 7 4 3 4 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 255 L b 1.1 7c76_A A4IFT3_BOVIN:TGFB1_HUMAN:LY86 protein[136 aa]:Transforming growth factor beta-1[168 aa] NAG 4 3 3 2 7 3 2 5 3 41 2 0 0 2 0 4 2 8 2 3 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 256 S T b 16.4 7c76_A CADH1_HUMAN:CADH1_MOUSE:A4IFT3_BOVIN:Epithelial-cadherin[103 aa]:Epithelial-cadherin[105 aa]:LY86 protein[136 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') NAG CL alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. PGS2_BOVIN:Decorin[305 aa] 6 1 6 6 3 9 4 2 3 4 2 9 2 4 3 20 7 3 0 4 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 257 N T e 28.5 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:LY96_MOUSE:LY96_HUMAN:A4IFT3_BOVIN:TGFB1_HUMAN:Q30BZ2_PHYSO:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[140 aa]:LY86 protein[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:Transforming growth factor beta-1[111 aa]:Cell 12A endoglucanase[222 aa]:Lymphocyte antigen 96[136 aa]:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] NAG CA:CL alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. MES:EDO 0 2 4 8 4 9 4 3 3 2 2 24 5 5 7 9 3 2 2 3 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 258 S b 0.8 7c76_A LY96_MOUSE:TGFB1_HUMAN:Lymphocyte antigen 96[135 aa]:Transforming growth factor beta-1[111 aa]:Anti-internalin A VHH24[121 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 6 3 3 2 6 3 0 3 4 4 4 34 4 2 2 10 6 5 0 0 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 259 Q e 39.3 7c76_A F1LW30_RAT:TGFB1_HUMAN:PROTEIN UNC5D[106 aa]:PTR-ILE-PTR-THR-GLN[5 aa]:Transforming growth factor beta-1[111 aa]:Anti-internalin A VHH24[121 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 5 0 4 4 1 6 3 2 11 5 1 12 3 14 6 8 2 2 0 9 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 260 L b 0.6 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa] NAG 0 0 6 6 6 6 6 6 6 6 6 6 6 0 6 6 6 6 6 6 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 261 S e 47.7 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[111 aa]:28G11 Fab heavy chain[182 aa] NAG 6 2 4 6 6 3 3 2 6 7 3 8 3 5 3 16 12 2 0 3 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 262 T E e 46.8 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa]:28G11 Fab heavy chain[182 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 6 3 4 5 2 6 4 6 7 5 2 6 3 4 3 8 14 7 2 3 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 263 T E b 3.2 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa]:28G11 Fab heavy chain[182 aa] 5 1 3 5 3 5 0 19 4 18 2 2 3 2 2 4 8 13 0 2 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 264 S e 28.1 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa]:28G11 Fab heavy chain[182 aa] NAG 3 2 6 6 3 8 2 8 3 4 2 5 19 2 4 17 4 3 0 1 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 265 N T e 48.5 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa] NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 7 1 9 7 5 4 2 5 4 3 0 13 16 4 3 7 3 2 1 3 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 266 T T e 44.2 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa]:28G11 Fab heavy chain[182 aa]:28G11 Fab light chain[173 aa] NAG 7 0 6 6 1 9 1 6 3 8 2 7 7 3 5 10 13 3 1 1 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 267 T T b 1.9 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa]:28G11 Fab heavy chain[182 aa]:28G11 Fab light chain[173 aa] 16 3 5 3 2 6 1 7 3 4 1 3 4 2 4 16 12 5 1 1 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 268 F T b 0.5 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa] NAG 2 2 1 2 39 3 2 7 2 15 5 1 3 0 3 3 2 5 0 3 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 269 L e 36.0 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LIGO1_HUMAN:Leucine-rich repeat and immunoglobulin-like domain.. SO4 7 1 4 5 4 3 1 5 7 25 2 2 3 4 3 8 4 6 1 2 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 270 G G b 1.2 7c76_A NAG LIGO1_HUMAN:Leucine-rich repeat and immunoglobulin-like domain.. SO4 8 2 5 2 2 35 5 2 5 3 1 9 3 2 3 8 3 1 0 1 REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 9":TOPO_DOM:/note="Lumenal" 271 L G b 1.7 7c76_A NAG LIGO1_HUMAN:Leucine-rich repeat and immunoglobulin-like domain.. 4 6 2 3 3 3 2 6 3 47 2 2 3 3 1 3 3 4 2 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 272 K G e 33.5 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. PO4 5 3 5 7 2 6 3 5 16 5 1 7 6 4 8 7 4 3 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 273 W G e 59.0 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR5_HUMAN:Toll-like receptor 5[797 aa] 6 4 3 3 7 5 2 3 4 19 2 3 6 4 4 4 5 3 7 6 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 274 T S b 3.9 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 6 6 2 7 1 3 1 2 4 6 4 8 5 2 7 15 15 6 0 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 275 N e 53.3 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:LIGO1_HUMAN:Toll-like receptor 8[747 aa]:Leucine-rich repeat and immunoglobulin-like domain.. MES 6 0 4 7 2 5 3 0 7 2 0 32 1 5 6 16 2 0 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 276 L b 2.2 7c76_A 1 1 0 0 3 3 0 4 1 68 3 1 3 1 0 1 2 7 0 0 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 277 T b 16.2 7c76_A LY96_HUMAN:BAK1_ARATH:IBP3_HUMAN:Lymphocyte antigen 96[140 aa]:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Insulin-like growth factor-binding protein 3[167 a.. UCG:06S alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. SO4:MES 4 1 3 7 1 2 2 3 4 3 2 3 3 10 8 12 26 7 0 1 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 278 M E b 10.1 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:CIF2_ARATH:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Cadherin-1[213 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. NAG:UCG:06S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. PGS2_BOVIN:Decorin[305 aa] MES:SO4:EDO 4 1 2 9 4 1 4 9 6 17 1 4 0 1 7 9 8 8 1 3 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 279 L E b 0.0 7c76_A 2 0 1 4 3 2 0 15 0 57 1 0 2 0 0 3 2 6 1 0 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 280 D E b 16.7 7c76_A CADH1_HUMAN:LY96_MOUSE:CLE41_ARATH:A0A178VDH8_ARATH:CIF2_ARATH:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:Epithelial-cadherin[105 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 96[135 aa]:flg22[21 aa]:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:TDIF/CLE41[12 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[134 aa]:Lymphocyte antigen 96[137 aa]:CLE41[12 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Anti-internalin A VHH24[121 aa] alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. PGS2_BOVIN:LGR4_XENTR:Decorin[305 aa]:Leucine-rich repeat-containing G-protein coupled r.. SO4:EDO 1 0 30 9 1 4 3 2 6 4 1 9 2 4 5 5 8 3 1 2 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 281 L b 0.0 7c76_A LY96_HUMAN:Lymphocyte antigen 96[140 aa] NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 3 2 2 2 7 0 0 7 0 54 3 2 2 1 2 2 1 7 0 1 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 282 S b 2.3 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:LY96_MOUSE:LY96_HUMAN:A4IFT3_BOVIN:CIF2_ARATH:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[140 aa]:LY86 protein[136 aa]:Phytosulfokine[5 aa]:PTR-ILE-PTR-THR-GLN[5 aa]:Lymphocyte antigen 96[137 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Lymphocyte antigen 96[136 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Cadherin-1[213 aa]:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3').. NAG CL:CA alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. INLA_LISMO:LGR4_XENTR:INTERNALIN A[462 aa]:Leucine-rich repeat-containing G-protein coupled r.. MES:SO4:EDO 4 0 4 4 3 7 3 1 2 1 0 7 2 5 7 39 5 2 0 2 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 283 Y S e 43.9 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:LY96_MOUSE:LY96_HUMAN:CLE41_ARATH:A0A178VDH8_ARATH:TGFB1_HUMAN:Q16J57_AEDAE:Q30BZ2_PHYSO:IDA_ARATH:IDL2_ARATH:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[140 aa]:Phytosulfokine[5 aa]:PTR-ILE-PTR-THR-GLN[5 aa]:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:TDIF/CLE41[12 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa]:CLE41[12 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[218 aa]:AAEL013433-PA[92 aa]:AAEL013433-PA[91 aa]:Cell 12A endoglucanase[222 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 2[14 aa]:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. UPT:EWU:EWX:NAG alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. Q2EEY0_HORSE:LGR4_XENTR:B3Y653_MACMU:TLR8_HUMAN:A0A6I8TEX2_AEDAE:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 7[776 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor[751 aa] MES:SO4:EDO 3 0 5 5 18 10 8 2 6 4 3 10 0 3 5 5 2 1 2 6 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 284 N S b 0.6 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[111 aa]:Anti-internalin A VHH24[121 aa] NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 2 2 4 5 0 2 1 1 3 2 2 62 0 2 2 3 4 2 0 0 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" N->I:LB/B:rs5743316: -; 285 N e 55.8 7c76_A Q7Q5N3_ANOGA:TGFB1_HUMAN:Q30BZ2_PHYSO:Leucine-rich Immune Molecule 1[482 aa]:Transforming growth factor beta-1[111 aa]:Cell 12A endoglucanase[222 aa]:Anti-internalin A VHH24[121 aa] NAG:GMP:RX8:IDQ:6T0:9K3:L07:C09:9JR:9K9:ACK:23G:EWL:EWU:EWX:EX0 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. Q2EEY0_HORSE:B3Y653_MACMU:G7NS93_MACMU:Toll-like receptor 9[749 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[771 aa] 5 3 1 6 2 6 6 2 9 2 0 17 8 8 6 11 3 0 0 5 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 286 L b 2.8 7c76_A 2 2 0 2 9 0 1 22 0 40 2 0 2 0 3 0 3 9 2 0 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 287 N e 39.4 7c76_A Q7Q5N3_ANOGA:TGFB1_HUMAN:Leucine-rich Immune Molecule 1[482 aa]:Transforming growth factor beta-1[111 aa]:28G11 Fab heavy chain[182 aa] EX0 beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4 3 1 6 8 2 5 2 1 5 1 1 11 1 10 9 17 11 4 1 1 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 288 V E e 32.7 7c76_A 28G11 Fab heavy chain[182 aa] 6 4 3 5 5 10 5 5 10 7 2 4 2 4 6 8 4 7 0 2 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 289 V E b 8.0 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 3 1 1 2 5 1 1 19 3 23 3 2 2 1 1 3 7 18 0 4 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 290 G b 19.0 7c76_A 28G11 Fab heavy chain[182 aa] NAG NA SO4 5 3 3 6 3 13 2 7 3 4 2 4 21 7 2 8 3 3 1 0 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 291 N T e 44.2 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be.. 6 0 7 11 2 7 2 2 4 2 1 15 18 2 8 6 3 2 1 2 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 292 D T e 33.3 7c76_A 28G11 Fab light chain[173 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LIGO1_HUMAN:Leucine-rich repeat and immunoglobulin-like domain.. 4 0 17 9 2 11 2 3 9 4 1 6 4 6 4 9 4 2 0 2 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 293 S T b 0.0 7c76_A NAG SO4 18 1 6 5 3 4 1 6 2 10 2 2 2 2 2 18 6 5 2 3 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 294 F T b 1.9 7c76_A 3 1 0 1 39 1 0 10 2 18 2 2 2 0 2 2 4 7 1 2 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 295 A T e 28.6 7c76_A NAG NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LIGO1_HUMAN:Leucine-rich repeat and immunoglobulin-like domain.. SO4 16 3 3 3 1 13 3 2 5 3 1 2 3 10 5 16 5 3 2 1 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 296 W T e 33.5 7c76_A LY86_HUMAN:A4IFT3_BOVIN:Lymphocyte antigen 86[139 aa]:LY86 protein[138 aa] NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LIGO1_HUMAN:Leucine-rich repeat and immunoglobulin-like domain.. SO4 5 2 4 4 5 15 8 2 6 4 1 10 5 3 3 9 2 3 8 3 REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 10":TOPO_DOM:/note="Lumenal" 297 L b 1.7 7c76_A SO4 2 6 1 3 5 1 2 7 1 50 5 1 1 1 1 1 3 6 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 298 P S e 31.8 7c76_A LY96_HUMAN:Lymphocyte antigen 96[140 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LIGO1_HUMAN:Leucine-rich repeat and immunoglobulin-like domain.. SO4 5 1 1 5 1 4 1 2 6 5 1 1 29 4 7 10 11 5 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 299 Q S e 38.8 7c76_A NAG CL alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:LIGO1_HUMAN:Toll-like receptor 8[747 aa]:Leucine-rich repeat and immunoglobulin-like domain.. SO4:MES 6 1 2 7 2 7 5 2 13 3 1 12 1 9 12 10 3 1 1 2 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 300 L b 0.6 7c76_A LY86_HUMAN:A4IFT3_BOVIN:Lymphocyte antigen 86[139 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa] 1 0 0 0 1 0 2 7 0 71 4 1 0 0 1 0 1 8 0 0 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 301 E e 32.7 7c76_A LY86_HUMAN:A4IFT3_BOVIN:IBP3_HUMAN:Lymphocyte antigen 86[139 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:Heavy Chain of Li81 Fab, VH3-23[221 aa]:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Insulin-like growth factor-binding protein 3[167 a.. UCG:NAG:06S MG L-glycero-alpha-D-manno-heptopyranose-(1-7)-L-glyc..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. SO4 2 2 4 23 1 2 4 2 10 3 2 3 2 14 14 3 4 2 1 1 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 302 Y E e 49.1 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:LY86_HUMAN:A4IFT3_BOVIN:FLIC_SALDU:CLE41_ARATH:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 86[139 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:Flagellin[295 aa]:Flagellin[284 aa]:Heavy Chain of Li81 Fab, VH3-23[221 aa]:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:Variable Lymphocyte Receptor 2[192 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Cadherin-1[213 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3')..:DNA (5'-D(*CP*CP*TP*CP*AP*AP*TP*AP*GP*GP*GP*TP*GP*.. UCG:06S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. PGS2_BOVIN:Decorin[305 aa] SO4:MES 2 1 2 9 12 3 7 4 5 5 1 4 2 2 6 9 7 7 2 8 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 303 F E b 0.0 7c76_A NAG L-glycero-alpha-D-manno-heptopyranose-(1-7)-L-glyc.. 1 2 3 2 8 3 2 8 0 51 3 0 0 2 0 4 3 5 1 2 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 304 F E b 18.2 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:LY96_HUMAN:CIF2_ARATH:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 96[140 aa]:Variable Lymphocyte Receptor 2[192 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa]:Cadherin-1[213 aa]:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3').. UCG:06S:NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. PGS2_BOVIN:LGR4_XENTR:Decorin[305 aa]:Leucine-rich repeat-containing G-protein coupled r.. MES:SO4:EDO 4 0 10 4 8 3 5 8 3 8 2 6 2 3 4 8 7 8 2 6 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 305 L b 5.6 7c76_A CL 3 3 0 0 3 3 0 10 0 58 2 3 0 0 0 2 3 7 0 2 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 306 E b 14.1 7c76_A CADH1_HUMAN:LY96_HUMAN:CIF2_ARATH:IDA_ARATH:IDL2_ARATH:IDL3_ARATH:Epithelial-cadherin[105 aa]:Epithelial-cadherin[107 aa]:Lymphocyte antigen 96[140 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 2[14 aa]:Peptide hormone IDL3[12 aa]:Cadherin-1[213 aa]:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3').. NAG CL alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. LGR4_XENTR:Leucine-rich repeat-containing G-protein coupled r.. MES:EDO 7 0 10 17 1 4 4 1 4 5 0 5 2 6 4 16 5 2 2 3 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 307 Y S e 31.7 7c76_A CADH1_HUMAN:FLIC_SALDU:LY96_HUMAN:E0U497_BACPZ:TGFB1_HUMAN:CIF2_ARATH:Q16J57_AEDAE:Q30BZ2_PHYSO:Epithelial-cadherin[105 aa]:Flagellin[295 aa]:Flagellin[284 aa]:Lymphocyte antigen 96[140 aa]:Flagellin[169 aa]:Variable Lymphocyte Receptor 2[192 aa]:Transforming growth factor beta-1[209 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:AAEL013433-PA[92 aa]:AAEL013433-PA[91 aa]:Cell 12A endoglucanase[222 aa]:Transforming growth factor beta-1[111 aa]:Anti-internalin A VHH24[121 aa] DNA (5'-D(*CP*CP*TP*GP*GP*AP*TP*GP*GP*GP*AP*A)-3').. C09:RX8:D87:D80:XG1:UPT:HB2:M0A:M4D:IDQ:MBL:NAG:CU8:7VF:7VL:DY3:U57:QLH:I6A:I5N:JRI:YHG ZN alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:Q2EEY0_HORSE:B3Y653_MACMU:TLR9_MOUSE:G7NS93_MACMU:A0A6I8TEX2_AEDAE:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor[751 aa]:Toll-like receptor[750 aa]:Toll-like receptor[752 aa]:Toll-like receptor[753 aa] 5 0 3 4 7 10 13 4 3 8 1 10 2 6 5 8 1 3 1 4 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" Y->D:LB/B:rs5743317: -; 308 N b 4.2 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[218 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 3 2 9 2 1 5 2 0 4 4 0 52 1 1 2 3 8 2 0 0 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 309 N e 26.1 7c76_A Q7Q5N3_ANOGA:TGFB1_HUMAN:Leucine-rich Immune Molecule 1[482 aa]:Transforming growth factor beta-1[111 aa] DNA (5'-D(*TP*CP*GP*C)-3') C09:L07:RX8:D87:D80:XG1:URI:HB2:M0A:M4D:IDQ:MBL:CU8:7VF:7VC:7VL:6T0:9K3:9JR:9K9:ACK:23G:DY3:EWX:EX0:QSM:U57:QLH:GD0:I6A:I5N:RQY:JRI:YHG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:B3Y653_MACMU:G7NS93_MACMU:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[740 aa] SO4 3 4 6 4 0 9 3 1 11 4 1 18 3 7 8 11 2 2 0 3 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 310 I B b 4.1 7c76_A DNA (5'-D(*TP*CP*GP*C)-3') RX8:URI:HB2:CU8:7VF:7VC:7VL:DY3:QSM:U57:QLH:GD0:I6A:I5N:RQY:JRI:YHG 1 1 1 2 5 2 1 28 0 36 4 1 3 1 1 2 2 8 0 0 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 311 Q S e 35.7 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[38 aa]:Transforming growth factor beta-1[111 aa] DNA (5'-D(*TP*CP*GP*C)-3') SO4 7 0 5 13 1 6 2 3 6 3 2 5 2 9 6 10 8 6 0 3 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 312 H E e 34.6 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[38 aa] DNA (5'-D(*TP*CP*GP*C)-3') NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR9_MOUSE:Toll-like receptor 9[751 aa] SO4 3 2 9 8 2 12 10 1 5 4 1 8 2 6 5 9 5 2 0 6 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 313 L E b 6.2 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[38 aa] DNA (5'-D(*TP*CP*GP*C)-3') 2 2 2 5 6 1 1 17 1 29 1 1 2 1 1 2 4 17 1 4 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 314 F e 31.1 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[38 aa] DNA (5'-D(*TP*CP*GP*C)-3') NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be.. 4 1 3 8 14 3 2 9 2 9 1 3 8 1 6 10 5 6 2 4 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 315 S T e 38.3 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[38 aa] DNA (5'-D(*TP*CP*GP*C)-3') NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be.. 8 0 5 4 3 4 0 3 4 2 0 4 31 3 4 15 4 5 0 1 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 316 H T e 40.8 7c76_A DNA (5'-D(*TP*CP*GP*C)-3') NAG:FUC 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 6 0 7 5 3 10 6 4 8 9 2 6 4 6 7 7 4 2 0 4 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 317 S T b 1.6 7c76_A KDO:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 16 1 8 6 2 4 3 4 3 6 2 2 2 3 3 24 5 5 2 1 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 318 L T b 5.6 7c76_A SO4 2 1 1 2 22 1 0 12 1 38 3 0 2 1 1 3 2 4 1 0 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 319 H e 27.7 7c76_A LY96_MOUSE:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be.. SO4 5 2 5 7 2 7 12 2 8 5 1 4 2 6 8 12 7 3 1 3 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 320 G S b 8.3 7c76_A LY96_MOUSE:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa] RNA (5'-R(*GP*UP*CP*CP*C)-3') NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B3Y653_MACMU:G7NS93_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa] SO4 5 1 6 3 1 29 3 3 10 3 1 12 3 3 2 9 4 1 1 0 REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 11":TOPO_DOM:/note="Lumenal" 321 L b 0.6 7c76_A B3Y653_MACMU:G7NS93_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa] 4 6 1 2 2 2 1 8 1 47 3 1 1 2 1 2 5 8 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 322 F S e 48.3 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be.. B3Y653_MACMU:G7NS93_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa] 5 0 3 4 11 5 3 5 6 8 3 2 9 4 4 11 10 5 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 323 N S e 28.5 7c76_A BAK1_ARATH:BRASSINOSTEROID INSENSITIVE 1-associated receptor .. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[be..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LIGO1_HUMAN:B3Y653_MACMU:G7NS93_MACMU:Leucine-rich repeat and immunoglobulin-like domain..:Toll-like receptor 7[776 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa] 3 1 7 5 2 3 6 1 6 3 2 24 2 4 4 19 5 2 0 2 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 324 V b 0.0 7c76_A BAK1_ARATH:BRASSINOSTEROID INSENSITIVE 1-associated receptor .. B3Y653_MACMU:G7NS93_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa] 6 6 6 0 6 6 6 6 6 6 6 6 6 6 6 6 6 6 0 0 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 325 R e 32.8 7c76_A FLIC_SALDU:IBP3_HUMAN:Flagellin[284 aa]:Heavy Chain of Li81 Fab, VH3-23[221 aa]:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Insulin-like growth factor-binding protein 3[167 a.. RNA (5'-R(P*UP*UP*UP*U)-3') :RNA (5'-R(*AP*UP*UP*AP*A)-3') :RNA (5'-R(P*UP*UP*CP*A)-3') :RNA (5'-R(P*UP*UP*GP*A)-3') :RNA (5'-R(*GP*UP*CP*CP*C)-3') :RNA (5'-R(P*UP*UP*AP*A)-3') NAG:UCG:06S B3Y653_MACMU:Toll-like receptor 7[772 aa] SO4:BME 4 3 3 6 0 8 5 4 11 7 0 4 3 6 14 7 7 4 0 3 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 326 Y E e 27.4 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:FLIC_SALDU:BAK1_ARATH:Q16J57_AEDAE:IBP3_HUMAN:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Flagellin[284 aa]:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Heavy Chain of Li81 Fab, VH3-23[221 aa]:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:AAEL013433-PA[99 aa]:Insulin-like growth factor-binding protein 3[167 a..:Cadherin-1[213 aa]:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] RNA (5'-R(P*UP*UP*UP*U)-3') :RNA (5'-R(*AP*UP*UP*AP*A)-3') :RNA (5'-R(P*UP*UP*CP*A)-3') :RNA (5'-R(P*UP*UP*GP*A)-3') :RNA (5'-R(*GP*UP*CP*CP*C)-3') :RNA (5'-R(P*UP*UP*AP*A)-3') 06S CL alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. MES:SO4 4 1 2 9 8 3 6 8 3 9 2 2 0 3 2 7 4 4 5 17 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 327 L E b 0.0 7c76_A CADH1_MOUSE:Epithelial-cadherin[105 aa] RNA (5'-R(P*UP*UP*UP*U)-3') :RNA (5'-R(*AP*UP*UP*AP*A)-3') :RNA (5'-R(P*UP*UP*CP*A)-3') :RNA (5'-R(P*UP*UP*GP*A)-3') :RNA (5'-R(*GP*UP*CP*CP*C)-3') :RNA (5'-R(P*UP*UP*AP*A)-3') SO4 4 2 2 4 4 2 2 8 3 45 2 3 2 2 0 4 3 5 2 0 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 328 N E b 10.3 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:CLE41_ARATH:A0A178VDH8_ARATH:CIF2_ARATH:Q16J57_AEDAE:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:TDIF/CLE41[12 aa]:CLE41[12 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:AAEL013433-PA[99 aa]:VHH10[119 aa]:Anti-internalin A VHH24[121 aa] RNA (5'-R(P*UP*UP*GP*A)-3') :RNA (5'-R(*GP*UP*CP*CP*C)-3') NAG:UCG:06S CL:ZN alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. MES:SO4 5 2 17 5 1 5 4 3 5 8 1 16 0 6 4 11 3 3 0 3 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 329 L b 2.8 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[38 aa] CL SO4 5 2 3 2 3 3 0 6 0 41 2 3 2 4 0 4 5 9 0 2 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 330 K T e 28.8 7c76_A LY86_HUMAN:A4IFT3_BOVIN:CLE41_ARATH:A0A178VDH8_ARATH:CIF2_ARATH:Lymphocyte antigen 86[139 aa]:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF/CLE41[12 aa]:CLE41[12 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa] RNA (5'-R(P*UP*UP*UP*U)-3') :RNA (5'-R(*AP*UP*UP*AP*A)-3') :RNA (5'-R(P*UP*UP*CP*A)-3') :RNA (5'-R(P*UP*UP*GP*A)-3') :RNA (5'-R(*GP*UP*CP*CP*C)-3') :RNA (5'-R(P*UP*UP*AP*A)-3') NAG CL alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. A0A6I8TEX2_AEDAE:Toll-like receptor[751 aa]:Toll-like receptor[750 aa] MES:SO4 7 2 4 4 3 7 3 2 3 10 0 6 7 9 9 14 6 4 0 1 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 331 R T e 24.5 7c76_A A4IFT3_BOVIN:FLIC_SALDU:E0U497_BACPZ:TGFB1_HUMAN:Q30BZ2_PHYSO:LY86 protein[138 aa]:Flagellin[295 aa]:Flagellin[284 aa]:Flagellin[169 aa]:Transforming growth factor beta-1[209 aa]:Cell 12A endoglucanase[222 aa]:Transforming growth factor beta-1[160 aa]:Transforming growth factor beta-1[111 aa]:Anti-internalin A VHH24[121 aa] RNA (5'-R(P*UP*UP*UP*U)-3') :DNA (5'-D(*TP*CP*GP*C)-3') :RNA (5'-R(*AP*UP*UP*AP*A)-3') :RNA (5'-R(P*UP*UP*CP*A)-3') :RNA (5'-R(P*UP*UP*GP*A)-3') :RNA (5'-R(*GP*UP*CP*CP*C)-3') :RNA (5'-R(P*UP*UP*AP*A)-3') UCG:06S:UPT 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. MES:SO4:FMT 3 1 3 7 2 11 5 2 9 6 1 7 4 4 18 9 3 2 1 1 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 332 S b 0.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[111 aa] RNA (5'-R(P*UP*UP*UP*U)-3') :RNA (5'-R(*AP*UP*UP*AP*A)-3') :RNA (5'-R(P*UP*UP*CP*A)-3') :RNA (5'-R(P*UP*UP*GP*A)-3') :RNA (5'-R(*GP*UP*CP*CP*C)-3') :RNA (5'-R(P*UP*UP*AP*A)-3') NAG:C09:RX8:D80:XG1:HB2:M0A:M4D:IDQ:MBL:CU8:7VF:7VC:7VL:QLH:I6A:I5N:JRI:YHG 4 1 5 5 0 4 1 3 4 11 0 30 3 2 2 15 6 1 0 1 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 333 F B b 0.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[112 aa]:Transforming growth factor beta-1[109 aa] RNA (5'-R(P*UP*UP*UP*U)-3') :RNA (5'-R(*AP*UP*UP*AP*A)-3') :RNA (5'-R(P*UP*UP*CP*A)-3') :RNA (5'-R(P*UP*UP*GP*A)-3') :RNA (5'-R(*GP*UP*CP*CP*C)-3') :RNA (5'-R(P*UP*UP*AP*A)-3') 2 3 3 3 19 3 4 6 3 21 1 3 3 3 2 5 2 5 2 7 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 334 T b 14.9 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[109 aa] RNA (5'-R(*GP*UP*CP*CP*C)-3') C09:L07:RX8:D87:D80:XG1:URI:HB2:M8D:M0A:M4D:IDQ:MBL:NAG:CU8:7VF:7VC:7VL:DY3:QSM:U57:QLH:GD0:I6A:I5N:RQY:JRI:YHG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. TLR8_HUMAN:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[733 aa]:Toll-like receptor 8[749 aa] SO4:EDO 5 2 3 3 7 4 1 7 3 14 2 7 4 3 3 9 14 6 3 2 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 335 K e 32.5 7c76_A TGFB1_HUMAN:SERK1_ARATH:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:Transforming growth factor beta-1[222 aa]:Transforming growth factor beta-1[109 aa]:Somatic embryogenesis receptor kinase 1[185 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa] EDO 4 2 5 10 4 8 0 4 12 10 1 5 4 4 9 7 4 2 3 2 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 336 Q e 85.2 7c76_A LY96_HUMAN:TGFB1_HUMAN:Lymphocyte antigen 96[140 aa]:Transforming growth factor beta-1[222 aa] TLR8_HUMAN:Toll-like receptor 8[751 aa]:Toll-like receptor 8[744 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[749 aa] SO4 5 3 4 9 2 10 5 4 4 7 1 6 5 11 2 8 4 5 3 2 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 337 S e 32.0 2a0z_A LY96_HUMAN:TGFB1_HUMAN:SERK1_ARATH:IDA_ARATH:IDL1_ARATH:IDL2_ARATH:CLE9_ARATH:IDL3_ARATH:Lymphocyte antigen 96[140 aa]:Transforming growth factor beta-1[222 aa]:Somatic embryogenesis receptor kinase 1[185 aa]:Protein IDA[14 aa]:Protein IDA-LIKE 1[14 aa]:Protein IDA-LIKE 2[14 aa]:CLAVATA3/ESR (CLE)-related protein 9[12 aa]:CLAVATA3/ESR (CLE)-related protein 9[11 aa]:Peptide hormone IDL3[12 aa] EDO 7 0 5 4 3 6 3 3 6 7 0 7 8 4 5 21 6 3 0 2 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 338 I S e 84.8 2a0z_A TGFB1_HUMAN:Transforming growth factor beta-1[222 aa] 4 3 2 2 8 5 2 18 2 21 3 4 5 3 2 4 3 7 0 2 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 339 S S e 79.7 2a0z_A LY96_HUMAN:Lymphocyte antigen 96[140 aa] 7 4 4 8 2 5 3 0 4 6 2 7 7 3 4 18 9 2 0 3 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 340 L S e 76.4 2a0z_A LY96_HUMAN:Lymphocyte antigen 96[140 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 4 4 2 4 10 4 3 10 3 29 2 3 3 3 5 3 1 5 0 3 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 341 A e 68.8 2a0z_A NAG 6 5 6 6 5 6 5 6 6 6 5 5 6 5 6 6 6 6 0 0 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 342 S e 32.0 2a0z_A TGFB1_HUMAN:Transforming growth factor beta-1[111 aa] LP4:NAG:ZKM 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. A0A6I8TEX2_AEDAE:Toll-like receptor[750 aa]:Toll-like receptor[753 aa] 7 2 5 5 3 5 3 3 4 4 2 4 5 6 7 22 4 3 0 3 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 343 L e 49.4 7c76_A EDO 2 2 2 2 4 2 1 15 2 44 2 3 3 2 0 3 2 5 0 3 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 344 P b 0.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[111 aa] alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. TLR4_MOUSE:Q4G1L2_EPTBU:Toll-like receptor 4,Variable lymphocyte receptor .. 4 1 3 5 2 2 3 3 5 3 2 5 32 4 3 9 6 3 0 2 REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 12":TOPO_DOM:/note="Lumenal" 345 K E e 45.3 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[38 aa] NAG TLR4_MOUSE:Q4G1L2_EPTBU:Toll-like receptor 4,Variable lymphocyte receptor .. PO4 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 346 I E b 4.1 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[38 aa] NAG alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. 5 5 5 5 5 5 5 5 0 5 5 5 5 5 5 5 5 5 5 5 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 347 D e 25.3 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[38 aa] NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 4 2 15 9 1 4 3 4 4 4 2 8 9 6 6 8 6 3 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 348 D T e 34.6 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:TGFB1_HUMAN:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Transforming growth factor beta-1[38 aa]:Cadherin-1[213 aa]:VHH10[119 aa] 06S:NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Leucine rich repeat neuronal 6A[473 aa] 5 0 18 10 1 4 2 3 4 4 0 6 10 5 4 13 5 5 0 0 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 349 F T e 39.2 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:TGFB1_HUMAN:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[107 aa]:Transforming growth factor beta-1[112 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[38 aa]:Cadherin-1[213 aa]:VHH10[119 aa] NAG CA alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa] 6 2 6 3 16 7 2 5 3 19 1 4 2 2 6 6 5 3 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 350 S T b 0.0 7c76_A CAD1_HUMAN:CADH1_HUMAN:CADH1_MOUSE:TGFB1_HUMAN:E-CADHERIN[105 aa]:Epithelial-cadherin; E-Cad/CTF1[105 aa]:Epithelial-cadherin[103 aa]:Epithelial-cadherin[105 aa]:Epithelial-cadherin[107 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[38 aa]:Cadherin-1[213 aa]:VHH10[119 aa] NAG CL alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 12 2 3 6 4 5 2 3 2 6 2 5 5 4 3 21 8 4 2 0 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 351 F T b 0.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa]:Transforming growth factor beta-1[111 aa]:Transforming growth factor beta-1[38 aa] D80:UPT:I5B TLR8_HUMAN:Toll-like receptor 8[754 aa]:Toll-like receptor 8[749 aa] 5 3 2 0 33 3 0 9 3 16 2 0 5 0 0 3 4 5 3 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 352 Q T e 29.6 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa]:Transforming growth factor beta-1[111 aa]:VHH10[119 aa] NAG CU Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa] MES 5 0 6 7 2 4 5 2 7 7 2 6 2 14 6 14 3 2 3 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 353 W T b 12.7 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[168 aa] NAG:D80:URI:I5B alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[749 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[740 aa] 7 3 5 5 4 8 4 3 3 6 3 5 3 6 4 6 4 2 12 6 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 354 L b 0.0 7c76_A SO4 6 5 0 6 5 6 5 6 6 6 5 5 6 5 6 6 6 6 0 5 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 355 K T e 41.0 7c76_A NAG:URI:I5B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LRC8D_HUMAN:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 4 1 2 4 0 5 1 3 16 4 0 8 7 7 13 11 7 4 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 356 C T e 20.7 7c76_A NAG:URI:I5B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:Toll-like receptor 8[740 aa] BME:SO4 8 10 6 1 0 7 3 5 6 6 2 7 3 4 3 15 6 3 1 3 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 357 L b 0.0 7c76_A 3 1 0 4 2 2 0 6 0 58 3 0 1 0 0 2 3 10 3 0 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 358 E e 35.7 7c76_A FLIC_SALDU:BAK1_ARATH:IBP3_HUMAN:Flagellin[284 aa]:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Heavy Chain of Li81 Fab, VH3-23[221 aa]:Insulin-like growth factor-binding protein 3[167 a.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. LRC8D_HUMAN:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 2 0 6 19 2 3 3 2 9 3 3 6 4 11 7 6 9 3 2 0 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 359 H e 21.5 7c76_A BAK1_ARATH:CLE41_ARATH:A0A178VDH8_ARATH:CIF2_ARATH:SERK1_ARATH:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF/CLE41[12 aa]:CLE41[12 aa]:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Somatic embryogenesis receptor kinase 1[185 aa] beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. SO4 4 1 2 13 5 2 11 4 4 8 2 5 5 4 5 4 11 4 1 5 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 360 L E b 0.0 7c76_A 2 3 0 0 4 4 0 9 2 49 1 2 2 3 0 4 3 9 0 2 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 361 N E b 9.1 7c76_A LY96_HUMAN:CLE41_ARATH:A0A178VDH8_ARATH:CIF2_ARATH:Lymphocyte antigen 96[140 aa]:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:TDIF/CLE41[12 aa]:CLE41[12 aa]:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa] UCG:06S ZN alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. SO4 2 0 14 8 1 3 6 2 3 4 2 20 2 4 7 12 5 3 1 2 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 362 M b 1.4 7c76_A LY96_MOUSE:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa] ZKM 4 5 0 0 5 3 0 8 3 35 8 3 4 3 2 2 3 9 0 3 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 363 E e 22.1 7c76_A LY86_HUMAN:A4IFT3_BOVIN:LY86_MOUSE:CLE41_ARATH:A0A178VDH8_ARATH:CIF2_ARATH:Lymphocyte antigen 86[139 aa]:LY86 protein[138 aa]:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:TDIF/CLE41[12 aa]:CLE41[12 aa]:Variable Lymphocyte Receptor 2[192 aa]:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa] KDO:NAG alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:L-glycero-alpha-D-manno-heptopyranose-(1-7)-L-glyc..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1.. A0A6I8TEX2_AEDAE:Toll-like receptor[750 aa] 4 0 6 11 3 4 4 3 11 2 0 4 3 8 8 15 5 2 3 3 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 364 D S e 27.8 7c76_A LY86_MOUSE:FLIC_SALDU:E0U497_BACPZ:TGFB1_HUMAN:Lymphocyte antigen 86[139 aa]:Flagellin[295 aa]:Flagellin[284 aa]:Flagellin[169 aa]:Transforming growth factor beta-1[218 aa]:Transforming growth factor beta-1[111 aa] LP4:LP5:C09:RX8:D80:UPT:HB2:M8D:M4D:MBL:NAG:CU8:7VF:7VC:7VL:DY3:QLH:RQY:JRI:YHG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. TLR8_HUMAN:Q2EEY0_HORSE:TLR9_BOVIN:LGR4_XENTR:B3Y653_MACMU:TLR9_MOUSE:G7NS93_MACMU:A0A6I8TEX2_AEDAE:G8E2R2_MACMU:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor[751 aa]:Toll-like receptor[750 aa]:Toll-like receptor[752 aa]:Toll-like receptor[753 aa]:Toll-like receptor 7[768 aa] SO4 5 0 12 8 8 8 3 4 4 6 3 9 0 4 5 5 5 3 0 6 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 365 N b 0.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[209 aa]:Transforming growth factor beta-1[218 aa] TLR9_BOVIN:B3Y653_MACMU:G7NS93_MACMU:TLR4_MOUSE:Q4G1L2_EPTBU:G8E2R2_MACMU:Toll-like receptor 9[714 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 4,Variable lymphocyte receptor ..:Toll-like receptor 7[768 aa] 4 4 4 4 4 6 4 4 4 5 0 38 0 4 4 4 6 0 0 0 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 366 D b 13.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[209 aa]:Transforming growth factor beta-1[218 aa]:Transforming growth factor beta-1[111 aa] C09:L07:RX8:D87:NAG:D80:XG1:URI:HB2:M8D:M0A:M4D:IDQ:MBL:CU8:7VF:7VC:7VL:DY3:QSM:U57:QLH:GD0:I6A:I5N:RQY:JRI:YHG TLR4_MOUSE:TLR8_HUMAN:Q2EEY0_HORSE:TLR9_BOVIN:B3Y653_MACMU:Q4G1L2_EPTBU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 4, Variable lymphocyte receptor..:Toll-like receptor 8[739 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa]:Toll-like receptor 4,Variable lymphocyte receptor ..:Toll-like receptor 8[733 aa]:Toll-like receptor 8[736 aa]:Toll-like receptor 7[731 aa]:Toll-like receptor 7[768 aa] GOL:SO4 8 3 16 9 3 4 3 3 5 4 0 5 4 5 6 6 11 4 0 0 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 367 I B b 1.2 7c76_A alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 4 4 0 4 5 0 5 27 4 19 4 0 4 0 0 0 4 8 4 0 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 368 P e 45.7 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[111 aa] EX3:O0W:I5N:I5B:JRI TLR8_HUMAN:Q2EEY0_HORSE:TLR9_BOVIN:B3Y653_MACMU:G7NS93_MACMU:TLR4_MOUSE:Q4G1L2_EPTBU:G8E2R2_MACMU:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[763 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[744 aa]:Toll-like receptor 4,Variable lymphocyte receptor ..:Toll-like receptor 8[733 aa]:Toll-like receptor 8[736 aa]:Toll-like receptor 7[731 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 7[768 aa] 5 5 5 5 5 5 5 5 5 5 0 5 5 5 5 5 5 5 5 5 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 369 G e 26.2 7c76_A NAG:EX3:O0W:I5N:I5B:JRI B3Y653_MACMU:TLR8_HUMAN:Toll-like receptor 7[763 aa]:Toll-like receptor 8[736 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 7[731 aa]:Toll-like receptor 8[733 aa] SO4 6 1 4 8 3 28 2 1 6 2 1 5 1 5 4 8 7 4 0 3 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 370 I b 15.8 7c76_A B3Y653_MACMU:TLR4_MOUSE:Q4G1L2_EPTBU:Toll-like receptor 7[763 aa]:Toll-like receptor 4,Variable lymphocyte receptor ..:Toll-like receptor 7[731 aa] 4 0 3 3 4 0 0 28 3 23 3 1 3 2 3 3 2 14 0 0 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 371 K e 46.2 7c76_A ZKM B3Y653_MACMU:Toll-like receptor 7[763 aa]:Toll-like receptor 7[731 aa] 4 1 3 7 2 5 2 5 12 5 1 3 21 6 6 6 4 4 0 1 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 372 S T e 54.7 7c76_A NAG Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa] SO4 7 2 7 7 1 5 3 1 5 3 1 6 17 3 5 20 6 3 1 1 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 373 N T e 30.9 7c76_A NAG Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa] SO4 5 2 11 10 3 14 2 0 3 5 2 16 1 4 4 9 3 2 2 2 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 374 M S b 0.5 7c76_A 13 1 4 5 2 2 2 10 3 16 8 3 1 3 2 7 7 9 1 2 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 375 F S b 1.0 7c76_A Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[471 aa] 3 2 2 2 43 1 0 8 0 17 3 0 3 1 0 3 2 4 2 4 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 376 T T e 25.3 7c76_A NAG Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa] 7 3 5 5 1 6 3 2 7 6 1 3 3 10 5 14 12 5 1 1 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 377 G T e 26.2 7c76_A NAG Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa] SO4 7 1 3 3 2 30 6 2 6 2 1 11 5 4 4 11 2 2 1 1 REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 13":TOPO_DOM:/note="Lumenal" 378 L b 2.8 7c76_A Q96FE5_HUMAN:Leucine rich repeat neuronal 6A[471 aa] 4 5 2 4 4 2 1 3 3 45 8 1 3 0 1 5 2 7 0 0 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 379 I S e 50.9 7c76_A BAK1_ARATH:BRASSINOSTEROID INSENSITIVE 1-associated receptor .. NAG Q96FE5_HUMAN:LRC8D_HUMAN:Leucine rich repeat neuronal 6A[471 aa]:Leucine rich repeat neuronal 6A[470 aa]:Leucine rich repeat neuronal 6A[473 aa]:Leucine rich repeat neuronal 6A[472 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. 6 0 2 6 2 4 1 11 7 11 2 4 7 4 5 10 9 9 0 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 380 N S e 41.2 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. Q96FE5_HUMAN:LRC8D_HUMAN:Leucine rich repeat neuronal 6A[470 aa]:Leucine rich repeat neuronal 6A[472 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 6 0 6 4 1 6 3 1 4 2 0 27 4 6 8 17 4 0 0 2 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 381 L b 0.0 7c76_A 3 2 0 2 1 0 1 3 1 68 2 2 3 1 0 2 3 3 0 2 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 382 K e 47.2 7c76_A BAK1_ARATH:IBP3_HUMAN:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Insulin-like growth factor-binding protein 3[167 a.. NAG LRC8D_HUMAN:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 5 0 3 15 1 2 3 2 12 3 2 4 3 10 17 6 8 2 0 2 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 383 Y E e 26.1 7c76_A BAK1_ARATH:CLE41_ARATH:A0A178VDH8_ARATH:SERK1_ARATH:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:TDIF/CLE41[12 aa]:CLE41[12 aa]:Somatic embryogenesis receptor kinase 1[185 aa] alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 4 2 1 8 7 1 6 6 5 5 1 2 1 5 2 7 12 10 3 12 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 384 L E b 0.6 7c76_A 2 2 1 0 3 1 1 8 1 55 5 3 1 1 0 3 4 6 0 1 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 385 S E b 1.6 7c76_A 06S:NAG alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. 2 1 21 4 2 6 6 4 2 1 1 12 2 2 2 17 6 5 0 5 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 386 L b 1.1 7c76_A NA 6 6 6 0 6 6 0 6 6 6 6 6 6 6 0 6 6 6 0 6 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 387 S T b 5.5 7c76_A A0A178VDH8_ARATH:TDIF/CLE41[12 aa]:CLE41[12 aa] 06S:UPT:NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:beta-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. 8 3 9 4 0 10 2 2 4 2 0 6 6 4 4 24 6 5 0 0 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 388 N T e 35.2 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[209 aa]:Transforming growth factor beta-1[218 aa]:Transforming growth factor beta-1[160 aa] NAG:D80:ZKM:I5B:JRI beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. TLR8_HUMAN:Q2EEY0_HORSE:TLR9_BOVIN:LGR4_XENTR:B3Y653_MACMU:G7NS93_MACMU:A0A6I8TEX2_AEDAE:G8E2R2_MACMU:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor[751 aa]:Toll-like receptor[750 aa]:Toll-like receptor[752 aa]:Toll-like receptor[753 aa]:Toll-like receptor 7[768 aa] GOL:SO4:EDO 3 1 5 10 4 9 6 0 5 4 2 28 3 3 4 4 3 2 1 3 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 389 S b 0.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[218 aa] URI:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. Q2EEY0_HORSE:TLR9_BOVIN:TLR8_HUMAN:B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 7[768 aa] FMT 5 3 4 4 3 4 3 0 4 3 5 24 5 4 6 13 3 3 0 3 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 390 F B b 2.9 7c76_A C09:RX8:D80:URI:HB2:M8D:M0A:IDQ:MBL:I5B:JRI beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. TLR4_MOUSE:TLR8_HUMAN:Q2EEY0_HORSE:TLR9_BOVIN:B3Y653_MACMU:G7NS93_MACMU:Q4G1L2_EPTBU:G8E2R2_MACMU:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 4,Variable lymphocyte receptor ..:Toll-like receptor 8[740 aa]:Toll-like receptor 7[768 aa] FMT 3 0 6 4 22 3 4 5 3 11 3 5 6 3 4 3 3 5 3 4 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 391 T S e 31.2 7c76_A O0W:I5N:I5B TLR8_HUMAN:A0A6I8TEX2_AEDAE:Toll-like receptor 8[748 aa]:Toll-like receptor[750 aa]:Toll-like receptor[752 aa]:Toll-like receptor[753 aa]:Toll-like receptor 8[733 aa]:Toll-like receptor 8[737 aa] FMT 6 3 3 3 2 3 2 13 3 5 4 10 3 4 2 8 15 6 0 3 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 392 S e 52.3 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[209 aa]:Transforming growth factor beta-1[218 aa] NAG:EX3:JRI ZN TLR4_MOUSE:Q2EEY0_HORSE:TLR9_BOVIN:TLR8_HUMAN:B3Y653_MACMU:G7NS93_MACMU:Q4G1L2_EPTBU:G8E2R2_MACMU:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[763 aa]:Toll-like receptor 4,Variable lymphocyte receptor ..:Toll-like receptor 7[731 aa]:Toll-like receptor 7[768 aa] SO4:FMT 6 4 3 4 2 11 4 3 7 3 1 6 2 8 4 25 5 3 0 0 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 393 L b 10.1 7c76_A O0W:I5N:I5B TLR4_MOUSE:Q4G1L2_EPTBU:Toll-like receptor 4,Variable lymphocyte receptor .. SO4 3 1 2 3 6 5 0 12 3 33 4 2 2 1 5 4 5 7 2 3 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 394 R e 38.3 7c76_A NAG:EX0:EX3:O0W:ZKM beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. TLR4_MOUSE:Q4G1L2_EPTBU:B3Y653_MACMU:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 4, Variable lymphocyte receptor..:Toll-like receptor 7[763 aa]:Toll-like receptor 4,Variable lymphocyte receptor ..:Toll-like receptor 7[731 aa] SO4 3 3 3 7 2 5 3 4 12 6 2 4 6 6 16 7 6 3 0 0 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 395 T E e 51.3 7c76_A Variable Lymphocyte Receptor 9 (VLR9)[166 aa] NAG:GMP:SDL:RX8:IDQ:6T0:9K3:L07:C09:9JR:9K9:ACK:23G:EWL:EWU:EWX:EX0:O0W:ZKM:ZWV:QEC:QCX B3Y653_MACMU:TLR8_HUMAN:Toll-like receptor 7[776 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[763 aa]:Toll-like receptor 7[731 aa]:Toll-like receptor 8[749 aa] SO4 6 2 3 6 1 6 3 6 5 4 1 8 8 4 3 12 12 5 2 3 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 396 L E b 0.0 7c76_A PCJ:PDJ:PXS 5 4 1 5 3 3 3 12 1 33 4 2 3 2 3 5 2 6 0 1 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 397 T e 37.0 7c76_A BAK1_ARATH:BRASSINOSTEROID INSENSITIVE 1-associated receptor .. PXS:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. TLR8_HUMAN:Toll-like receptor 8[750 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[749 aa] SO4 7 2 8 6 0 6 3 5 6 5 2 3 12 2 3 10 14 5 1 1 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 398 N T e 34.5 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. 6 3 7 6 3 6 2 5 5 6 2 14 13 2 4 9 4 2 0 2 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 399 E T e 53.8 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:Toll-like receptor 8[748 aa] 5 1 6 17 1 10 4 4 5 6 2 7 5 5 6 9 2 3 0 2 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 400 T S b 9.7 7c76_A PXS:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. TLR8_HUMAN:Toll-like receptor 8[746 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[748 aa] 12 1 4 2 2 5 2 5 4 5 3 4 7 6 5 12 13 6 1 1 REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 14":TOPO_DOM:/note="Lumenal" 401 F S b 1.4 7c76_A PCJ:PDJ:PXS:LTC:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. TLR8_HUMAN:Toll-like receptor 8[746 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[708 aa] PCW 2 2 0 2 38 4 1 7 0 13 4 2 6 2 2 2 4 3 4 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 402 V G e 20.7 7c76_A NAG TLR8_HUMAN:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa] 6 5 3 5 3 9 2 5 6 10 3 3 7 4 4 6 5 8 2 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 403 S G b 8.6 7c76_A beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 7 2 6 5 6 10 5 0 7 4 2 8 9 4 3 12 6 2 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 404 L G b 1.1 7c76_A PXS:MAN alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(2-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. 6 5 6 0 5 6 0 6 6 6 5 5 6 5 6 6 6 6 5 5 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 405 A T e 40.2 7c76_A PCJ:PDJ:PXS:NAG LRC8D_HUMAN:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 13 4 7 5 2 13 2 3 5 6 1 4 7 3 3 10 4 6 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 406 H T e 86.9 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[160 aa] NAG:MAN alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(2-3)-[beta-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. LRC8D_HUMAN:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 4 2 3 7 2 3 14 2 9 8 1 12 6 5 3 7 3 3 1 5 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 407 S b 8.6 7c76_A NAG:MAN alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(2-3)-[beta-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. SO4 6 2 4 3 2 6 2 4 6 8 2 5 7 5 5 15 9 7 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 408 P e 32.6 7c76_A NAG:UCG 5 2 3 3 5 4 2 1 5 6 1 4 25 3 3 15 5 3 1 2 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 409 L b 1.1 7c76_A UCG:06S 2 1 0 1 3 2 0 5 4 49 2 2 3 5 5 3 1 6 0 2 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 410 H e 29.3 7c76_A SERK1_ARATH:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Somatic embryogenesis receptor kinase 1[185 aa] NAG LRC8D_HUMAN:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 4 2 3 8 2 5 10 5 11 3 2 4 0 6 10 6 7 3 2 6 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 411 I E e 35.7 7c76_A NTNG1_HUMAN:CIF2_ARATH:NETRIN-G1[326 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa] NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 4 3 3 4 4 2 2 17 4 11 3 1 3 3 3 5 11 12 2 4 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 412 L E b 1.7 7c76_A LY86_MOUSE:Lymphocyte antigen 86[139 aa] alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 3 0 0 2 4 2 0 6 2 56 2 2 3 2 3 2 2 5 2 3 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" L->F:LB/B:rs3775291: -; 413 N E e 22.4 7c76_A CIF2_ARATH:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa] NAG:06S 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-..:beta-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1.. 2 2 12 5 3 4 7 5 2 1 1 21 1 4 7 7 5 2 1 6 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 414 L b 0.0 7c76_A L-glycero-alpha-D-manno-heptopyranose-(1-7)-L-glyc.. GOL 3 2 3 2 6 4 0 5 2 49 3 0 3 2 3 2 3 4 0 2 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 415 T b 7.1 7c76_A NTNG2_HUMAN:CLE41_ARATH:A0A178VDH8_ARATH:NETRIN-G2[303 aa]:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:TDIF/CLE41[12 aa]:CLE41[12 aa] GLC:NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1.. TLR4_HUMAN:Toll-like receptor 4[601 aa]:Toll-like receptor 4[605 aa] 5 5 3 5 2 5 4 3 8 0 4 6 2 4 6 17 10 4 2 5 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 416 K S e 44.3 7c76_A A4IFT3_BOVIN:FLIC_SALDU:NTNG1_HUMAN:E0U497_BACPZ:LY86 protein[138 aa]:LY86 protein[136 aa]:LY86 protein[135 aa]:Fab15 heavy chain[225 aa]:Flagellin[295 aa]:Flagellin[284 aa]:NETRIN-G1[326 aa]:Flagellin[169 aa] D80:NAG:UPT:I5B:YHG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1.. TLR4_HUMAN:TLR8_HUMAN:LGR4_XENTR:TLR9_MOUSE:B3Y653_MACMU:A0A6I8TEX2_AEDAE:G8E2R2_MACMU:Toll-like receptor 4[601 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[754 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor[751 aa]:Toll-like receptor[750 aa]:Toll-like receptor[752 aa]:Toll-like receptor[753 aa]:Toll-like receptor 7[768 aa] GOL:SO4 5 5 5 5 5 5 5 5 5 5 5 5 0 5 5 5 5 5 5 5 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 417 N S b 0.0 7c76_A Fab15 heavy chain[225 aa] PCJ:PDJ:NAG alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. TLR4_HUMAN:TLR4_MOUSE:TLR8_HUMAN:LGR4_XENTR:Q4G1L2_EPTBU:Toll-like receptor 4[601 aa]:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 4, Variable lymphocyte receptor..:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 4,Variable lymphocyte receptor .. 2 3 2 3 3 3 0 3 4 9 0 46 3 3 3 8 3 3 0 0 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 418 K e 42.5 7c76_A FLIC_SALDU:Fab15 heavy chain[225 aa]:Flagellin[295 aa]:Flagellin[284 aa] NAG:D80:URI:O0W:I5B 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR4_HUMAN:TLR4_MOUSE:TLR8_HUMAN:Q2EEY0_HORSE:TLR9_BOVIN:LGR4_XENTR:B3Y653_MACMU:Q4G1L2_EPTBU:TLR9_MOUSE:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 4[601 aa]:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 4[605 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[754 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 4, Variable lymphocyte receptor..:Toll-like receptor 8[739 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 4,Variable lymphocyte receptor ..:Toll-like receptor 7[768 aa] SO4 3 3 4 12 3 8 2 2 12 5 0 6 7 5 13 4 2 2 0 6 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 419 I b 0.0 7c76_A PCJ:PDJ:PXS:BLD PCW 7 7 0 0 7 7 7 7 0 7 7 0 7 0 0 7 7 7 7 7 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 420 S e 28.1 7c76_A DNA (5'-D(*TP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*GP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*CP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*TP*CP*GP*T)-3') NAG:GMP:SDL:RX8:CU8:7VF:7VC:7VL:IDQ:6T0:9K3:L07:C09:9JR:9K9:ACK:23G:DY3:EWL:EWU:EWX:EX0:QSM:QLH:GD0:I6A:I5N:RQY:JRI:YHG:ZWV:QEC:QCX TLR4_MOUSE:TLR8_HUMAN:TLR13_MOUSE:B3Y653_MACMU:TLR9_BOVIN:TLR9_MOUSE:Q4G1L2_EPTBU:G8E2R2_MACMU:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 13[709 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[763 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa]:Toll-like receptor 4,Variable lymphocyte receptor ..:Toll-like receptor 8[733 aa]:Toll-like receptor 7[731 aa]:Toll-like receptor 7[768 aa] 3 1 5 5 4 9 2 4 5 5 1 4 4 3 6 18 16 3 0 2 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 421 K E e 37.7 7c76_A CU8:7VF:7VC:7VL:DY3:QSM:QLH:GD0:I6A:RQY:JRI:YHG TLR8_HUMAN:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[744 aa]:Toll-like receptor 8[733 aa]:Toll-like receptor 8[749 aa] PO4 4 1 9 8 4 14 3 5 7 6 2 5 2 3 5 11 6 3 2 1 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 422 I E b 4.7 7c76_A DNA (5'-D(*TP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*GP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*CP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*TP*CP*GP*T)-3') GMP:SDL:RX8:IDQ:6T0:9K3:L07:C09:9JR:9K9:ACK:23G:EWL:EWU:EWX:EX0:ZWV:QEC:QCX TLR4_MOUSE:Q4G1L2_EPTBU:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 4, Variable lymphocyte receptor..:Toll-like receptor 4,Variable lymphocyte receptor .. SO4 5 3 2 2 4 2 1 24 2 19 3 3 2 1 0 3 4 16 0 3 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 423 E e 33.7 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4 7 2 6 10 2 6 5 6 5 5 1 3 13 4 7 7 4 4 1 2 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 424 S T e 43.8 7c76_A LY96_MOUSE:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa] LP5:NAG:V2A:ZKM beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-alp..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:Toll-like receptor 8[737 aa]:Toll-like receptor 8[750 aa] SO4 5 4 4 4 6 5 1 3 5 4 2 5 18 2 7 12 6 2 3 2 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 425 D T e 26.5 7c76_A LY96_MOUSE:TGFB1_HUMAN:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa]:Transforming growth factor beta-1[111 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 6 3 11 11 1 10 2 2 8 2 0 9 7 5 6 7 3 2 0 4 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 426 A T b 0.0 7c76_A LY96_MOUSE:TGFB1_HUMAN:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa]:Transforming growth factor beta-1[111 aa] 17 2 2 7 0 7 2 4 3 7 2 4 4 4 3 12 7 7 2 1 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 427 F T b 0.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[38 aa]:Transforming growth factor beta-1[111 aa] 1 3 2 3 42 1 2 5 1 21 2 1 3 1 1 2 1 4 1 1 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 428 S T e 30.5 7c76_A LY96_MOUSE:TGFB1_HUMAN:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa]:Transforming growth factor beta-1[38 aa] NAG 8 2 5 3 2 9 2 1 8 3 1 6 3 8 7 19 7 3 0 2 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 429 W T e 39.4 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1[38 aa] NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 4 5 4 4 3 15 3 3 7 4 2 8 1 3 6 9 6 2 5 5 REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 15":TOPO_DOM:/note="Lumenal" 430 L b 1.7 7c76_A PCJ:LTC 2 5 1 1 6 1 1 5 2 48 5 1 2 2 2 7 2 3 1 4 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 431 G S e 28.6 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. LRC8D_HUMAN:Volume-regulated anion channel subunit LRRC8D[714 .. 7 2 4 3 2 23 4 1 8 3 1 5 10 3 4 11 6 2 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 432 H S e 57.1 7c76_A BAK1_ARATH:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa] NAG LRC8D_HUMAN:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 5 2 2 6 1 3 9 0 12 3 1 11 2 9 8 16 4 1 0 4 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 433 L b 0.6 7c76_A 2 3 0 5 2 0 0 5 2 63 4 0 2 0 0 2 3 3 0 3 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 434 E e 33.2 7c76_A SERK1_ARATH:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Somatic embryogenesis receptor kinase 1[185 aa] NAG LRC8D_HUMAN:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 4 1 5 19 1 2 4 2 10 2 2 3 2 12 5 7 9 5 0 4 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 435 V E e 20.7 7c76_A NTNG1_HUMAN:IBP3_HUMAN:NETRIN-G1[326 aa]:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Insulin-like growth factor-binding protein 3[167 a.. 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1.. 4 2 2 5 6 1 3 8 5 12 3 6 0 2 4 8 8 8 2 9 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 436 L E b 0.0 7c76_A PCJ:PDJ 3 0 2 2 6 2 0 7 2 51 2 1 0 2 4 2 5 5 0 2 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 437 D E b 19.8 7c76_A NTNG2_HUMAN:NTNG1_HUMAN:RSPO1_HUMAN:RSPO2_MOUSE:CLE41_ARATH:A0A178VDH8_ARATH:CIF2_ARATH:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:R-SPONDIN-1[104 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-2[102 aa]:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:TDIF/CLE41[12 aa]:CLE41[12 aa]:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa] GLC:NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-..:beta-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1.. 3 2 35 6 1 2 2 5 2 2 2 13 3 2 4 3 4 1 0 6 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 438 L b 0.0 7c76_A PCJ:PXS:LTC:PDK PCW 2 3 0 3 4 0 0 7 4 53 4 4 3 3 2 0 0 6 0 0 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 439 G b 4.8 7c76_A NTNG1_HUMAN:Q2G0X7_STAA8:CLE41_ARATH:A0A178VDH8_ARATH:CIF2_ARATH:Pam2CSK4[6 aa]:NETRIN-G1[326 aa]:Staphylococcal Superantigen-Like protein 3[190 aa]..:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:TDIF/CLE41[12 aa]:CLE41[12 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa] GLC:NAG alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. EDO 5 0 4 3 4 21 3 2 3 2 0 3 3 4 6 26 4 2 1 3 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 440 L S e 46.6 7c76_A Q2G0X7_STAA8:TGFB1_HUMAN:Fab15 light chain[214 aa]:Fab15 heavy chain[225 aa]:Staphylococcal Superantigen-Like protein 3[190 aa]..:Transforming growth factor beta-1 proprotein[308 a.. PXS:LTC:PDK:NAG:I5B alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. TLR8_HUMAN:LGR4_XENTR:TLR13_MOUSE:TLR9_MOUSE:TLR4_MOUSE:Q4G1L2_EPTBU:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[754 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 13[709 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 4,Variable lymphocyte receptor .. GOL 4 1 7 4 3 5 11 5 3 13 0 10 2 2 5 9 5 4 1 6 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 441 N S b 6.7 7c76_A FLIC_SALDU:Q2G0X7_STAA8:Fab15 heavy chain[225 aa]:Flagellin[295 aa]:Staphylococcal Superantigen-Like protein 3[190 aa].. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:LGR4_XENTR:TLR13_MOUSE:TLR9_MOUSE:Toll-like receptor 8[747 aa]:Toll-like receptor 8[749 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 13[709 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa] GOL 1 1 2 4 0 1 0 2 1 1 1 69 2 1 2 4 4 1 1 1 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 442 E e 41.7 7c76_A Fab15 heavy chain[225 aa] D80:URI:NAG:DY3:QSM:QLH:I6A:I5N:RQY:YHG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR4_MOUSE:TLR8_HUMAN:TLR13_MOUSE:Q4G1L2_EPTBU:TLR9_MOUSE:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 13[709 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 4, Variable lymphocyte receptor..:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa]:Toll-like receptor 4,Variable lymphocyte receptor .. GOL:SO4 3 1 8 17 1 4 4 0 9 5 1 4 4 12 9 10 3 2 1 2 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 443 I b 0.6 7c76_A 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. Q2EEY0_HORSE:TLR9_BOVIN:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa] PCW 1 2 1 1 8 3 1 31 1 27 4 2 0 3 2 2 2 6 0 2 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 444 G E b 17.9 7c76_A Q2G0X7_STAA8:Staphylococcal Superantigen-Like protein 3[190 aa].. NAG:CU8:7VF:7VC:7VL:DY3:O0W:QSM:QLH:GD0:I6A:I5N:I5B:RQY:JRI:YHG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR4_HUMAN:TLR4_MOUSE:TLR8_HUMAN:Q4G1L2_EPTBU:TLR9_MOUSE:Toll-like receptor 4[601 aa]:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 4[605 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 4, Variable lymphocyte receptor..:Toll-like receptor 8[739 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 4,Variable lymphocyte receptor ..:Toll-like receptor 8[736 aa]:Toll-like receptor 8[740 aa] 6 2 4 3 3 12 2 2 7 7 0 5 5 4 4 19 9 3 1 2 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 445 Q E b 4.1 7c76_A NAG:LP5:V2A:CU8:7VF:7VC:7VL:DY3:QSM:GD0:ZKM:JRI:YHG TLR4_HUMAN:TLR8_HUMAN:TLR13_MOUSE:CD33_HUMAN:LRFN4_MOUSE:Toll-like receptor 4[601 aa]:Toll-like receptor 4[605 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 13[709 aa]:Myeloid cell surface antigen CD33,Leucine-rich rep..:Toll-like receptor 8[736 aa]:Toll-like receptor 8[734 aa] 3 2 2 9 3 10 2 2 8 4 2 5 4 11 8 11 6 3 1 3 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 446 E E e 46.2 7c76_A Fab1068 light chain[215 aa] RX8:NAG:URI:M4D:MBL:CU8:7VF:7VC:7VL:DY3:U57:GD0 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. Q2EEY0_HORSE:LGR4_XENTR:TLR8_HUMAN:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[747 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 8[751 aa] SO4 8 2 4 18 4 3 2 7 5 6 2 4 2 5 3 14 4 5 1 2 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 447 L b 2.2 7c76_A LY96_MOUSE:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa] PCJ:PDJ:PXS:LTC:PDK 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. Q2EEY0_HORSE:TLR9_BOVIN:TLR8_HUMAN:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 8[736 aa]:Toll-like receptor 8[734 aa] PCW 2 3 2 2 4 2 0 15 2 28 3 2 4 2 2 3 3 15 0 4 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 448 T e 44.2 7c76_A LY96_MOUSE:Fab1068 light chain[215 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa] LP5:NAG:V2A MG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-alp..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. Q2EEY0_HORSE:TLR9_BOVIN:TLR8_HUMAN:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 8[736 aa]:Toll-like receptor 8[734 aa] 5 3 6 4 2 4 3 5 2 6 4 6 15 4 3 9 11 6 0 2 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 449 G S b 1.2 7c76_A LY96_MOUSE:Fab1068 light chain[215 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[137 aa] DNA (5'-D(*TP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*GP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*CP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*TP*CP*GP*T)-3') LP5:V2A:NAG:ZKM MG Q2EEY0_HORSE:TLR9_BOVIN:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa] SO4 6 3 4 4 4 23 3 4 3 4 2 4 11 2 4 11 4 3 0 2 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 450 Q e 29.1 7c76_A Fab1068 light chain[215 aa] DNA (5'-D(*TP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*GP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*CP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*TP*CP*GP*T)-3') V2A:LP5:NAG:ZKM beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-alp..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR9_BOVIN:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa] 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 451 E T b 2.0 7c76_A LY96_HUMAN:Lymphocyte antigen 96[140 aa] TLR8_HUMAN:B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 8[754 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[768 aa] SO4 14 3 10 14 2 2 2 5 3 6 2 4 5 3 3 10 5 6 0 0 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 452 W T b 2.0 7c76_A B3Y653_MACMU:G7NS93_MACMU:TLR7_HUMAN:G8E2R2_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[763 aa]:Toll-like receptor 7[786 aa]:Toll-like receptor 7[731 aa]:Toll-like receptor 7[768 aa] 4 5 2 1 28 3 2 4 2 17 2 1 5 1 2 1 2 3 10 4 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 453 R T e 43.1 7c76_A LY96_MOUSE:Fab1068 light chain[215 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 8 2 2 7 3 8 2 3 11 5 2 3 3 8 19 8 4 3 1 1 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 454 G T b 17.9 7c76_A LY96_MOUSE:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa] DNA (5'-D(*TP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*GP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*CP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*TP*CP*GP*T)-3') NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[768 aa] SO4 5 2 3 2 3 33 2 1 8 2 4 8 5 5 3 9 3 3 0 1 REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 16":TOPO_DOM:/note="Lumenal" 455 L b 1.1 7c76_A DNA (5'-D(*TP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*GP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*CP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*TP*CP*GP*T)-3') PCJ:PDJ:PXS:LTC:NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[763 aa]:Toll-like receptor 7[731 aa]:Toll-like receptor 7[768 aa] 4 4 2 1 3 1 3 4 2 47 6 1 5 1 3 5 1 3 2 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 456 E S e 62.3 7c76_A DNA (5'-D(*GP*CP*GP*CP*AP*C)-3') NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. LGR4_XENTR:B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[763 aa]:Toll-like receptor 7[731 aa]:Toll-like receptor 7[768 aa] SO4 4 0 7 18 1 6 4 2 9 2 1 7 9 5 6 8 8 2 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 457 N S e 43.6 7c76_A TLR6_MOUSE:Q4G1L3_EPTBU:BAK1_ARATH:Toll-like receptor 6, Variable lymphocyte receptor..:BRASSINOSTEROID INSENSITIVE 1-associated receptor .. 06S:GMP:SDL:RX8:IDQ:9K3:L07:C09:9JR:9K9:ACK:NAG:23G:EWL:EWU:EWX:EX0:ZWV:QEC:QCX 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[763 aa]:Toll-like receptor 7[731 aa]:Toll-like receptor 7[768 aa] 4 3 4 3 0 9 2 0 6 2 2 27 4 5 6 11 6 2 0 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 458 I b 0.0 7c76_A PCJ:PDJ:PXS:LTC:PDK:NAG:BLD:UPT:GMP:SDL:RX8:IDQ:6T0:9K3:L07:C09:9JR:9K9:ACK:23G:EWL:EWU:EWX:EX0:ZWV:QEC:QCX alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[763 aa]:Toll-like receptor 7[731 aa]:Toll-like receptor 7[768 aa] PCW 3 3 2 1 3 2 2 11 0 44 4 1 3 1 2 3 3 11 0 0 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 459 F e 30.1 7c76_A TLR6_MOUSE:Q4G1L3_EPTBU:Q2G0X7_STAA8:Toll-like receptor 6, Variable lymphocyte receptor..:Pam2CSK4[6 aa]:Staphylococcal Superantigen-Like protein 3[190 aa]..:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa] PCJ:PDJ:PXS:LTC:PDK:UPT:GMP:SDL:RX8:NAG:IDQ:6T0:9K3:L07:C09:9JR:9K9:ACK:23G:EWL:EWU:EWX:EX0:ZWV:QEC:QCX alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. LGR4_XENTR:B3Y653_MACMU:G7NS93_MACMU:LRC8D_HUMAN:G8E2R2_MACMU:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Volume-regulated anion channel subunit LRRC8D[714 ..:Toll-like receptor 7[768 aa] PCW 5 3 2 7 11 3 3 3 5 12 2 3 7 6 6 4 8 7 2 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 460 E E b 17.1 7c76_A BAK1_ARATH:Q2G0X7_STAA8:CLE41_ARATH:A0A178VDH8_ARATH:CIF2_ARATH:LRC8A_MOUSE:C562_ECOLX:Pam2CSK4[6 aa]:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Staphylococcal Superantigen-Like protein 3[190 aa]..:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:TDIF/CLE41[12 aa]:CLE41[12 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. PCJ:PDJ:PXS:LTC:PDK:06S:UPT alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. LGR4_XENTR:Leucine-rich repeat-containing G-protein coupled r.. SO4:PCW 3 1 5 20 1 5 4 2 6 4 1 4 3 4 7 9 8 8 2 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 461 I E b 0.0 7c76_A PCJ:PXS:06S:UPT:NAG NA SO4 5 3 2 2 2 4 2 15 2 38 4 3 0 1 1 5 0 9 0 0 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 462 Y E e 25.2 7c76_A NTNG2_HUMAN:NTNG1_HUMAN:Q2G0X7_STAA8:CLE41_ARATH:A0A178VDH8_ARATH:CIF2_ARATH:Pam2CSK4[6 aa]:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:Staphylococcal Superantigen-Like protein 3[190 aa]..:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:CLE41[12 aa]:Protein CASPARIAN STRIP INTEGRITY FACTOR 2[21 aa] GLC:PCJ:PDJ:PXS:PDK:NAG:06S alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:beta-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1.. PCW 4 3 8 5 6 2 5 4 5 7 1 8 4 3 5 5 2 5 2 16 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 463 L b 1.7 7c76_A 3 1 2 1 4 2 2 10 2 45 4 1 9 1 2 2 1 6 0 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 464 S b 10.9 7c76_A NTNG2_HUMAN:NTNG1_HUMAN:Q2G0X7_STAA8:SERK1_ARATH:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:Staphylococcal Superantigen-Like protein 3[190 aa]..:TDIF[12 aa]:Somatic embryogenesis receptor kinase 1[185 aa] GLC:NAG alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 9 5 3 4 3 6 2 2 3 2 1 6 4 6 3 27 8 5 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 465 Y S e 41.3 7c76_A RSPO1_HUMAN:RSPO2_MOUSE:SERK1_ARATH:TGFB1_HUMAN:Fab15 light chain[214 aa]:Fab15 heavy chain[225 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:Somatic embryogenesis receptor kinase 1[185 aa]:Transforming growth factor beta-1[160 aa] PCJ:PDJ:PXS:LTC:NAG CL alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. LGR4_XENTR:TLR13_MOUSE:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 13[709 aa] PCW 3 0 6 6 8 9 8 4 4 3 2 6 0 2 5 8 6 4 3 14 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 466 N b 10.3 7c76_A TGFB1_HUMAN:Fab15 heavy chain[225 aa]:Transforming growth factor beta-1[160 aa] NAG NA TLR4_HUMAN:TLR13_MOUSE:Toll-like receptor 4[601 aa]:Toll-like receptor 4[605 aa]:Toll-like receptor 13[709 aa] 2 4 2 2 3 4 3 2 2 5 0 52 0 0 3 5 5 3 2 0 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 467 K S e 58.5 7c76_A SERK1_ARATH:TGFB1_HUMAN:Fab15 heavy chain[225 aa]:Somatic embryogenesis receptor kinase 1[185 aa]:Transforming growth factor beta-1[160 aa] NAG CA:NA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR4_HUMAN:TLR4_MOUSE:TLR13_MOUSE:Q4G1L2_EPTBU:LRFN5_HUMAN:LRFN1_MOUSE:TLR9_MOUSE:LRFN5_MOUSE:Toll-like receptor 4[601 aa]:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 4[605 aa]:Toll-like receptor 13[709 aa]:Toll-like receptor 4, Variable lymphocyte receptor..:Leucine-rich repeat and fibronectin type-III domai..:Leucine-rich repeat and fibronectin type III domai..:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 4,Variable lymphocyte receptor .. 3 0 2 7 3 3 2 3 16 5 3 9 5 7 15 7 3 2 1 1 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 468 Y E e 34.3 7c76_A Q2G0X7_STAA8:SERK1_ARATH:Fab15 heavy chain[225 aa]:Staphylococcal Superantigen-Like protein 3[190 aa]..:Somatic embryogenesis receptor kinase 1[185 aa] BLD:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. TLR4_HUMAN:Toll-like receptor 4[601 aa]:Toll-like receptor 4[605 aa] 6 0 0 6 5 6 5 6 6 6 5 5 6 5 6 6 6 6 5 5 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 469 L E b 0.0 7c76_A FLIC_SALDU:E0U497_BACPZ:Flagellin[295 aa]:Flagellin[284 aa]:Flagellin[169 aa] DNA (5'-D(*TP*CP*GP*C)-3') NAG CA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR13_MOUSE:LRFN5_HUMAN:Toll-like receptor 13[709 aa]:Leucine-rich repeat and fibronectin type-III domai.. 4 1 4 4 2 4 1 7 5 28 3 1 0 4 5 9 11 5 0 1 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 470 Q E e 30.1 7c76_A TLR6_MOUSE:Q4G1L3_EPTBU:Q2G0X7_STAA8:Toll-like receptor 6, Variable lymphocyte receptor..:Staphylococcal Superantigen-Like protein 3[190 aa].. NAG CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. 4 0 7 7 3 12 4 3 9 5 2 4 2 7 6 10 6 4 2 4 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 471 L b 0.0 7c76_A TLR6_MOUSE:Q4G1L3_EPTBU:LY96_MOUSE:Q2G0X7_STAA8:Toll-like receptor 6, Variable lymphocyte receptor..:Lymphocyte antigen 96[135 aa]:Staphylococcal Superantigen-Like protein 3[190 aa]..:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa] DNA (5'-D(*TP*CP*GP*C)-3') PDK TLR9_MOUSE:Toll-like receptor 9[753 aa] 2 1 2 3 6 1 1 14 2 37 4 2 3 1 2 3 3 11 0 3 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 472 T b 18.8 7c76_A LY96_HUMAN:LY96_MOUSE:Lymphocyte antigen 96[140 aa]:Fab1068 light chain[215 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa] FTT:LP5:BLD:V2A:NAG CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. 5 0 5 4 3 4 4 7 4 4 2 5 14 3 5 14 11 4 0 3 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 473 R T e 64.0 7c76_A LY96_HUMAN:LY96_MOUSE:Lymphocyte antigen 96[140 aa]:Fab1068 light chain[215 aa]:Fab1068 heavy chain[217 aa]:Lymphocyte antigen 96[135 aa]:Lymphocyte antigen 96[136 aa]:Lymphocyte antigen 96[137 aa] BLD:NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:A0A6I8TEX2_AEDAE:Toll-like receptor 8[754 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor[751 aa]:Toll-like receptor[752 aa] 5 1 7 6 2 6 4 2 6 4 2 6 17 4 11 8 2 2 1 2 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 474 N T e 50.3 7c76_A TLR6_MOUSE:Q4G1L3_EPTBU:LY96_HUMAN:LY96_MOUSE:Q2G0X7_STAA8:Toll-like receptor 6, Variable lymphocyte receptor..:Lymphocyte antigen 96[140 aa]:Fab1068 light chain[215 aa]:Fab1068 heavy chain[217 aa]:Lymphocyte antigen 96[135 aa]:Staphylococcal Superantigen-Like protein 3[190 aa]..:Lymphocyte antigen 96[137 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. TLR8_HUMAN:Toll-like receptor 8[754 aa]:Toll-like receptor 8[749 aa] 5 2 8 5 3 10 2 4 5 4 1 23 3 3 4 8 3 3 0 3 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 475 S S b 0.0 7c76_A C09:L07:RX8:D80:XG1:URI:HB2:NAG:M8D:M0A:M4D:IDQ:MBL:U57:GD0:YHG TLR8_HUMAN:A0A6I8TEX2_AEDAE:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[754 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor[752 aa] 11 1 4 5 2 7 3 6 3 9 2 4 10 3 2 16 4 5 2 2 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 476 F S b 0.0 7c76_A 2 2 2 3 38 2 2 8 3 19 2 2 3 0 3 2 3 2 2 3 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 477 A S e 35.7 7c76_A LY96_HUMAN:LY96_MOUSE:Lymphocyte antigen 96[140 aa]:Fab1068 heavy chain[217 aa]:Lymphocyte antigen 96[135 aa] NAG:C09:L07:RX8:D80:XG1:URI:HB2:M8D:M0A:M4D:IDQ:MBL:U57:I5B alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:Toll-like receptor 8[754 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[740 aa] SO4 10 3 3 4 2 13 3 2 7 3 2 4 3 7 8 12 5 4 2 2 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 478 L S e 36.0 7c76_A Fab1068 light chain[215 aa]:Fab1068 heavy chain[217 aa] NAG:I5B MG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:Toll-like receptor 8[740 aa] SO4 6 3 5 6 1 11 4 5 5 16 2 7 4 5 3 5 3 4 2 2 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 479 V b 0.0 7c76_A DNA (5'-D(*TP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*GP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*CP*CP*GP*CP*AP*C)-3') NAG MG Q2EEY0_HORSE:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa] SO4 4 5 3 3 6 0 3 7 3 30 5 4 5 3 3 3 4 6 3 3 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 480 P T e 59.7 7c76_A DNA (5'-D(*TP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*GP*CP*GP*CP*AP*C)-3') :DNA (5'-D(*CP*CP*GP*CP*AP*C)-3') NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4 6 5 6 6 5 6 5 6 6 6 0 5 6 5 6 6 6 6 0 5 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 481 S T e 21.9 7c76_A NAG:NDG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR9_BOVIN:LRC8D_HUMAN:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 9 2 6 7 2 6 2 0 5 3 1 9 0 5 4 28 6 3 0 2 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 482 L b 0.0 7c76_A DNA (5'-D(*TP*CP*GP*T)-3') NAG TLR9_BOVIN:Toll-like receptor 9[714 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa] 2 2 2 2 2 4 0 7 0 52 4 2 2 3 3 3 3 6 1 3 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 483 Q e 33.2 7c76_A IGG1_HUMAN:IBP3_HUMAN:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Immunoglobulin gamma-1 heavy chain[198 aa]:Insulin-like growth factor-binding protein 3[167 a.. DNA (5'-D(*TP*CP*GP*T)-3') NAG LRC8D_HUMAN:Volume-regulated anion channel subunit LRRC8D[714 .. SO4:PO4 3 0 2 12 2 3 3 3 10 5 2 3 5 19 8 4 6 4 3 1 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 484 R E e 28.1 7c76_A NTNG2_HUMAN:NTNG1_HUMAN:IL6_HUMAN:CLE41_ARATH:SERK2_ARATH:A0A178VDH8_ARATH:BTK_HUMAN:IGG1_HUMAN:ASC_HUMAN:IBP3_HUMAN:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:Interleukin-6[166 aa]:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:Somatic embryogenesis receptor kinase 2[185 aa]:TDIF/CLE41[12 aa]:CLE41[12 aa]:Tyrosine-protein kinase BTK[104 aa]:Immunoglobulin gamma-1 heavy chain[198 aa]:Apoptosis-associated speck-like protein containing..:Insulin-like growth factor-binding protein 3[167 a.. PAB CL alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. RTN4R_MOUSE:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa] 1PE:GOL 3 0 6 9 4 7 3 3 9 5 2 4 3 4 14 8 6 4 2 5 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 485 L E b 0.0 7c76_A IL6_HUMAN:Interleukin-6[155 aa] 4 2 0 3 3 4 2 6 0 56 2 2 2 2 2 3 2 3 0 0 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 486 M E b 17.9 7c76_A NTNG2_HUMAN:NTNG1_HUMAN:IL6_HUMAN:BAK1_ARATH:CLE41_ARATH:A0A178VDH8_ARATH:ASC_HUMAN:SERK1_ARATH:SPIKE_SARS2:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Peptide from CLAVATA3/ESR (CLE)-related protein 41..:TDIF[12 aa]:TDIF/CLE41[12 aa]:CLE41[12 aa]:Apoptosis-associated speck-like protein containing..:Somatic embryogenesis receptor kinase 1[185 aa]:Spike protein S1[196 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. PAB CL alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. TLR8_HUMAN:RTN4R_MOUSE:Toll-like receptor 8[747 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa] GOL 2 1 7 6 4 2 4 6 3 12 10 9 2 2 5 10 6 4 2 4 REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 17":TOPO_DOM:/note="Lumenal" 487 L b 1.1 7c76_A SERK1_ARATH:Somatic embryogenesis receptor kinase 1[185 aa] NA TLR8_HUMAN:Toll-like receptor 8[747 aa] 3 2 2 2 6 4 2 10 0 44 3 0 2 1 2 5 5 4 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 488 R e 27.7 7c76_A NTNG2_HUMAN:BAK1_ARATH:ASC_HUMAN:SERK1_ARATH:SPIKE_SARS2:Fab15 light chain[214 aa]:NETRIN-G2[303 aa]:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Apoptosis-associated speck-like protein containing..:Somatic embryogenesis receptor kinase 1[185 aa]:Spike protein S1[196 aa]:Spike glycoprotein[1036 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. CL alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. RTN4R_MOUSE:TLR9_MOUSE:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa] SO4:GOL 5 0 7 4 2 5 4 4 6 8 0 8 2 9 14 14 4 3 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 489 R S e 62.5 7c76_A TLR6_MOUSE:Q4G1L3_EPTBU:FLIC_SALDU:RSPO1_HUMAN:RSPO2_MOUSE:CO5_HUMAN:E0U497_BACPZ:ASC_HUMAN:SERK1_ARATH:TGFB1_HUMAN:Toll-like receptor 6, Variable lymphocyte receptor..:Fab15 light chain[214 aa]:Fab15 heavy chain[225 aa]:Flagellin[295 aa]:Flagellin[284 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:C5a anaphylatoxin[72 aa]:Flagellin[169 aa]:Apoptosis-associated speck-like protein containing..:Somatic embryogenesis receptor kinase 1[185 aa]:Transforming growth factor beta-1 proprotein[308 a.. 46-MER:DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) CL:NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:A0A6I8TEX2_AEDAE:Toll-like receptor 8[708 aa]:Toll-like receptor[752 aa] SO4 4 0 6 5 2 12 8 3 3 5 2 11 3 5 15 8 2 3 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 490 V S b 1.3 7c76_A CO5_HUMAN:BTK_HUMAN:C5a anaphylatoxin[72 aa]:Tyrosine-protein kinase BTK[104 aa] NAG NA:CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. SO4 4 3 2 2 4 3 0 11 0 15 0 27 2 0 2 4 4 8 2 4 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 491 A e 41.1 7c76_A TLR6_MOUSE:Q4G1L3_EPTBU:FLIC_SALDU:RSPO2_MOUSE:E0U497_BACPZ:Toll-like receptor 6, Variable lymphocyte receptor..:Fab15 light chain[214 aa]:Fab15 heavy chain[225 aa]:Flagellin[295 aa]:Flagellin[284 aa]:R-SPONDIN-2[102 aa]:Flagellin[169 aa] PDK:NAG:U57 CL:CA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. TLR4_HUMAN:TLR8_HUMAN:LRFN5_HUMAN:LRFN1_MOUSE:LRFN5_MOUSE:CD33_HUMAN:LRFN4_MOUSE:Toll-like receptor 4[601 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 4[605 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[735 aa]:Leucine-rich repeat and fibronectin type-III domai..:Leucine-rich repeat and fibronectin type III domai..:Myeloid cell surface antigen CD33,Leucine-rich rep..:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[737 aa] SO4 15 2 4 6 4 9 3 0 4 5 2 6 3 6 4 15 6 3 0 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 492 L b 3.9 7c76_A FLIC_SALDU:RSPO2_MOUSE:E0U497_BACPZ:Fab15 heavy chain[225 aa]:Flagellin[295 aa]:Flagellin[284 aa]:R-SPONDIN-2[102 aa]:Flagellin[169 aa] UPT:NAG alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa] 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 0 5 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 493 K B e 42.9 7c76_A TLR6_MOUSE:Q4G1L3_EPTBU:Toll-like receptor 6, Variable lymphocyte receptor..:Fab fragment 1D9 light chain[219 aa]:Fab15 heavy chain[225 aa] UPT:NAG:U57 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR4_HUMAN:TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 4[601 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 4[605 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa] 5 1 3 5 2 5 1 3 13 5 0 11 3 7 9 13 9 2 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 494 N S e 40.0 7c76_A FLIC_SALDU:E0U497_BACPZ:Fab fragment 1D9 light chain[219 aa]:Flagellin[295 aa]:Flagellin[284 aa]:Flagellin[169 aa] DNA (5'-D(*TP*CP*GP*C)-3') FTT:C09:L07:RX8:LP5:D80:XG1:URI:UPT:HB2:M8D:M0A:M4D:IDQ:MBL:NAG:U57 CL:NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa] SO4 4 1 7 5 3 8 7 2 4 2 2 16 3 3 7 13 9 3 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 495 V b 6.7 7c76_A FLIC_SALDU:E0U497_BACPZ:Flagellin[295 aa]:Flagellin[284 aa]:Flagellin[169 aa] DNA (5'-D(*TP*CP*GP*C)-3') C09:L07:RX8:D80:XG1:URI:HB2:M8D:M0A:M4D:IDQ:U57 CL TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[744 aa] SO4 3 1 2 1 2 3 0 21 1 28 3 3 1 0 2 6 6 14 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 496 D e 43.8 7c76_A FLIC_SALDU:E0U497_BACPZ:Fab fragment 1D9 heavy chain[219 aa]:Flagellin[295 aa]:Flagellin[284 aa]:Flagellin[169 aa] DNA (5'-D(*TP*CP*GP*C)-3') C09:L07:RX8:D80:XG1:URI:HB2:M8D:M0A:M4D:IDQ:MBL:NAG:U57 CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. TLR8_HUMAN:B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 8[739 aa]:Toll-like receptor 8[734 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 8[730 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 7[768 aa] SO4 5 1 15 12 2 11 1 2 5 4 0 8 8 4 5 6 8 2 0 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 497 S b 19.5 7c76_A LY96_HUMAN:Lymphocyte antigen 96[140 aa] DNA (5'-D(*TP*CP*GP*C)-3') NAG CL B3DIN1_DANRE:Q4G1L2_EPTBU:TLR8_HUMAN:RTN4R_MOUSE:Toll-like receptor 5b and variable lymphocyte rece..:Toll-like receptor 8[754 aa]:Toll-like receptor 8[749 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa] SO4 7 1 7 5 3 5 2 6 7 10 3 4 3 2 5 17 7 4 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 498 S S e 71.9 7c76_A LY96_HUMAN:Lymphocyte antigen 96[140 aa]:Fab1068 heavy chain[217 aa] FTT:LP5:NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. RTN4R_MOUSE:TLR8_HUMAN:TLR3_HUMAN:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[733 aa]:Toll-like receptor 3[668 aa]:Toll-like receptor 3[659 aa] SO4:EDO 7 2 3 4 2 8 4 10 2 11 2 6 3 3 5 19 5 5 0 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 499 P S e 26.4 7c76_A LY96_HUMAN:FLIC_SALDU:E0U497_BACPZ:Lymphocyte antigen 96[140 aa]:Fab fragment 1D9 heavy chain[219 aa]:Fab1068 heavy chain[217 aa]:Flagellin[295 aa]:Flagellin[284 aa]:Flagellin[169 aa] FTT:LP5:CU8 TLR8_HUMAN:Toll-like receptor 8[750 aa] BU3:SO4:EDO 8 3 3 4 3 7 2 3 1 6 1 2 37 2 2 7 4 3 0 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 500 S b 3.9 7c76_A NAG CA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:Toll-like receptor 8[743 aa]:Toll-like receptor 8[734 aa] SO4 10 2 4 7 4 13 3 3 3 5 2 5 3 4 5 16 4 3 1 4 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 501 P T b 1.6 7c76_A FLIC_SALDU:E0U497_BACPZ:Flagellin[295 aa]:Flagellin[284 aa]:Flagellin[169 aa] Q2EEY0_HORSE:TLR8_HUMAN:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 8[743 aa] SO4 12 1 6 8 2 8 2 3 3 4 3 2 18 1 2 10 6 6 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 502 F T b 0.0 7c76_A FLIC_SALDU:E0U497_BACPZ:Flagellin[295 aa]:Flagellin[284 aa]:Flagellin[169 aa] TLR8_HUMAN:Toll-like receptor 8[743 aa] EDO 3 1 1 1 43 3 1 8 0 21 2 1 1 1 2 2 1 4 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 503 Q S e 46.9 7c76_A LY96_HUMAN:Lymphocyte antigen 96[140 aa]:Fab fragment 1D9 heavy chain[219 aa]:Fab fragment 1D9 heavy chain[216 aa]:Fab1068 heavy chain[217 aa] NAG RTN4R_MOUSE:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[308 aa] EDO 8 2 4 5 3 9 3 1 6 6 3 2 6 14 7 8 7 3 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 504 P S e 24.8 7c76_A LY96_HUMAN:Lymphocyte antigen 96[140 aa]:Fab fragment 1D9 heavy chain[219 aa]:Fab fragment 1D9 heavy chain[216 aa]:Fab1068 heavy chain[217 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. A0A6I8TEX2_AEDAE:Toll-like receptor[754 aa] EDO 6 1 5 6 1 14 4 1 6 3 1 8 19 3 6 8 4 1 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 505 L b 0.0 7c76_A F8W3J5_DANRE:Q4G1L2_EPTBU:Toll-like receptor 5b, Variable lymphocyte recepto.. EDO 4 6 0 1 2 3 2 2 1 54 6 2 2 0 0 2 3 7 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 506 R T e 40.3 7c76_A BAK1_ARATH:F8W3J5_DANRE:Q4G1L2_EPTBU:Fab fragment 1D9 heavy chain[219 aa]:Fab fragment 1D9 heavy chain[216 aa]:Fab1068 heavy chain[217 aa]:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Toll-like receptor 5b, Variable lymphocyte recepto.. NAG:NDG alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:RTN4R_MOUSE:Toll-like receptor 8[747 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa] 7 2 2 4 1 4 2 1 10 3 1 2 10 7 20 6 8 5 1 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 507 N T e 38.8 7c76_A BAK1_ARATH:F8W3J5_DANRE:Q4G1L2_EPTBU:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Toll-like receptor 5b, Variable lymphocyte recepto.. NAG:NDG CL alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. TLR8_HUMAN:LRC8D_HUMAN:Toll-like receptor 8[747 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. 4 0 3 4 1 4 2 2 7 2 2 27 1 5 5 20 5 3 0 2 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16043704, ECO:0000269|PubMed:22579623":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 508 L b 0.0 7c76_A 4 2 0 3 0 2 0 4 3 68 2 0 2 0 1 1 2 4 0 1 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 509 T b 18.8 7c76_A RSPO1_HUMAN:BAK1_ARATH:F8W3J5_DANRE:Q4G1L2_EPTBU:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Toll-like receptor 5b, Variable lymphocyte recepto.. NAG:BLD CL:CA LRC8D_HUMAN:Volume-regulated anion channel subunit LRRC8D[714 .. 2 1 1 8 2 3 1 3 9 2 4 2 2 7 10 10 23 4 2 1 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 510 I E b 11.7 7c76_A NTNG2_HUMAN:NTNG1_HUMAN:IL6_HUMAN:EGFR_HUMAN:PTPRD_MOUSE:CO5_HUMAN:SERK2_ARATH:F8W3J5_DANRE:Q4G1L2_EPTBU:BTK_HUMAN:ASC_HUMAN:IBP3_HUMAN:SPIKE_SARS2:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:Interleukin-6[166 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:C5a anaphylatoxin[72 aa]:Somatic embryogenesis receptor kinase 2[185 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Tyrosine-protein kinase BTK[104 aa]:Apoptosis-associated speck-like protein containing..:Insulin-like growth factor-binding protein 3[167 a..:Spike glycoprotein[1036 aa] BLD CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. AMGO1_MOUSE:RTN4R_MOUSE:LRC8D_HUMAN:Amphoterin-induced protein 1[333 aa]:Amphoterin-induced protein 1[331 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. GOL:1PE 5 5 1 5 6 0 6 7 2 17 2 4 0 1 4 8 7 13 2 5 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 511 L E b 0.6 7c76_A 3 2 0 0 4 0 0 7 0 65 6 0 0 0 0 4 0 6 0 0 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 512 D E b 7.4 7c76_A NTNG2_HUMAN:NTNG1_HUMAN:RSPO1_HUMAN:IL6_HUMAN:RSPO2_MOUSE:CO5_HUMAN:F8W3J5_DANRE:Q4G1L2_EPTBU:BTK_HUMAN:IGG1_HUMAN:ASC_HUMAN:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:R-SPONDIN-1[103 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:R-SPONDIN-2[102 aa]:C5a anaphylatoxin[72 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Tyrosine-protein kinase BTK[104 aa]:Immunoglobulin gamma-1 heavy chain[198 aa]:Apoptosis-associated speck-like protein containing.. DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:RNA (5'-R(*GP*UP*CP*CP*C)-3') PAB:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. K0IE77_PETMA:RTN4R_MOUSE:Variable lymphocyte receptor[217 aa]:Variable lymphocyte receptor[218 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa] GOL:SO4:ETE:MES 5 0 24 9 2 2 8 2 6 3 1 7 0 5 5 6 2 6 3 4 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 513 L b 2.2 7c76_A CO5_HUMAN:C5a anaphylatoxin[72 aa] RNA (5'-R(*AP*UP*UP*AP*A)-3') :RNA (5'-R(*GP*UP*CP*CP*C)-3') 4 2 0 0 7 5 0 11 0 50 4 2 0 0 0 0 2 7 3 0 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 514 S b 0.0 7c76_A RSPO1_HUMAN:IL6_HUMAN:RSPO2_MOUSE:CO5_HUMAN:F8W3J5_DANRE:Q4G1L2_EPTBU:IGG1_HUMAN:ASC_HUMAN:SPIKE_SARS2:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:R-SPONDIN-2[102 aa]:C5a anaphylatoxin[72 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Immunoglobulin gamma-1 heavy chain[198 aa]:Apoptosis-associated speck-like protein containing..:Spike glycoprotein[1036 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. NAG CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. RTN4R_MOUSE:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa] SO4 11 2 6 5 2 6 2 0 5 6 3 5 0 3 4 31 3 1 1 2 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 515 N S b 17.0 7c76_A NTNG1_HUMAN:RSPO1_HUMAN:RSPO2_MOUSE:CO5_HUMAN:F8W3J5_DANRE:Q4G1L2_EPTBU:BTK_HUMAN:IGG1_HUMAN:ASC_HUMAN:TGFB1_HUMAN:Fab15 light chain[214 aa]:NETRIN-G1[326 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:C5a anaphylatoxin[72 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Tyrosine-protein kinase BTK[104 aa]:Immunoglobulin gamma-1 heavy chain[198 aa]:Apoptosis-associated speck-like protein containing..:Transforming growth factor beta-1[160 aa] 46-MER:DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG CL:NA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. AMGO1_MOUSE:LRC8D_HUMAN:Amphoterin-induced protein 1[333 aa]:Volume-regulated anion channel subunit LRRC8D[714 ..:Volume-regulated anion channel subunit LRRC8D[713 .. SO4:GOL 3 0 5 4 2 16 5 0 3 5 2 25 4 2 6 7 3 0 2 5 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 516 N S b 2.4 7c76_A CO5_HUMAN:Fab15 light chain[214 aa]:C5a anaphylatoxin[72 aa] RNA (5'-R(P*UP*UP*UP*U)-3') :RNA (5'-R(*AP*UP*UP*AP*A)-3') :RNA (5'-R(P*UP*UP*CP*A)-3') :RNA (5'-R(P*UP*UP*GP*A)-3') :RNA (5'-R(*GP*UP*CP*CP*C)-3') :RNA (5'-R(P*UP*UP*AP*A)-3') :RNA (81-MER) B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 7[768 aa] 2 3 3 0 2 6 0 2 4 3 3 58 1 2 2 4 4 0 0 0 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 517 N e 63.0 7c76_A TLR2_HUMAN:Q4G1L2_EPTBU:TLR2_MOUSE:FLIC_SALDU:RSPO1_HUMAN:E0U497_BACPZ:F8W3J5_DANRE:TGFB1_HUMAN:Toll-like receptor 2,Variable lymphocyte receptor ..:Toll-like receptor 2, Variable lymphocyte receptor..:Fab15 light chain[214 aa]:Fab15 heavy chain[225 aa]:Flagellin[295 aa]:Flagellin[284 aa]:R-SPONDIN-1[104 aa]:Flagellin[169 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Transforming growth factor beta-1 proprotein[308 a..:Transforming growth factor beta-1[160 aa] 46-MER:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR4_HUMAN:TLR4_MOUSE:K0IE77_PETMA:TLR8_HUMAN:B3Y653_MACMU:Q4G1L2_EPTBU:LRFN5_HUMAN:LRFN1_MOUSE:G7NS93_MACMU:LRFN5_MOUSE:CD33_HUMAN:LRFN4_MOUSE:G8E2R2_MACMU:Toll-like receptor 4[601 aa]:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 4[605 aa]:Variable lymphocyte receptor[217 aa]:Variable lymphocyte receptor[218 aa]:Toll-like receptor 8[754 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 4, Variable lymphocyte receptor..:Leucine-rich repeat and fibronectin type-III domai..:Leucine-rich repeat and fibronectin type III domai..:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Myeloid cell surface antigen CD33,Leucine-rich rep..:Toll-like receptor 4,Variable lymphocyte receptor ..:Toll-like receptor 7[768 aa] SO4 5 1 3 6 5 5 4 1 10 5 1 15 3 7 15 8 2 3 0 2 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 518 I b 7.0 7c76_A B3Y653_MACMU:G7NS93_MACMU:TLR8_HUMAN:G8E2R2_MACMU:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 7[768 aa] 0 0 0 1 8 2 0 27 0 44 1 3 0 0 0 1 2 7 0 3 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 519 A e 25.0 7c76_A TLR2_HUMAN:Q4G1L2_EPTBU:TLR2_MOUSE:Toll-like receptor 2,Variable lymphocyte receptor ..:Toll-like receptor 2, Variable lymphocyte receptor..:Fab fragment 1D9 light chain[219 aa]:Fab15 heavy chain[225 aa] 46-MER:DNA (5'-D(*CP*AP*TP*GP*AP*CP*GP*TP*TP*CP*CP*T)-3')..:DNA (5'-D(P*GP*GP*CP*GP*TP*T)-3') :RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) D80:URI 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR5_HUMAN:TLR4_MOUSE:TLR8_HUMAN:B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 5[632 aa]:Toll-like receptor 4[596 aa]:Toll-like receptor 4[581 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 7[768 aa] 8 5 6 10 0 3 4 2 8 5 1 4 1 4 6 12 13 6 0 1 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 520 N e 46.1 7c76_A Fab fragment 1D9 light chain[219 aa] 46-MER:DNA (5'-D(*CP*AP*TP*GP*AP*CP*GP*TP*TP*CP*CP*T)-3')..:DNA (5'-D(P*GP*GP*CP*GP*TP*T)-3') :RNA component of mitochondrial RNAase P (Rmrp), RN.. U57 CL:NA TLR8_HUMAN:Q2EEY0_HORSE:TLR9_BOVIN:TLR9_MOUSE:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa] 6 1 5 10 2 12 3 2 2 2 1 11 1 3 5 15 7 6 1 5 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 521 I b 6.4 7c76_A TLR2_HUMAN:Q4G1L2_EPTBU:LY96_HUMAN:Toll-like receptor 2,Variable lymphocyte receptor ..:Lymphocyte antigen 96[140 aa] DNA (5'-D(*TP*CP*GP*C)-3') D80:URI Q2EEY0_HORSE:B3Y653_MACMU:TLR9_MOUSE:G7NS93_MACMU:TLR8_HUMAN:G8E2R2_MACMU:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 7[768 aa] SO4 3 1 2 3 3 1 1 24 2 25 3 2 1 1 2 4 2 19 0 1 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 522 N e 32.1 7c76_A LY96_HUMAN:Lymphocyte antigen 96[140 aa]:Fab1068 heavy chain[217 aa] DNA (5'-D(*TP*CP*GP*C)-3') NAG:U57 CL TLR8_HUMAN:Q2EEY0_HORSE:TLR9_BOVIN:RTN4R_MOUSE:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[308 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa] GOL:SO4 8 2 5 9 3 7 2 7 2 4 1 3 24 4 3 8 3 3 0 2 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 523 D S e 52.5 7c76_A TLR2_MOUSE:Q4G1L2_EPTBU:LY96_HUMAN:Toll-like receptor 2, Variable lymphocyte receptor..:Lymphocyte antigen 96[140 aa]:Fab1068 heavy chain[217 aa] NAG CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:RTN4R_MOUSE:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Toll-like receptor 8[681 aa] GOL:EDO 5 0 15 11 1 8 1 1 5 2 2 7 20 2 2 10 4 2 1 2 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 524 D T e 34.0 7c76_A TLR2_MOUSE:Q4G1L2_EPTBU:LY96_HUMAN:Toll-like receptor 2, Variable lymphocyte receptor..:Lymphocyte antigen 96[140 aa]:Fab1068 heavy chain[217 aa] CA TLR9_BOVIN:RTN4R_MOUSE:A0A6I8TEX2_AEDAE:Toll-like receptor 9[714 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor[752 aa] GOL 6 1 12 10 2 17 2 2 8 3 0 10 3 4 4 10 2 1 1 1 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 525 M T b 4.8 7c76_A 16 2 3 4 4 4 1 10 2 14 2 2 2 5 1 10 8 7 0 1 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 526 L S b 1.7 7c76_A NAG BU3 1 6 0 1 31 3 0 6 2 35 2 0 5 0 0 0 3 2 1 0 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 527 E e 31.2 7c76_A LY96_HUMAN:Lymphocyte antigen 96[140 aa]:Fab1068 heavy chain[217 aa] NAG RTN4R_MOUSE:A0A6I8TEX2_AEDAE:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Toll-like receptor[754 aa]:Toll-like receptor[752 aa] GOL 10 1 5 12 3 9 3 2 7 3 2 3 2 12 8 12 4 2 0 1 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 528 G S e 44.0 7c76_A NAG RTN4R_MOUSE:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa] 6 1 5 4 1 33 5 2 5 3 1 12 3 2 2 7 4 1 4 1 REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 18":TOPO_DOM:/note="Lumenal" 529 L b 0.6 7c76_A NAG 2 5 0 0 3 0 0 5 0 56 7 2 5 2 0 1 3 6 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 530 E T e 43.7 7c76_A BAK1_ARATH:Q30BZ2_PHYSO:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Cell 12A endoglucanase[222 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. RTN4R_MOUSE:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa] ACT 4 0 3 15 1 4 2 3 6 4 0 2 18 5 5 12 9 4 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 531 K T e 29.7 7c76_A BAK1_ARATH:Q30BZ2_PHYSO:BRASSINOSTEROID INSENSITIVE 1-associated receptor ..:Cell 12A endoglucanase[222 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. K0IE77_PETMA:RTN4R_MOUSE:Variable lymphocyte receptor[218 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa] ACT 5 1 2 7 2 3 3 0 16 3 1 19 2 5 8 18 4 2 0 1 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 532 L b 0.0 7c76_A Q30BZ2_PHYSO:Cell 12A endoglucanase[222 aa] NAG 1 0 0 1 1 0 0 4 1 77 3 1 1 0 1 1 0 6 0 0 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 533 E e 34.7 7c76_A RSPO1_HUMAN:PTPRD_MOUSE:SERK2_ARATH:F8W3J5_DANRE:Q4G1L2_EPTBU:Q30BZ2_PHYSO:LRC8A_MOUSE:C562_ECOLX:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:Somatic embryogenesis receptor kinase 2[185 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Cell 12A endoglucanase[222 aa]:Volume-regulated anion channel subunit LRRC8A,Solu..:Volume-regulated anion channel subunit LRRC8A[407 .. BLD:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. K0IE77_PETMA:LRC8D_HUMAN:Variable lymphocyte receptor[218 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 2 0 1 22 1 1 2 1 12 3 1 3 0 15 12 7 9 3 0 2 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 534 I E e 24.6 7c76_A NTNG2_HUMAN:NTNG1_HUMAN:IL6_HUMAN:PTPRD_HUMAN:PTPRD_MOUSE:F8W3J5_DANRE:Q4G1L2_EPTBU:BTK_HUMAN:ERBB2_HUMAN:ASC_HUMAN:LRC8A_MOUSE:C562_ECOLX:SPIKE_SARS2:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:Toll-like receptor 5b, Variable lymphocyte recepto..:Variable Lymphocyte Receptor 9 (VLR9)[166 aa]:Variable Lymphocyte Receptor 9 (VLR9)[165 aa]:Tyrosine-protein kinase BTK[104 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa]:Apoptosis-associated speck-like protein containing..:Volume-regulated anion channel subunit LRRC8A,Solu..:Volume-regulated anion channel subunit LRRC8A[407 ..:Spike glycoprotein[1036 aa] BLD:NAG CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. RTN4R_MOUSE:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Reticulon-4 receptor[311 aa] GOL:BU3:1PE:SO4:PEG 4 1 3 11 2 2 3 10 3 6 1 2 0 3 4 9 9 13 3 9 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 535 L E b 0.6 7c76_A NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. 0 1 0 2 2 1 0 6 0 76 3 1 1 0 1 1 1 2 2 1 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 536 D E b 19.8 7c76_A NTNG2_HUMAN:RSPO1_HUMAN:IL6_HUMAN:RSPO2_MOUSE:CO5_HUMAN:BTK_HUMAN:ERBB2_HUMAN:ASC_HUMAN:SPIKE_SARS2:NETRIN-G2[303 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:R-SPONDIN-2[102 aa]:C5a anaphylatoxin[72 aa]:Tyrosine-protein kinase BTK[104 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa]:Apoptosis-associated speck-like protein containing..:Spike glycoprotein[1036 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-a..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. RTN4R_MOUSE:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa] GOL:SO4:PEG 0 0 30 3 2 3 5 4 5 3 1 13 1 4 3 10 3 1 2 5 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 537 L b 2.2 7c76_A CO5_HUMAN:C5a anaphylatoxin[72 aa] BU3 2 1 1 0 7 1 0 6 0 68 5 0 0 0 0 1 0 6 0 0 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 538 Q b 9.2 7c76_A NTNG1_HUMAN:RSPO1_HUMAN:IL6_HUMAN:RSPO2_MOUSE:EGFR_HUMAN:PTPRD_MOUSE:BTK_HUMAN:IGG1_HUMAN:ASC_HUMAN:NETRIN-G1[326 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:Tyrosine-protein kinase BTK[104 aa]:Immunoglobulin gamma-1 heavy chain[198 aa]:Apoptosis-associated speck-like protein containing.. NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-..:beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-a..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. AMGO1_MOUSE:RTN4R_MOUSE:Amphoterin-induced protein 1[333 aa]:Amphoterin-induced protein 1[331 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa] SO4:GOL:ETE:PEG 5 1 5 4 0 6 3 1 3 2 1 7 2 10 8 33 3 2 1 2 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 539 H S e 37.7 7c76_A TLR2_MOUSE:Q4G1L2_EPTBU:NTNG2_HUMAN:RSPO1_HUMAN:RSPO2_MOUSE:EGFR_HUMAN:PTPRD_MOUSE:CO5_HUMAN:F8W3J5_DANRE:BTK_HUMAN:ASC_HUMAN:TGFB1_HUMAN:SPIKE_SARS2:Toll-like receptor 2, Variable lymphocyte receptor..:Fab15 light chain[214 aa]:NETRIN-G2[303 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:C5a anaphylatoxin[72 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Tyrosine-protein kinase BTK[104 aa]:Apoptosis-associated speck-like protein containing..:Transforming growth factor beta-1 proprotein[308 a..:Spike protein S1[196 aa] 46-MER:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. AMGO1_MOUSE:LRC8D_HUMAN:Amphoterin-induced protein 1[333 aa]:Volume-regulated anion channel subunit LRRC8D[714 ..:Volume-regulated anion channel subunit LRRC8D[713 .. SO4:ETE:PEG 4 2 6 4 3 18 16 0 6 2 2 14 0 2 5 6 1 1 0 10 MUTAGEN:/note="H->A: No effect.":MUTAGEN:/note="H->E: Loss of RNA binding. Constitutive activation of NF-kappa-B.":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":MUTAGEN:/note="H->A: No effect.":MUTAGEN:/note="H->E: Loss of RNA binding. Constitutive activation of NF-kappa-B.":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 540 N S b 1.8 7c76_A TLR2_HUMAN:Q4G1L2_EPTBU:TLR2_MOUSE:RSPO2_MOUSE:Toll-like receptor 2,Variable lymphocyte receptor ..:Toll-like receptor 2, Variable lymphocyte receptor..:R-SPONDIN-2[102 aa] 46-MER:RNA (80-MER):RNA (46-MER) 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. CD33_HUMAN:LRFN4_MOUSE:Myeloid cell surface antigen CD33,Leucine-rich rep.. 2 2 1 1 1 2 0 1 1 4 0 77 0 0 0 2 5 1 0 0 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 541 N e 49.7 7c76_A TLR2_HUMAN:Q4G1L2_EPTBU:TLR2_MOUSE:RSPO1_HUMAN:TGFB1_HUMAN:Toll-like receptor 2,Variable lymphocyte receptor ..:Toll-like receptor 2, Variable lymphocyte receptor..:Fab15 heavy chain[225 aa]:R-SPONDIN-1[104 aa]:Transforming growth factor beta-1 proprotein[308 a.. 46-MER:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. K0IE77_PETMA:CD33_HUMAN:LRFN4_MOUSE:Variable lymphocyte receptor[217 aa]:Variable lymphocyte receptor[218 aa]:Myeloid cell surface antigen CD33,Leucine-rich rep.. 4 1 3 5 2 6 5 0 11 1 2 17 4 13 11 12 1 1 0 1 MUTAGEN:/note="N->A: Loss of RNA binding. Abolishes activation of NF-kappa-B.":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":MUTAGEN:/note="N->A: Loss of RNA binding. Abolishes activation of NF-kappa-B.":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 542 L b 1.1 7c76_A 0 1 0 0 9 1 0 25 0 50 2 0 0 1 2 2 0 3 1 0 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 543 A T b 17.0 7c76_A TLR2_HUMAN:Q4G1L2_EPTBU:TLR2_MOUSE:IBP3_HUMAN:Toll-like receptor 2,Variable lymphocyte receptor ..:Toll-like receptor 2, Variable lymphocyte receptor..:Fab fragment 1D9 light chain[219 aa]:anti-MBP[231 aa]:Insulin-like growth factor-binding protein 3[167 a.. 46-MER:DNA (5'-D(*CP*AP*TP*GP*AP*CP*GP*TP*TP*CP*CP*T)-3')..:DNA (5'-D(P*GP*GP*CP*GP*TP*T)-3') :RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG SO4:PG4:PO4 8 1 3 11 2 4 3 2 6 5 1 1 2 6 6 17 16 6 0 1 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 544 R T e 46.6 7c76_A Q16J57_AEDAE:IBP3_HUMAN:Fab15 heavy chain[225 aa]:anti-MBP[231 aa]:AAEL013433-PA[92 aa]:Insulin-like growth factor-binding protein 3[167 a.. 46-MER:DNA (5'-D(*CP*AP*TP*GP*AP*CP*GP*TP*TP*CP*CP*T)-3')..:DNA (5'-D(P*GP*GP*CP*GP*TP*T)-3') :DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') :RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG TLR8_HUMAN:Q2EEY0_HORSE:TLR9_BOVIN:B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 8[754 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 9[732 aa]:Toll-like receptor 9[738 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 7[768 aa] SO4:PO4 8 1 5 6 3 7 3 1 8 3 0 3 2 5 18 12 5 5 0 4 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 545 L T b 5.6 7c76_A Q16J57_AEDAE:TGFB1_HUMAN:AAEL013433-PA[99 aa]:Transforming growth factor beta-1 proprotein[305 a.. DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. I5B TLR8_HUMAN:Toll-like receptor 8[754 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[740 aa] 2 1 1 2 4 1 1 17 2 36 4 3 1 1 1 3 2 16 1 1 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 546 W S b 1.6 7c76_A Q16J57_AEDAE:AAEL013433-PA[92 aa]:AAEL013433-PA[96 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. TLR8_HUMAN:Toll-like receptor 8[708 aa]:Toll-like receptor 8[740 aa] 6 1 6 5 6 6 2 5 2 6 1 3 14 3 3 7 4 6 9 4 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 547 K e 27.8 7c76_A TLR2_MOUSE:Q4G1L2_EPTBU:Q16J57_AEDAE:Toll-like receptor 2, Variable lymphocyte receptor..:AAEL013433-PA[99 aa]:AAEL013433-PA[92 aa]:AAEL013433-PA[96 aa]:AAEL013433-PA[91 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. NAG TLR9_MOUSE:TLR8_HUMAN:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[740 aa] 7 1 5 8 4 5 1 3 9 9 2 5 11 3 5 11 5 5 0 2 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 548 H S e 74.9 7c76_A Q16J57_AEDAE:AAEL013433-PA[92 aa]:AAEL013433-PA[96 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') UPT:NAG TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[754 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa] 5 2 5 10 3 9 10 3 3 3 1 9 3 5 7 11 3 4 2 2 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 549 A S e 86.6 7c76_A Q16J57_AEDAE:AAEL013433-PA[96 aa] UPT TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[754 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[681 aa]:Toll-like receptor 8[740 aa] 19 5 3 5 3 9 1 6 5 6 2 3 3 3 2 11 6 5 1 4 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 550 N S b 18.8 7c76_A Q16J57_AEDAE:AAEL013433-PA[96 aa] D80:UPT TLR8_HUMAN:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[754 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[681 aa] 6 2 5 4 6 6 2 7 3 10 2 17 6 3 3 7 5 5 1 2 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 551 P T e 102.3 7c76_A D80:URI TLR8_HUMAN:Toll-like receptor 8[743 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[754 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[730 aa] 6 1 6 5 3 5 1 4 3 7 1 4 26 3 4 6 6 5 1 2 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 552 G T e 113.1 7c76_A SERK2_ARATH:Q16J57_AEDAE:Somatic embryogenesis receptor kinase 2[185 aa]:AAEL013433-PA[99 aa]:AAEL013433-PA[96 aa] D80:URI TLR8_HUMAN:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[754 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 8[681 aa] 6 1 4 5 4 19 2 5 4 8 2 5 5 3 4 9 5 4 1 3 REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 19":TOPO_DOM:/note="Lumenal" 553 G e 27.4 7c76_A beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[737 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[752 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[742 aa]:Toll-like receptor 8[724 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 8[681 aa] EDO 9 2 4 7 3 18 2 3 4 9 2 4 3 3 5 11 5 4 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 554 P e 25.6 7c76_A NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 5 3 5 5 2 4 1 4 3 5 1 3 33 3 3 10 4 3 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" P->S:LP/P:rs1214344: Immunodeficiency 83, susceptibility to viral infections (IMD83) ; 555 I b 16.4 7c76_A RTN4R_MOUSE:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa] SO4:EDO 6 1 5 4 6 4 1 14 4 13 3 3 7 4 2 4 6 9 2 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 556 Y e 35.7 7c76_A Q16J57_AEDAE:AAEL013433-PA[99 aa]:AAEL013433-PA[96 aa] GLC:NAG SO4 10 2 4 7 6 6 3 4 4 6 2 5 9 4 4 8 5 4 2 4 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 557 F b 1.0 7c76_A LRC8A_MOUSE:C562_ECOLX:Volume-regulated anion channel subunit LRRC8A,Solu.. NAG BU3:EDO 8 3 2 4 18 5 4 5 4 9 3 4 4 2 3 6 4 6 2 4 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 558 L S b 0.6 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1 proprotein[305 a.. BU3 2 1 1 2 20 3 2 7 2 42 3 1 2 1 1 3 2 5 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 559 K S e 50.5 7c76_A Q16J57_AEDAE:AAEL013433-PA[99 aa] GLC:NAG RTN4R_MOUSE:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa] SO4:EDO 5 0 4 6 1 8 2 3 14 2 0 6 2 11 12 9 8 3 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 560 G S e 42.9 7c76_A NAG alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. RTN4R_MOUSE:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa] EDO 5 2 6 5 2 33 2 1 4 2 0 11 2 3 3 10 5 1 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 561 L b 0.0 7c76_A EDO 3 5 1 2 5 1 1 4 1 55 4 2 1 2 1 1 3 5 0 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 562 S e 22.7 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. K0IE77_PETMA:Variable lymphocyte receptor[218 aa] SO4 7 0 3 4 3 6 2 3 9 2 1 4 7 5 8 16 11 5 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 563 H S e 44.5 7c76_A BTK_HUMAN:Q30BZ2_PHYSO:Tyrosine-protein kinase BTK[104 aa]:Cell 12A endoglucanase[222 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:K0IE77_PETMA:RTN4R_MOUSE:LRC8D_HUMAN:Toll-like receptor 8[747 aa]:Variable lymphocyte receptor[218 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. SO4:ACT 4 0 2 3 3 6 15 0 9 2 1 13 2 7 6 17 4 3 0 5 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 564 L b 0.0 7c76_A 2 1 1 1 3 2 0 4 0 73 3 2 0 0 0 1 1 4 0 0 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 565 H e 23.0 7c76_A RSPO1_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:SERK2_ARATH:F8W3J5_DANRE:Q4G1L2_EPTBU:BTK_HUMAN:ERBB2_HUMAN:Q30BZ2_PHYSO:R-SPONDIN-1[104 aa]:R-SPONDIN-1[103 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:Somatic embryogenesis receptor kinase 2[185 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Tyrosine-protein kinase BTK[104 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa]:Cell 12A endoglucanase[222 aa] NAG MG:CL:CA LRFN1_MOUSE:LRC8D_HUMAN:Leucine-rich repeat and fibronectin type III domai..:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 3 2 5 10 2 2 10 3 6 4 1 3 2 14 11 9 7 3 0 5 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 566 I E e 29.8 7c76_A NTNG2_HUMAN:RSPO1_HUMAN:IL6_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:EGFR_HUMAN:SERK2_ARATH:F8W3J5_DANRE:Q4G1L2_EPTBU:IGG1_HUMAN:ERBB2_HUMAN:ASC_HUMAN:NETRIN-G2[303 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:Somatic embryogenesis receptor kinase 2[185 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Immunoglobulin gamma-1 heavy chain[198 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa]:Apoptosis-associated speck-like protein containing.. I3C:NAG CL:CA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-.. RTN4R_MOUSE:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa] GOL:1PE:SO4:PEG 4 1 1 9 5 3 2 19 5 11 1 1 0 2 3 5 7 14 1 7 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 567 L E b 1.1 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1 proprotein[305 a.. I3C:NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 2 0 2 0 3 4 1 4 0 68 2 2 2 0 0 4 1 3 0 0 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 568 N E b 15.2 7c76_A LYSC_CHICK:NTNG2_HUMAN:RSPO1_HUMAN:IL6_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:CO5_HUMAN:ERBB2_HUMAN:ASC_HUMAN:Lysozyme C[124 aa]:NETRIN-G2[303 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:C5a anaphylatoxin[72 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa]:Apoptosis-associated speck-like protein containing.. DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. I3C:GAL:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-..:beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-a..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:3-O-sulfo-beta-D-galactopyranose-(1-4)-2-acetamido..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. AMGO1_MOUSE:RTN4R_MOUSE:Amphoterin-induced protein 1[333 aa]:Amphoterin-induced protein 1[331 aa]:Reticulon-4 receptor[315 aa] GOL:PEG 3 1 22 4 3 3 7 2 2 3 1 18 2 4 5 8 2 2 2 6 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 569 L b 0.0 7c76_A TLR8_HUMAN:Toll-like receptor 8[708 aa] 2 2 1 2 5 2 0 6 1 61 3 2 1 0 0 1 1 8 0 2 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 570 E e 22.1 7c76_A LYSC_CHICK:NTNG1_HUMAN:RSPO1_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:CO5_HUMAN:F8W3J5_DANRE:Q4G1L2_EPTBU:SPIKE_SARS2:Lysozyme C[124 aa]:NETRIN-G1[326 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:C5a anaphylatoxin[72 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Spike glycoprotein[1038 aa] GAL:NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-a..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. AMGO1_MOUSE:Amphoterin-induced protein 1[331 aa] PEG 4 1 6 14 0 3 4 2 4 4 0 7 3 7 9 25 4 1 0 1 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 571 S S e 27.3 7c76_A NTNG1_HUMAN:RSPO1_HUMAN:IL6_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:EGFR_HUMAN:CO5_HUMAN:F8W3J5_DANRE:Q4G1L2_EPTBU:IGG1_HUMAN:AGRB1_MOUSE:SPIKE_SARS2:Fab15 light chain[214 aa]:NETRIN-G1[326 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:C5a anaphylatoxin[72 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Immunoglobulin gamma-1 heavy chain[198 aa]:Vasculostatin-120[44 aa]:Vasculostatin-120[40 aa]:Spike protein S1[196 aa] 46-MER:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) CL:NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-..:beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-a.. AMGO1_MOUSE:B3DIN1_DANRE:Q4G1L2_EPTBU:RTN4R_MOUSE:LRC8D_HUMAN:CD33_HUMAN:LRFN4_MOUSE:Amphoterin-induced protein 1[333 aa]:Amphoterin-induced protein 1[331 aa]:Toll-like receptor 5b and variable lymphocyte rece..:Reticulon-4 receptor[291 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[313 aa]:Reticulon-4 receptor[317 aa]:Volume-regulated anion channel subunit LRRC8D[714 ..:Volume-regulated anion channel subunit LRRC8D[713 ..:Myeloid cell surface antigen CD33,Leucine-rich rep.. GOL 4 1 5 5 4 9 5 0 5 2 1 13 3 4 5 17 3 5 2 4 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 572 N S b 7.9 7c76_A DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) B3DIN1_DANRE:Q4G1L2_EPTBU:LRC8D_HUMAN:CD33_HUMAN:LRFN4_MOUSE:Toll-like receptor 5b and variable lymphocyte rece..:Volume-regulated anion channel subunit LRRC8D[713 ..:Myeloid cell surface antigen CD33,Leucine-rich rep.. 2 4 0 0 0 3 3 0 3 4 2 56 0 6 0 9 3 3 0 0 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 573 G e 23.8 7c76_A F8W3J5_DANRE:Q4G1L2_EPTBU:SPIKE_SARS2:Toll-like receptor 5b, Variable lymphocyte recepto..:Spike protein S1[196 aa]:Spike glycoprotein[1036 aa] 46-MER:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR4_HUMAN:B3DIN1_DANRE:Q4G1L2_EPTBU:K0IE77_PETMA:LRFN5_HUMAN:LRC8D_HUMAN:CD33_HUMAN:LRFN4_MOUSE:Toll-like receptor 4[601 aa]:Toll-like receptor 5b and variable lymphocyte rece..:Toll-like receptor 4[605 aa]:Variable lymphocyte receptor[217 aa]:Leucine-rich repeat and fibronectin type-III domai..:Volume-regulated anion channel subunit LRRC8D[713 ..:Myeloid cell surface antigen CD33,Leucine-rich rep.. PG4 9 2 4 4 3 20 4 3 7 4 2 6 3 7 9 9 2 2 0 2 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 574 F b 0.5 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1 proprotein[308 a.. beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:Toll-like receptor 8[708 aa] 3 0 0 0 15 1 0 20 0 37 3 0 0 0 0 5 0 5 5 3 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 575 D e 30.9 7c76_A F8W3J5_DANRE:Q4G1L2_EPTBU:Toll-like receptor 5b, Variable lymphocyte recepto.. DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') :RNA (5'-R(P*UP*UP*UP*U)-3') :RNA (5'-R(*AP*UP*UP*AP*A)-3') :RNA (5'-R(P*UP*UP*CP*A)-3') NAG CL alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-..:alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-.. TLR4_HUMAN:TLR8_HUMAN:B3Y653_MACMU:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 4[605 aa]:Toll-like receptor 8[754 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[731 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 7[768 aa] GOL:SO4:PG4:PO4 4 1 12 7 1 8 4 2 9 2 2 4 1 7 9 12 8 2 1 2 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 576 E e 40.7 7c76_A TGFB1_HUMAN:anti-repebody[226 aa]:Transforming growth factor beta-1 proprotein[308 a.. DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3') NAG TLR8_HUMAN:B3Y653_MACMU:RTN4R_MOUSE:TLR9_MOUSE:G7NS93_MACMU:G8E2R2_MACMU:Toll-like receptor 8[754 aa]:Toll-like receptor 8[738 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[735 aa]:Toll-like receptor 8[743 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[727 aa]:Toll-like receptor 7[776 aa]:Toll-like receptor 7[762 aa]:Toll-like receptor 7[772 aa]:Reticulon-4 receptor[284 aa]:Reticulon-4 receptor[289 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[777 aa]:Toll-like receptor 7[771 aa]:Toll-like receptor 8[708 aa]:Toll-like receptor 7[768 aa] SO4 6 2 5 18 3 4 4 2 3 2 2 7 3 5 5 13 8 4 1 3 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 577 I b 9.9 7c76_A TLR8_HUMAN:TLR9_MOUSE:Toll-like receptor 8[754 aa]:Toll-like receptor 8[749 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 8[708 aa] 4 2 1 0 6 2 0 25 0 23 3 1 2 5 0 3 2 19 0 1 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 578 P b 10.1 7c76_A F8W3J5_DANRE:Q4G1L2_EPTBU:TGFB1_HUMAN:Toll-like receptor 5b, Variable lymphocyte recepto..:Transforming growth factor beta-1 proprotein[305 a.. NAG CA TLR9_MOUSE:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa] 4 1 5 5 2 4 2 4 1 3 0 2 41 5 3 8 4 2 0 2 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 579 V S e 46.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1 proprotein[305 a.. NAG CA RTN4R_MOUSE:Reticulon-4 receptor[284 aa]:Reticulon-4 receptor[289 aa] 9 1 5 5 3 6 1 2 3 5 3 6 21 3 5 6 3 10 2 1 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 580 E S e 54.3 7c76_A F8W3J5_DANRE:Q4G1L2_EPTBU:TGFB1_HUMAN:Toll-like receptor 5b, Variable lymphocyte recepto..:Transforming growth factor beta-1 proprotein[305 a.. GLC TLR9_MOUSE:Toll-like receptor 9[753 aa]:Toll-like receptor 9[751 aa] 6 1 9 23 2 16 1 0 2 2 1 9 2 6 3 11 3 1 0 1 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 581 V S b 2.7 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1 proprotein[305 a.. NAG 19 1 4 2 2 5 1 9 1 15 6 2 2 1 0 9 7 12 1 3 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 582 F S b 3.8 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1 proprotein[305 a.. 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 2 2 2 2 47 2 0 5 3 19 0 0 4 1 0 2 1 2 2 4 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 583 K S e 37.3 7c76_A F8W3J5_DANRE:Q4G1L2_EPTBU:Q16J57_AEDAE:Toll-like receptor 5b, Variable lymphocyte recepto..:AAEL013433-PA[99 aa]:AAEL013433-PA[96 aa] GLC:NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. RTN4R_MOUSE:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa] PO4:EDO 8 1 4 4 2 10 4 1 12 5 1 6 4 7 8 14 5 1 2 1 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 584 D S b 13.0 7c76_A F8W3J5_DANRE:Q4G1L2_EPTBU:Q16J57_AEDAE:TGFB1_HUMAN:Toll-like receptor 5b, Variable lymphocyte recepto..:AAEL013433-PA[99 aa]:AAEL013433-PA[96 aa]:Transforming growth factor beta-1 proprotein[305 a.. NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO 5 3 14 3 2 16 2 2 3 2 1 12 8 4 4 12 4 2 1 1 REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 20":TOPO_DOM:/note="Lumenal" 585 L b 0.0 7c76_A TGFB1_HUMAN:Transforming growth factor beta-1 proprotein[305 a.. beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO 3 4 0 0 5 1 1 3 1 62 4 1 1 1 1 1 3 4 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 586 F S e 34.9 7c76_A Q16J57_AEDAE:AAEL013433-PA[99 aa] NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-alp..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. 4 1 1 5 6 6 3 2 8 6 2 2 16 6 7 10 8 4 1 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 587 E S e 32.2 7c76_A NDG:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-alp..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. K0IE77_PETMA:Variable lymphocyte receptor[218 aa] 4 1 2 10 2 4 5 0 11 4 2 16 1 11 5 13 3 1 0 3 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 588 L b 0.0 7c76_A 1 0 0 1 1 0 1 4 1 81 2 0 1 0 0 1 0 4 0 0 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 589 K e 35.8 7c76_A RSPO1_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:SERK2_ARATH:F8W3J5_DANRE:Q4G1L2_EPTBU:Q30BZ2_PHYSO:LRC8A_MOUSE:C562_ECOLX:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:Somatic embryogenesis receptor kinase 2[185 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Cell 12A endoglucanase[222 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. NAG CA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. K0IE77_PETMA:LRC8D_HUMAN:Variable lymphocyte receptor[218 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. SO4 1 0 2 10 1 2 2 1 18 3 1 3 1 22 15 5 6 5 0 2 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 590 I B e 42.1 7c76_A LYSC_CHICK:RSPO1_HUMAN:IL6_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:EGFR_HUMAN:PTPRD_MOUSE:F8W3J5_DANRE:Q4G1L2_EPTBU:BTK_HUMAN:ERBB2_HUMAN:ASC_HUMAN:Lysozyme C[124 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:Interleukin-6[166 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Tyrosine-protein kinase BTK[104 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa]:Apoptosis-associated speck-like protein containing.. I3C:NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-.. AMGO1_MOUSE:RTN4R_MOUSE:LRC8D_HUMAN:Amphoterin-induced protein 1[333 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. SO4:GOL:1PE 4 1 3 12 3 0 5 8 6 8 2 1 0 3 6 6 11 14 2 4 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 591 I b 1.8 7c76_A RSPO1_HUMAN:RSPO2_MOUSE:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:R-SPONDIN-2[102 aa] SO4 2 0 2 1 5 1 0 11 1 57 5 2 0 0 0 3 1 8 0 0 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 592 D b 12.3 7c76_A LYSC_CHICK:NTNG2_HUMAN:NTNG1_HUMAN:RSPO1_HUMAN:IL6_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:PTPRD_MOUSE:F8W3J5_DANRE:Q4G1L2_EPTBU:IGG1_HUMAN:ASC_HUMAN:Lysozyme C[124 aa]:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Immunoglobulin gamma-1 heavy chain[198 aa]:Apoptosis-associated speck-like protein containing.. NAG:I3C CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-..:beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-a..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:3-O-sulfo-beta-D-galactopyranose-(1-4)-2-acetamido.. AMGO1_MOUSE:RTN4R_MOUSE:Amphoterin-induced protein 1[333 aa]:Amphoterin-induced protein 1[331 aa]:Reticulon-4 receptor[291 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[317 aa] SO4:PEG 3 0 33 5 4 1 3 2 3 2 1 11 0 4 3 5 5 5 3 6 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 593 L b 4.5 7c76_A 1 2 0 0 2 1 0 11 0 63 4 0 0 0 0 3 5 4 0 2 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 594 G b 0.0 7c76_A LYSC_CHICK:NTNG2_HUMAN:PTPRD_HUMAN:PTPRD_MOUSE:Lysozyme C[124 aa]:NETRIN-G2[303 aa]:Receptor-type tyrosine-protein phosphatase delta[3.. NAG:GAL CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-a..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-..:3-O-sulfo-beta-D-galactopyranose-(1-4)-2-acetamido.. RTN4R_MOUSE:LRC8D_HUMAN:CD33_HUMAN:LRFN4_MOUSE:Reticulon-4 receptor[291 aa]:Volume-regulated anion channel subunit LRRC8D[714 ..:Volume-regulated anion channel subunit LRRC8D[713 ..:Myeloid cell surface antigen CD33,Leucine-rich rep.. EDO 9 1 8 4 0 12 2 0 4 1 3 3 1 3 5 35 4 2 0 1 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 595 L S e 27.5 7c76_A NTNG1_HUMAN:RSPO1_HUMAN:IL6_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:EGFR_HUMAN:PTPRD_MOUSE:CO5_HUMAN:TGFB1_HUMAN:SPIKE_SARS2:Fab15 light chain[214 aa]:NETRIN-G1[326 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:C5a anaphylatoxin[72 aa]:Transforming growth factor beta-1 proprotein[308 a..:Spike protein S1[196 aa]:Spike glycoprotein[1038 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:RNA component of mitochondrial RNAase P (Rmrp), RN.. NAG CL alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-.. AMGO1_MOUSE:TLR5_HUMAN:B3DIN1_DANRE:Q4G1L2_EPTBU:RTN4R_MOUSE:LRC8D_HUMAN:CD33_HUMAN:LRFN4_MOUSE:Amphoterin-induced protein 1[333 aa]:Amphoterin-induced protein 1[331 aa]:Toll-like receptor 5[632 aa]:Toll-like receptor 5b and variable lymphocyte rece..:Reticulon-4 receptor[291 aa]:Reticulon-4 receptor[290 aa]:Volume-regulated anion channel subunit LRRC8D[714 ..:Volume-regulated anion channel subunit LRRC8D[713 ..:Myeloid cell surface antigen CD33,Leucine-rich rep.. GOL:EDO 2 5 6 5 6 13 11 3 3 8 1 14 0 2 8 5 2 1 1 4 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 596 N S b 0.6 7c76_A SPIKE_SARS2:Spike protein S1[196 aa] NAG TLR5_HUMAN:B3DIN1_DANRE:Q4G1L2_EPTBU:LRFN5_HUMAN:LRFN1_MOUSE:LRFN5_MOUSE:LRC8D_HUMAN:Toll-like receptor 5[632 aa]:Toll-like receptor 5b and variable lymphocyte rece..:Leucine-rich repeat and fibronectin type-III domai..:Leucine-rich repeat and fibronectin type III domai..:Volume-regulated anion channel subunit LRRC8D[714 ..:Volume-regulated anion channel subunit LRRC8D[713 .. GOL:PG4 4 1 2 1 2 3 0 0 3 2 0 70 0 3 2 2 3 1 0 0 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 597 N e 49.1 7c76_A SPIKE_SARS2:anti-repebody[226 aa]:Spike protein S1[196 aa] RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG B3DIN1_DANRE:Q4G1L2_EPTBU:TLR4_MOUSE:K0IE77_PETMA:LGR5_HUMAN:LRFN5_HUMAN:LRFN1_MOUSE:LRFN5_MOUSE:CD33_HUMAN:LRFN4_MOUSE:Toll-like receptor 5b and variable lymphocyte rece..:Toll-like receptor 4[596 aa]:Variable lymphocyte receptor[218 aa]:Leucine-rich repeat-containing G-protein coupled r..:Leucine-rich repeat and fibronectin type-III domai..:Leucine-rich repeat and fibronectin type III domai..:Myeloid cell surface antigen CD33,Leucine-rich rep.. GOL:SO4:PG4 5 1 4 4 1 2 6 1 12 5 2 15 4 12 10 10 1 1 0 2 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 598 L b 1.1 7c76_A 1 0 0 0 8 1 2 25 0 48 4 0 0 0 0 0 0 7 0 0 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 599 N e 45.5 7c76_A anti-repebody[226 aa] NAG NI TLR3_MOUSE:B3DIN1_DANRE:Q4G1L2_EPTBU:TLR8_HUMAN:Q2EEY0_HORSE:LGR5_HUMAN:TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 5b and variable lymphocyte rece..:Toll-like receptor 8[746 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[748 aa]:Toll-like receptor 3[669 aa]:Toll-like receptor 3[659 aa] GOL:SO4:PG4 6 2 4 10 1 6 3 1 7 3 2 8 1 8 7 13 12 3 1 1 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 600 T e 62.3 7c76_A anti-repebody[226 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. NAG TLR3_MOUSE:TLR8_HUMAN:RTN4R_MOUSE:TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 8[749 aa]:Reticulon-4 receptor[284 aa]:Toll-like receptor 3[669 aa]:Toll-like receptor 3[659 aa] SO4:MLI:PG4 8 2 3 4 3 10 3 2 6 3 1 5 1 4 7 17 15 4 1 2 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 601 L b 16.9 7c76_A SO4:PG4 2 0 0 2 3 2 1 22 1 47 2 1 2 1 0 2 2 9 0 2 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 602 P e 30.2 7c76_A FLIC_SALDU:Flagellin[284 aa]:Flagellin[295 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. RTN4R_MOUSE:Reticulon-4 receptor[284 aa] SO4:PG4 4 0 3 7 1 3 3 6 1 2 1 2 47 3 2 6 5 4 0 0 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 603 A S e 47.3 7c76_A FLIC_SALDU:Q16J57_AEDAE:Flagellin[284 aa]:Flagellin[295 aa]:anti-repebody[226 aa]:AAEL013433-PA[99 aa] NAG CL SO4 10 2 8 8 1 8 1 1 4 2 1 2 21 3 7 9 3 5 1 2 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 604 S S e 43.8 7c76_A Q16J57_AEDAE:AAEL013433-PA[99 aa]:AAEL013433-PA[96 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 5 2 10 9 2 16 4 0 2 3 1 10 2 3 5 15 6 2 1 3 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 605 V S b 3.3 7c76_A Q16J57_AEDAE:AAEL013433-PA[99 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 17 1 3 3 4 6 1 7 1 16 3 1 3 2 1 11 7 12 0 2 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 606 F S b 7.2 7c76_A GOL 2 2 1 1 48 3 1 6 1 18 1 1 4 0 1 2 2 3 1 4 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 607 N T e 49.1 7c76_A Q16J57_AEDAE:AAEL013433-PA[99 aa]:AAEL013433-PA[96 aa] NAG MG alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL:PO4:EDO 9 0 10 7 3 9 3 2 6 4 2 9 2 6 9 10 3 5 1 1 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 608 N T e 25.5 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. 2 3 5 3 1 17 6 1 3 5 2 18 4 6 6 9 5 2 0 2 REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 21":TOPO_DOM:/note="Lumenal" 609 Q b 1.0 7c76_A NAG GOL 5 3 1 3 5 2 1 2 6 37 5 2 3 6 2 5 3 6 2 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 610 V T e 55.3 7c76_A NAG alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. TLR8_HUMAN:K0IE77_PETMA:Toll-like receptor 8[747 aa]:Variable lymphocyte receptor[218 aa] GOL 6 0 2 3 2 4 2 5 9 8 1 3 12 3 5 11 11 10 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 611 S T e 25.0 7c76_A RSPO1_HUMAN:SERK2_ARATH:Q30BZ2_PHYSO:R-SPONDIN-1[103 aa]:Somatic embryogenesis receptor kinase 2[185 aa]:Cell 12A endoglucanase[222 aa] NDG:NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-alp..:alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:K0IE77_PETMA:LRC8D_HUMAN:Toll-like receptor 8[747 aa]:Variable lymphocyte receptor[218 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. GOL 11 0 1 3 1 5 4 3 8 2 1 12 2 3 6 32 2 2 0 2 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 612 L b 2.2 7c76_A GOL 2 0 0 0 1 0 2 8 0 74 2 0 0 0 0 1 1 6 0 0 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 613 K e 29.7 7c76_A RSPO1_HUMAN:RSPO2_MOUSE:PTPRD_MOUSE:BTK_HUMAN:ERBB2_HUMAN:LRC8A_MOUSE:C562_ECOLX:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:R-SPONDIN-2[102 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:Tyrosine-protein kinase BTK[104 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. TLR8_HUMAN:LRC8D_HUMAN:Toll-like receptor 8[747 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. SO4:GOL 2 1 2 11 1 1 1 2 17 5 1 2 2 7 18 7 9 6 0 3 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 614 S E e 24.2 7c76_A LYSC_CHICK:NTNG2_HUMAN:RSPO1_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:EGFR_HUMAN:PTPRD_MOUSE:F8W3J5_DANRE:Q4G1L2_EPTBU:IGG1_HUMAN:SPIKE_SARS2:Lysozyme C[124 aa]:NETRIN-G2[303 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Immunoglobulin gamma-1 heavy chain[198 aa]:Spike protein S1[196 aa]:Spike glycoprotein[1036 aa] NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. K0IE77_PETMA:RTN4R_MOUSE:Variable lymphocyte receptor[217 aa]:Variable lymphocyte receptor[218 aa]:Reticulon-4 receptor[291 aa] SO4:GOL:PO4 5 1 3 10 2 4 5 4 5 3 1 3 1 2 6 17 11 9 3 5 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 615 L E b 0.6 7c76_A 1 1 0 2 2 1 0 5 1 69 3 2 0 1 0 1 0 8 0 1 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 616 N E b 13.3 7c76_A LYSC_CHICK:RSPO1_HUMAN:IL6_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:EGFR_HUMAN:PTPRD_MOUSE:F8W3J5_DANRE:Q4G1L2_EPTBU:BTK_HUMAN:IGG1_HUMAN:ASC_HUMAN:AGRB1_MOUSE:SPIKE_SARS2:Lysozyme C[124 aa]:R-SPONDIN-1[104 aa]:R-SPONDIN-1[103 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Tyrosine-protein kinase BTK[104 aa]:Immunoglobulin gamma-1 heavy chain[198 aa]:Apoptosis-associated speck-like protein containing..:Vasculostatin-120[44 aa]:Vasculostatin-120[40 aa]:Spike protein S1[196 aa]:Spike glycoprotein[1036 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. NAG:GAL CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-..:beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-a..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. RTN4R_MOUSE:Reticulon-4 receptor[291 aa] SO4:GOL:PEG 2 0 16 2 1 1 7 4 2 3 2 31 1 4 5 9 1 1 1 7 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 617 L b 6.7 7c76_A CL 1 2 0 1 2 0 0 11 0 65 4 1 0 2 2 0 0 6 0 1 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 618 Q T b 16.3 7c76_A LYSC_CHICK:RSPO1_HUMAN:IL6_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:EGFR_HUMAN:PTPRD_MOUSE:F8W3J5_DANRE:Q4G1L2_EPTBU:SPIKE_SARS2:Lysozyme C[124 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Spike protein S1[196 aa]:Spike glycoprotein[1036 aa] DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. NAG:GAL CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-a..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b..:3-O-sulfo-beta-D-galactopyranose-(1-4)-2-acetamido..:beta-D-glucopyranose-(1-3)-alpha-L-fucopyranose RTN4R_MOUSE:Reticulon-4 receptor[291 aa] SO4:EDO 9 0 6 11 0 7 4 0 4 2 0 5 1 9 8 27 2 1 0 1 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 619 K T e 47.6 7c76_A NTNG2_HUMAN:RSPO1_HUMAN:IL6_HUMAN:PTPRD_HUMAN:RSPO2_MOUSE:PTPRD_MOUSE:SPIKE_SARS2:NETRIN-G2[303 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:R-SPONDIN-2[102 aa]:R-SPONDIN-2[103 aa]:Spike glycoprotein[1036 aa] 46-MER:DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C)..:RNA component of mitochondrial RNAase P (Rmrp), RN..:RNA (81-MER):RNA (80-MER):RNA (46-MER) NAG:GAL CL:NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-a..:2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-..:alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-..:3-O-sulfo-beta-D-galactopyranose-(1-4)-2-acetamido.. B3DIN1_DANRE:Q4G1L2_EPTBU:K0IE77_PETMA:TLR13_MOUSE:LRFN5_HUMAN:LRFN1_MOUSE:LRFN5_MOUSE:LRC8D_HUMAN:Toll-like receptor 5b and variable lymphocyte rece..:Variable lymphocyte receptor[218 aa]:Variable lymphocyte receptor[217 aa]:Toll-like receptor 13[709 aa]:Leucine-rich repeat and fibronectin type-III domai..:Leucine-rich repeat and fibronectin type III domai..:Volume-regulated anion channel subunit LRRC8D[714 ..:Volume-regulated anion channel subunit LRRC8D[713 .. GOL:SO4:PG4 6 0 6 3 2 16 11 1 6 1 1 17 3 6 8 8 1 0 0 4 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 620 N b 2.4 7c76_A K0IE77_PETMA:LRFN5_HUMAN:LRFN1_MOUSE:LRC8D_HUMAN:Variable lymphocyte receptor[218 aa]:Variable lymphocyte receptor[217 aa]:Leucine-rich repeat and fibronectin type-III domai..:Leucine-rich repeat and fibronectin type III domai..:Volume-regulated anion channel subunit LRRC8D[713 .. SO4 2 0 2 4 0 3 0 2 1 1 1 76 1 2 1 2 1 1 0 1 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 621 L e 46.1 7c76_A SPIKE_SARS2:anti-repebody[226 aa]:Spike glycoprotein[1036 aa] NAG TLR5_HUMAN:B3DIN1_DANRE:Q4G1L2_EPTBU:TLR8_HUMAN:Q2EEY0_HORSE:TLR4_HUMAN:K0IE77_PETMA:LGR5_HUMAN:LRFN5_HUMAN:LRFN1_MOUSE:LRC8D_HUMAN:Toll-like receptor 5[632 aa]:Toll-like receptor 5b and variable lymphocyte rece..:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 4[601 aa]:Variable lymphocyte receptor[218 aa]:Variable lymphocyte receptor[217 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[751 aa]:Toll-like receptor 8[748 aa]:Leucine-rich repeat and fibronectin type-III domai..:Leucine-rich repeat and fibronectin type III domai..:Volume-regulated anion channel subunit LRRC8D[714 ..:Volume-regulated anion channel subunit LRRC8D[713 .. GOL:PG4:PO4:SO4 8 2 2 4 6 1 3 4 8 14 2 6 3 9 13 8 2 3 1 1 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 622 I b 3.5 7c76_A 2 0 2 1 10 1 0 31 1 40 1 0 2 0 1 1 1 3 1 1 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 623 T e 30.5 7c76_A anti-repebody[226 aa] NAG NI 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR3_MOUSE:B3DIN1_DANRE:Q4G1L2_EPTBU:TLR8_HUMAN:Q2EEY0_HORSE:TLR9_BOVIN:LGR5_HUMAN:TLR9_MOUSE:TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 5b and variable lymphocyte rece..:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[751 aa]:Toll-like receptor 8[740 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 3[669 aa]:Toll-like receptor 3[659 aa] SO4:PG4 7 1 3 7 0 2 2 2 6 5 3 7 5 5 5 21 18 2 1 1 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 624 S e 20.3 7c76_A Q16J57_AEDAE:AAEL013433-PA[99 aa]:AAEL013433-PA[96 aa] TLR3_MOUSE:TLR8_HUMAN:TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 8[754 aa]:Toll-like receptor 3[659 aa] SO4:MLI:PG4 8 2 3 3 2 12 4 3 7 2 0 3 2 4 2 22 14 5 1 3 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 625 V b 0.7 7c76_A CL MLI 2 0 1 3 5 2 0 23 2 30 2 1 3 1 1 4 3 16 0 2 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 626 E e 37.7 7c76_A NAG CL TLR3_MOUSE:TLR3_HUMAN:Toll-like receptor 3[669 aa]:Toll-like receptor 3[668 aa] SO4:MLI:PG4 5 0 5 10 1 5 3 5 5 6 1 2 25 4 2 12 3 2 0 3 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 627 K H e 62.7 7c76_A PTPRD_HUMAN:PTPRD_MOUSE:Receptor-type tyrosine-protein phosphatase delta[2..:Receptor-type tyrosine-protein phosphatase delta[3.. NAG CL 5 0 3 11 2 4 2 2 17 5 0 3 17 6 6 4 3 4 1 3 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 628 K H e 73.6 7c76_A NAG CL:MG TLR5_HUMAN:Toll-like receptor 5[632 aa] EDO:SO4 5 1 10 9 1 14 3 2 10 3 1 8 2 6 7 11 3 2 1 2 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 629 V H b 12.7 7c76_A NAG 11 3 3 7 4 3 1 14 1 10 4 2 1 6 1 4 12 10 2 1 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 630 F H b 2.9 7c76_A AMGO1_MOUSE:Amphoterin-induced protein 1[331 aa] GOL:SO4 3 1 1 1 44 3 1 5 2 18 2 1 1 1 1 3 2 7 0 3 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 631 G T e 33.3 7c76_A NAG EDO:SO4 8 2 10 5 4 18 2 3 4 5 1 6 4 6 4 12 4 3 1 1 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 632 P G e 36.4 7c76_A NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 3 1 5 7 2 6 3 4 4 7 1 4 25 5 5 8 3 4 1 1 REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal":REPEAT:/note="LRR 22":TOPO_DOM:/note="Lumenal" 633 A G b 0.9 7c76_A PTPRD_MOUSE:Receptor-type tyrosine-protein phosphatase delta[3.. DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. NAG CA alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. GOL 13 3 2 5 3 10 3 3 3 9 1 2 5 5 3 20 3 5 0 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 634 F G b 4.3 7c76_A DNA (5'-R(P*AP*CP*GP*GP*AP*AP*AP*GP*AP*CP*CP*CP*C).. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. TLR13_MOUSE:Toll-like receptor 13[709 aa] 4 4 1 2 18 3 1 2 1 37 6 1 6 1 2 2 3 3 1 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 635 R S e 53.0 7c76_A SERK2_ARATH:PTPRD_MOUSE:Q30BZ2_PHYSO:Somatic embryogenesis receptor kinase 2[185 aa]:Receptor-type tyrosine-protein phosphatase delta[2..:Cell 12A endoglucanase[222 aa] NAG CL:CA 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. K0IE77_PETMA:Variable lymphocyte receptor[218 aa] SO4:GOL:PO4:MES 4 0 6 3 1 5 5 2 11 5 1 5 10 8 13 11 7 3 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 636 N S e 62.4 7c76_A RSPO1_HUMAN:RSPO2_MOUSE:Q30BZ2_PHYSO:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:R-SPONDIN-2[102 aa]:Cell 12A endoglucanase[222 aa] NAG 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-2-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. TLR8_HUMAN:K0IE77_PETMA:TLR13_MOUSE:LRC8D_HUMAN:Toll-like receptor 8[747 aa]:Variable lymphocyte receptor[218 aa]:Toll-like receptor 13[709 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. SO4:GOL:PO4 6 0 3 3 2 9 2 1 8 2 1 29 2 6 2 17 5 1 1 1 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":TOPO_DOM:/note="Lumenal" 637 L b 3.9 7c76_A NAG GOL 1 1 0 0 1 1 0 11 0 72 2 0 0 2 0 1 0 4 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 638 T e 48.1 7c76_A RSPO1_HUMAN:PTPRD_HUMAN:EGFR_HUMAN:PTPRD_MOUSE:SERK2_ARATH:ERBB2_HUMAN:LRC8A_MOUSE:C562_ECOLX:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:Somatic embryogenesis receptor kinase 2[185 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa]:Volume-regulated anion channel subunit LRRC8A,Solu.. NAG CL K0IE77_PETMA:Variable lymphocyte receptor[217 aa]:Variable lymphocyte receptor[218 aa] SO4:PO4 6 1 2 14 1 2 1 3 10 2 1 3 3 5 10 9 21 7 1 1 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 639 E E e 45.7 7c76_A LYSC_CHICK:NTNG2_HUMAN:NTNG1_HUMAN:RSPO1_HUMAN:PTPRD_HUMAN:EGFR_HUMAN:PTPRD_MOUSE:BTK_HUMAN:IGG1_HUMAN:ERBB2_HUMAN:ASC_HUMAN:SPIKE_SARS2:LRC8A_MOUSE:C562_ECOLX:Lysozyme C[124 aa]:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:R-SPONDIN-1[103 aa]:R-SPONDIN-1[104 aa]:R-spondin-1[98 aa]:R-spondin-1[94 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:Tyrosine-protein kinase BTK[104 aa]:Immunoglobulin gamma-1 heavy chain[198 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa]:Apoptosis-associated speck-like protein containing..:Spike protein S1[196 aa]:Volume-regulated anion channel subunit LRRC8A,Solu..:Volume-regulated anion channel subunit LRRC8A[407 ..:Spike glycoprotein[1036 aa] NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. K0IE77_PETMA:Variable lymphocyte receptor[217 aa]:Variable lymphocyte receptor[218 aa] GOL 3 0 4 15 3 2 5 4 4 4 2 4 0 8 7 13 14 5 1 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 640 L E b 1.1 7c76_A NTNG2_HUMAN:NETRIN-G2[303 aa] 2 0 0 0 4 1 0 17 0 62 1 1 1 0 0 1 2 6 0 0 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 641 D E b 16.0 7c76_A LYSC_CHICK:NTNG2_HUMAN:NTNG1_HUMAN:EGFR_HUMAN:ERBB2_HUMAN:ASC_HUMAN:SPIKE_SARS2:Lysozyme C[124 aa]:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa]:Apoptosis-associated speck-like protein containing..:Spike glycoprotein[1036 aa] NAG:GAL CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-galactopyranose-(1-3)-2-acetamido-2-deoxy-a..:3-O-sulfo-beta-D-galactopyranose-(1-4)-2-acetamido.. AMGO1_MOUSE:RTN4R_MOUSE:Amphoterin-induced protein 1[333 aa]:Reticulon-4 receptor[308 aa]:Reticulon-4 receptor[315 aa]:Reticulon-4 receptor[312 aa]:Reticulon-4 receptor[316 aa]:Reticulon-4 receptor[313 aa]:Reticulon-4 receptor[311 aa]:Reticulon-4 receptor[317 aa] SO4 2 1 32 8 2 2 4 2 3 3 0 14 0 2 5 7 4 2 1 5 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 642 M b 0.5 7c76_A 9 0 0 0 4 1 0 8 0 55 6 2 1 0 0 1 1 10 0 0 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 643 R b 11.9 7c76_A NTNG2_HUMAN:IL6_HUMAN:EGFR_HUMAN:NETRIN-G2[303 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:EPIDERMAL GROWTH FACTOR RECEPTOR[612 aa] BTN 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:3-O-sulfo-beta-D-galactopyranose-(1-4)-2-acetamido.. LRFN1_MOUSE:LRC8D_HUMAN:Leucine-rich repeat and fibronectin type III domai..:Volume-regulated anion channel subunit LRRC8D[714 ..:Volume-regulated anion channel subunit LRRC8D[713 .. PO4 3 0 6 6 2 10 9 0 5 2 1 7 1 4 13 18 9 0 0 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 644 F S e 51.7 7c76_A NTNG2_HUMAN:NTNG1_HUMAN:IL6_HUMAN:PTPRD_HUMAN:PTPRD_MOUSE:SPIKE_SARS2:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:Interleukin-6[155 aa]:Interleukin-6[166 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:anti-repebody[226 aa]:Spike glycoprotein[1038 aa] BTN alpha-L-fucopyranose-(1-2)-beta-D-galactopyranose-..:beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. AMGO1_MOUSE:B3DIN1_DANRE:Q4G1L2_EPTBU:LGR5_HUMAN:K0IE77_PETMA:TLR13_MOUSE:LRFN5_HUMAN:LRFN1_MOUSE:LRFN5_MOUSE:LRC8D_HUMAN:Amphoterin-induced protein 1[333 aa]:Amphoterin-induced protein 1[331 aa]:Toll-like receptor 5b and variable lymphocyte rece..:LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED R..:Variable lymphocyte receptor[218 aa]:Variable lymphocyte receptor[217 aa]:Toll-like receptor 13[709 aa]:Leucine-rich repeat and fibronectin type-III domai..:Leucine-rich repeat and fibronectin type III domai..:Volume-regulated anion channel subunit LRRC8D[714 ..:Volume-regulated anion channel subunit LRRC8D[713 .. PO4 5 0 8 5 8 25 6 1 2 2 0 10 0 4 5 8 1 1 1 9 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 645 N b 5.5 7c76_A anti-repebody[226 aa] CA B3DIN1_DANRE:Q4G1L2_EPTBU:K0IE77_PETMA:LRC8D_HUMAN:Toll-like receptor 5b and variable lymphocyte rece..:Variable lymphocyte receptor[218 aa]:Variable lymphocyte receptor[217 aa]:Volume-regulated anion channel subunit LRRC8D[714 .. 0 0 2 1 0 1 0 0 0 2 0 90 1 0 0 1 0 0 0 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 646 P e 27.9 7c76_A anti-repebody[226 aa] NAG B3DIN1_DANRE:Q4G1L2_EPTBU:TLR8_HUMAN:K0IE77_PETMA:LGR5_HUMAN:TLR13_MOUSE:B3Y653_MACMU:LRC8D_HUMAN:G8E2R2_MACMU:Toll-like receptor 5b and variable lymphocyte rece..:Toll-like receptor 8[747 aa]:Variable lymphocyte receptor[218 aa]:Variable lymphocyte receptor[217 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[746 aa]:Toll-like receptor 13[709 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 7[773 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 7[775 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 7[771 aa]:Volume-regulated anion channel subunit LRRC8D[714 ..:Toll-like receptor 7[768 aa] SO4 2 1 4 2 0 1 2 0 9 2 2 8 51 2 2 8 2 1 0 1 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 647 F E b 0.0 7c76_A anti-repebody[226 aa] 0 2 1 0 33 0 2 9 0 25 1 0 0 0 0 0 0 2 23 1 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 648 D E e 20.4 7c76_A Q16J57_AEDAE:anti-repebody[226 aa]:AAEL013433-PA[99 aa] NAG TLR3_MOUSE:TLR8_HUMAN:K0IE77_PETMA:LGR5_HUMAN:LRC8D_HUMAN:TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Variable lymphocyte receptor[218 aa]:Variable lymphocyte receptor[217 aa]:Leucine-rich repeat-containing G-protein coupled r..:Toll-like receptor 8[751 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[750 aa]:Volume-regulated anion channel subunit LRRC8D[714 ..:Volume-regulated anion channel subunit LRRC8D[713 ..:Toll-like receptor 3[659 aa] 10 2 18 8 1 1 7 6 1 5 0 10 1 6 6 8 6 4 0 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 649 C b 5.3 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] MLI 2 78 1 0 3 5 0 1 1 2 1 0 0 0 1 1 0 1 1 1 DISULFID::DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DISULFID::DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 650 T e 30.5 7c76_A Q16J57_AEDAE:UN93B_HUMAN:UN93B_MOUSE:anti-repebody[226 aa]:AAEL013433-PA[96 aa]:Protein unc-93 homolog B1[483 aa] NAG TLR3_MOUSE:K0IE77_PETMA:Toll-like receptor 3[668 aa]:Variable lymphocyte receptor[218 aa]:Variable lymphocyte receptor[217 aa] 5 0 26 2 0 3 1 4 1 7 1 12 1 1 1 11 15 7 0 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 651 C H b 18.7 7c76_A Q16J57_AEDAE:UN93B_HUMAN:UN93B_MOUSE:AAEL013433-PA[99 aa]:AAEL013433-PA[96 aa]:Protein unc-93 homolog B1[483 aa] 1 73 0 1 0 4 0 4 1 2 0 1 5 0 0 2 1 2 0 0 DISULFID::DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DISULFID::DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 652 E H e 68.3 7c76_A Q16J57_AEDAE:UN93B_HUMAN:UN93B_MOUSE:AAEL013433-PA[99 aa]:AAEL013433-PA[96 aa]:Protein unc-93 homolog B1[483 aa] NAG TLR3_MOUSE:TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 3[669 aa]:Toll-like receptor 3[659 aa] SO4 4 0 13 28 2 7 5 1 4 3 0 2 4 8 8 6 1 1 1 1 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 653 S H b 2.3 7c76_A anti-repebody[226 aa] TLR3_MOUSE:TLR3_HUMAN:Toll-like receptor 3[669 aa]:Toll-like receptor 3[668 aa]:Toll-like receptor 3[659 aa] SO4 6 1 6 4 5 6 6 2 3 13 1 13 6 3 2 10 6 5 0 3 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 654 I H b 0.0 7c76_A G8E2R2_MACMU:Toll-like receptor 7[772 aa] SO4 2 1 1 2 2 2 0 17 1 39 7 1 1 5 3 3 1 8 0 4 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 655 A H b 8.0 7c76_A CL SO4 12 1 4 2 2 13 3 3 7 9 2 1 4 6 7 17 2 3 1 1 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 656 W H e 21.9 7c76_A G8E2R2_MACMU:Toll-like receptor 7[772 aa] SO4 6 0 4 3 2 5 2 1 2 6 2 4 3 2 6 2 5 2 37 7 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 657 F H b 1.0 7c76_A SO4 1 0 1 2 36 1 1 1 2 35 4 0 2 0 1 0 1 8 4 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 658 V H b 10.0 7c76_A G8E2R2_MACMU:Toll-like receptor 7[772 aa] POL 8 0 1 3 2 4 3 7 3 22 1 0 4 2 11 5 4 14 2 1 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 659 N H e 41.8 7c76_A NAG CL beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. G8E2R2_MACMU:Toll-like receptor 7[772 aa] GOL 4 0 8 7 1 2 3 0 3 2 1 18 5 14 12 7 4 4 2 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 660 W H b 11.2 7c76_A GOL:SO4 1 0 1 3 9 3 0 1 0 7 2 2 0 1 2 1 1 0 63 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 661 I H e 21.1 7c76_A 8 0 0 1 3 1 0 16 1 33 5 1 0 5 3 1 3 16 0 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 662 N H e 81.2 7c76_A NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. G8E2R2_MACMU:Toll-like receptor 7[772 aa] POL 3 1 3 6 0 4 2 0 19 5 1 18 2 9 12 4 5 4 0 2 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 663 E S e 61.8 7c76_A NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:Toll-like receptor 8[747 aa] GOL 6 0 8 23 1 2 4 0 7 5 1 6 0 15 9 5 3 2 0 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 664 T e 35.1 7c76_A NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 6 0 1 3 1 5 3 2 4 11 2 7 0 10 4 14 16 7 2 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 665 H S e 102.1 7c76_A NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. TLR8_HUMAN:Toll-like receptor 8[747 aa] SO4:GOL 6 2 2 5 7 6 6 1 10 7 1 13 1 5 13 8 4 0 1 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 666 T b 7.1 7c76_A NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 9 0 2 3 3 6 1 3 5 9 0 5 3 6 5 9 13 16 0 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 667 N B e 58.8 7c76_A NAG K0IE77_PETMA:Variable lymphocyte receptor[217 aa]:Variable lymphocyte receptor[218 aa] GOL:SO4 3 1 8 4 3 13 2 1 6 5 2 16 2 7 3 12 9 5 0 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 668 I b 11.7 7c76_A SPIKE_SARS2:Spike glycoprotein[1038 aa] K0IE77_PETMA:Variable lymphocyte receptor[217 aa]:Variable lymphocyte receptor[218 aa] 1 0 1 1 1 1 1 18 1 25 2 4 2 2 1 4 3 27 2 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 669 P S e 41.9 7c76_A NTNG1_HUMAN:NETRIN-G1[326 aa] beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 4 0 3 4 1 2 0 7 2 5 2 2 30 2 10 8 4 11 0 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 670 E S e 58.8 7c76_A NTNG1_HUMAN:ERBB2_HUMAN:NETRIN-G1[326 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. AMGO1_MOUSE:Amphoterin-induced protein 1[333 aa]:Amphoterin-induced protein 1[331 aa] 2 1 17 22 5 12 0 3 7 3 0 2 3 4 5 5 2 3 1 3 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 671 L b 11.8 7c76_A NTNG2_HUMAN:NETRIN-G2[303 aa] AMGO1_MOUSE:Amphoterin-induced protein 1[333 aa]:Amphoterin-induced protein 1[331 aa] SO4 3 2 3 4 3 6 0 8 3 31 6 2 2 2 2 2 3 9 8 1 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 672 S T e 52.3 7c76_A NTNG1_HUMAN:F8W3J5_DANRE:Q4G1L2_EPTBU:IGG1_HUMAN:NETRIN-G1[326 aa]:Toll-like receptor 5b, Variable lymphocyte recepto..:Immunoglobulin gamma-1 heavy chain[198 aa] TLR3_MOUSE:Toll-like receptor 3[671 aa] 9 3 4 8 1 5 1 3 4 3 1 3 11 6 4 15 12 4 0 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 673 S T e 66.4 7c76_A IGG1_HUMAN:Immunoglobulin gamma-1 heavy chain[198 aa] TLR3_MOUSE:Toll-like receptor 3[671 aa] SO4:PO4 7 0 16 14 1 5 0 1 5 3 0 9 4 3 5 13 8 2 0 4 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 674 H T e 26.2 7c76_A NTNG2_HUMAN:NTNG1_HUMAN:PTPRD_HUMAN:F8W3J5_DANRE:Q4G1L2_EPTBU:IGG1_HUMAN:ERBB2_HUMAN:NETRIN-G2[303 aa]:NETRIN-G1[326 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:Toll-like receptor 5b, Variable lymphocyte recepto..:Immunoglobulin gamma-1 heavy chain[198 aa]:Receptor tyrosine-protein kinase erbB-2[72 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. AMGO1_MOUSE:Amphoterin-induced protein 1[333 aa]:Amphoterin-induced protein 1[331 aa] PO4:SO4 2 1 11 6 3 8 7 1 3 3 1 9 3 8 11 13 4 1 0 3 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 675 Y b 1.3 7c76_A SO4 5 1 1 1 3 3 3 11 3 5 7 1 6 3 2 4 8 14 0 19 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 676 L e 37.6 7c76_A TLR3_MOUSE:Toll-like receptor 3[674 aa] SO4 4 3 1 4 5 2 1 8 7 18 8 0 1 3 9 3 9 6 0 5 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 677 C E b 2.7 7c76_A 0 86 0 0 0 3 0 1 0 0 0 0 0 0 0 1 1 1 2 5 DISULFID::DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DISULFID::DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 678 N E e 34.5 7c76_A PTPRD_MOUSE:Receptor-type tyrosine-protein phosphatase delta[3.. TLR3_MOUSE:Q2EEY0_HORSE:TLR8_HUMAN:TLR9_MOUSE:TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 9[753 aa]:Toll-like receptor 3[669 aa]:Toll-like receptor 3[659 aa] PO4:SO4 29 0 11 7 1 5 6 1 3 1 1 5 3 6 2 7 6 4 0 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 679 T E e 45.5 7c76_A PTPRD_MOUSE:Receptor-type tyrosine-protein phosphatase delta[3.. TLR3_MOUSE:TLR8_HUMAN:Q2EEY0_HORSE:TLR9_BOVIN:TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 9[714 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 3[669 aa]:Toll-like receptor 3[659 aa] 7 0 1 2 3 14 2 2 1 1 2 4 0 1 4 24 13 6 0 12 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 680 P S e 42.6 7c76_A PTPRD_MOUSE:UN93B_MOUSE:UN93B_HUMAN:Receptor-type tyrosine-protein phosphatase delta[3..:Protein unc-93 homolog B1[483 aa] TLR3_MOUSE:TLR8_HUMAN:Q2EEY0_HORSE:TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 3[659 aa] 2 0 0 0 0 0 0 1 1 0 1 0 86 2 0 1 1 1 0 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 681 P G e 88.4 7c76_A PTPRD_HUMAN:PTPRD_MOUSE:NRX1B_HUMAN:UN93B_HUMAN:Receptor-type tyrosine-protein phosphatase delta[3..:Neurexin-1-beta[178 aa]:Protein unc-93 homolog B1[483 aa] TLR3_MOUSE:TLR8_HUMAN:Q2EEY0_HORSE:TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 3[669 aa]:Toll-like receptor 3[659 aa] 5 0 3 12 3 9 1 1 7 8 2 1 27 1 2 14 1 4 0 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 682 H G e 75.4 7c76_A PTPRD_HUMAN:PTPRD_MOUSE:NRX1B_HUMAN:UN93B_HUMAN:UN93B_MOUSE:Receptor-type tyrosine-protein phosphatase delta[3..:Neurexin-1-beta[178 aa]:Protein unc-93 homolog B1[483 aa] TLR3_MOUSE:TLR3_HUMAN:G8E2R2_MACMU:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 3[669 aa]:Toll-like receptor 3[659 aa]:Toll-like receptor 7[772 aa] 5 0 8 14 1 1 15 1 7 3 1 6 1 6 9 15 1 2 0 4 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 683 Y G e 36.1 7c76_A UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] PO4:SO4 3 0 1 2 8 0 2 2 3 34 8 2 0 1 1 6 1 15 0 12 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 684 H T e 61.8 7c76_A PTPRD_HUMAN:PTPRD_MOUSE:NRX1B_HUMAN:Receptor-type tyrosine-protein phosphatase delta[3..:Neurexin-1-beta[178 aa] TLR3_MOUSE:TLR8_HUMAN:Q2EEY0_HORSE:B3Y653_MACMU:TLR9_MOUSE:TLR3_HUMAN:Toll-like receptor 3[668 aa]:Toll-like receptor 3[661 aa]:Toll-like receptor 8[746 aa]:Toll-like receptor 8[747 aa]:Toll-like receptor 8[751 aa]:Toll-like receptor 9[749 aa]:Toll-like receptor 9[747 aa]:Toll-like receptor 8[745 aa]:Toll-like receptor 8[748 aa]:Toll-like receptor 8[750 aa]:Toll-like receptor 7[772 aa]:Toll-like receptor 9[751 aa]:Toll-like receptor 7[774 aa]:Toll-like receptor 3[669 aa]:Toll-like receptor 3[674 aa]:Toll-like receptor 3[659 aa] 10 0 0 1 0 0 7 0 15 1 0 2 2 23 27 8 2 1 0 1 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 685 G T e 50.0 7c76_A NTNG1_HUMAN:PTPRD_HUMAN:NRX1B_HUMAN:NETRIN-G1[326 aa]:Receptor-type tyrosine-protein phosphatase delta[3..:Neurexin-1-beta[178 aa] TLR3_MOUSE:Toll-like receptor 3[671 aa]:Toll-like receptor 3[674 aa] SO4 4 1 5 2 0 71 1 0 4 2 0 4 0 0 1 1 1 2 0 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 686 F e 46.4 7c76_A TLR3_MOUSE:Toll-like receptor 3[671 aa]:Toll-like receptor 3[674 aa] SO4:PO4 5 0 1 3 7 2 4 2 7 11 10 2 1 13 7 10 6 4 2 4 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 687 P e 21.7 7c76_A TLR3_MOUSE:Toll-like receptor 3[671 aa]:Toll-like receptor 3[674 aa] SO4 9 0 7 3 1 1 1 1 1 9 0 7 25 6 4 14 5 1 0 3 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 688 V G b 4.0 7c76_A alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 2 0 1 1 3 1 0 11 1 30 2 0 2 1 0 6 2 37 0 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 689 R G e 56.1 7c76_A alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 3 0 3 1 8 2 4 2 11 11 1 0 0 10 29 5 2 5 0 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 690 L G e 67.4 7c76_A alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. TLR3_MOUSE:Toll-like receptor 3[671 aa]:Toll-like receptor 3[674 aa] 7 0 12 7 2 2 1 1 1 29 3 2 0 3 6 15 2 5 0 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 691 F b 12.0 7c76_A alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 2 0 2 2 27 1 0 6 5 23 0 0 1 6 2 4 2 11 2 3 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 692 D e 50.6 7c76_A CA beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. G8E2R2_MACMU:Toll-like receptor 7[772 aa] 2 0 33 6 0 0 4 0 4 6 0 11 4 6 10 6 3 3 0 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 693 T e 24.0 7c76_A NAG G8E2R2_MACMU:Toll-like receptor 7[772 aa] 7 3 5 11 5 1 0 4 2 16 5 10 3 3 2 5 6 8 0 3 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 694 S S e 66.4 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] G8E2R2_MACMU:Toll-like receptor 7[772 aa] SO4 14 0 0 6 1 6 2 2 3 5 0 2 0 2 8 35 8 3 0 2 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 695 S S e 62.5 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] G8E2R2_MACMU:Toll-like receptor 7[772 aa] PO4:SO4 2 2 2 11 1 4 2 3 0 12 1 8 5 4 1 18 21 1 0 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 696 C S b 16.0 7c76_A UN93B_MOUSE:UN93B_HUMAN:Protein unc-93 homolog B1[483 aa] 2 60 0 0 2 0 0 0 3 14 0 0 2 3 0 5 2 0 0 5 DISULFID::DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DISULFID::DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 697 K T e 80.7 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] G8E2R2_MACMU:Toll-like receptor 7[772 aa] 1 1 2 7 0 4 9 3 21 5 0 3 9 10 4 11 5 3 0 3 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 698 D T e 74.1 7c76_A 1 17 31 9 3 1 2 4 2 3 1 2 3 4 8 4 4 1 0 0 DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal":DOMAIN:/note="LRRCT":TOPO_DOM:/note="Lumenal" 699 S T e 46.9 7c76_A UN93B_HUMAN:Protein unc-93 homolog B1[483 aa] 4 0 10 8 0 4 3 3 3 2 2 5 8 1 7 24 11 2 0 4 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 700 A S e 42.0 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] 26 4 1 1 2 8 2 4 6 14 0 0 3 1 2 6 14 5 0 0 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 701 P e 65.1 7c76_A 10 0 1 5 1 4 0 1 3 12 0 1 36 1 3 3 13 5 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 702 F H e 47.8 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] 7 0 3 1 14 4 2 7 1 20 3 4 2 2 3 9 3 9 2 3 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 703 E H e 71.4 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] 1 0 1 27 1 7 0 6 6 13 2 1 1 4 3 10 2 5 7 4 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 704 L H e 48.9 7c76_A TLR5_HUMAN:Toll-like receptor 5[632 aa]:Toll-like receptor 5[797 aa] 1 2 7 1 1 3 0 12 3 32 2 1 1 1 3 7 4 17 0 2 TOPO_DOM:/note="Lumenal":TOPO_DOM:/note="Lumenal" 705 F H e 55.0 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:Toll-like receptor 3[34 aa] 4 7 1 1 28 4 2 5 1 13 0 2 1 3 1 5 1 16 0 4 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 706 F H e 65.6 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] 3 0 1 1 23 8 5 8 1 11 0 1 1 4 1 11 10 8 0 4 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 707 M H e 44.9 7c76_A TLR5_HUMAN:Toll-like receptor 5[797 aa] 9 2 2 0 5 9 4 12 0 13 15 0 2 2 0 9 5 8 0 3 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 708 I H e 46.2 7c76_A TLR5_HUMAN:Toll-like receptor 5[632 aa] 1 15 0 1 3 6 0 21 1 12 8 3 2 0 3 5 4 15 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 709 N H e 62.4 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:Toll-like receptor 3[34 aa] 10 10 3 4 3 7 4 0 9 3 2 5 6 0 0 24 6 5 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 710 T H e 36.4 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:Toll-like receptor 3[34 aa] 9 4 0 6 6 0 0 5 0 12 2 3 7 2 0 4 27 11 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 711 S H e 43.8 7c76_A TLR3_HUMAN:TLR5_HUMAN:Toll-like receptor 3[34 aa]:Toll-like receptor 5[797 aa] 15 0 2 0 2 7 6 10 2 18 6 4 0 2 0 18 5 3 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 712 I H e 62.6 7c76_A UN93B_HUMAN:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:TLR5_HUMAN:Toll-like receptor 3[34 aa]:Toll-like receptor 5[632 aa] 8 2 0 0 5 2 2 19 0 28 6 0 0 0 2 4 1 18 0 4 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 713 L H e 58.4 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:Toll-like receptor 3[34 aa] 5 0 0 4 6 3 0 5 0 31 1 0 3 4 0 4 8 28 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 714 L H e 61.2 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:Toll-like receptor 3[34 aa] 10 0 0 2 6 1 0 7 0 44 1 0 2 0 3 6 4 8 0 4 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 715 I H e 69.0 7c76_A TLR3_HUMAN:Toll-like receptor 3[34 aa] 10 0 0 0 6 0 0 7 0 29 2 0 2 0 0 11 7 24 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 716 F H e 61.2 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:Toll-like receptor 3[34 aa] 3 0 0 3 14 7 0 5 0 25 0 0 0 2 3 7 3 22 0 4 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 717 I H e 50.3 7c76_A UN93B_MOUSE:UN93B_HUMAN:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:Toll-like receptor 3[34 aa] 7 0 0 0 3 1 0 16 0 27 10 0 5 0 3 0 7 19 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 718 F H e 74.2 7c76_A TLR3_HUMAN:Toll-like receptor 3[34 aa] 8 0 1 1 15 7 0 3 1 14 2 0 1 3 3 8 11 19 3 2 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 719 I H e 46.8 7c76_A TLR3_HUMAN:Toll-like receptor 3[34 aa] 8 3 0 1 7 7 0 17 0 5 2 0 3 2 0 0 18 27 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 720 V H e 47.3 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:Toll-like receptor 3[34 aa] 13 3 0 0 6 6 0 6 0 18 7 4 8 0 0 2 0 26 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 721 L H e 45.5 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:Toll-like receptor 3[34 aa] 3 0 0 0 0 3 0 8 4 41 12 0 0 0 0 0 5 14 0 6 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 722 L H e 52.8 7c76_A TLR3_HUMAN:Toll-like receptor 3[34 aa] 9 19 1 1 5 1 0 1 1 29 3 0 3 0 1 1 5 21 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 723 I H e 68.4 7c76_A 3 3 1 1 4 4 22 16 1 9 3 0 1 3 1 13 2 12 0 3 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 724 H H e 73.3 7c76_A UN93B_HUMAN:UN93B_MOUSE:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:Toll-like receptor 3[34 aa] 9 0 5 1 0 1 29 1 4 9 0 1 3 1 11 4 1 7 2 11 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 725 F H e 69.4 7c76_A UN93B_HUMAN:Protein unc-93 homolog B1[483 aa] TLR3_HUMAN:Toll-like receptor 3[34 aa] 0 3 4 0 38 0 0 1 0 29 0 0 0 3 3 0 0 11 2 3 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 726 E e 101.5 7c76_A 10 8 15 9 6 7 11 0 3 3 0 0 0 5 9 2 0 6 3 2 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 727 G H e 40.5 8ar1_A 4 0 0 3 2 45 0 3 4 1 4 0 11 0 3 3 5 8 0 3 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 728 W H e 79.7 8ar1_A TLR3_HUMAN:Toll-like receptor 3[34 aa] 1 0 9 1 5 1 0 2 3 16 6 3 0 0 6 1 0 1 44 2 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 729 R H e 51.0 8ar1_A TLR3_HUMAN:Toll-like receptor 3[34 aa] 1 4 13 1 6 1 0 3 8 2 2 6 0 0 27 1 4 8 0 14 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 730 I H e 39.8 8ar1_A TLR3_HUMAN:Toll-like receptor 3[34 aa] 4 0 0 0 5 0 3 12 0 24 19 0 0 0 0 3 0 17 0 11 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 731 S H e 75.0 8ar1_A 7 2 0 0 0 3 5 4 21 5 0 0 5 0 7 10 3 8 19 2 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 732 F H e 86.6 8ar1_A 2 12 0 0 32 0 2 7 3 14 12 0 0 0 0 0 0 0 0 15 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" F->L:LB/B:rs9885865: -; 733 Y T e 35.2 8ar1_A 0 8 0 0 10 0 2 5 0 6 11 0 3 12 0 3 3 2 5 28 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 734 W e 73.3 8ar1_A 3 7 0 0 24 2 0 0 0 0 0 0 0 0 0 0 0 0 49 13 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 735 N S e 113.3 8ar1_A 8 3 3 1 0 3 27 1 8 8 0 6 1 2 4 3 13 1 0 8 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 736 V S e 51.3 8ar1_A 8 2 1 1 2 1 6 1 3 32 7 1 1 14 1 1 1 9 2 10 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 737 S e 51.6 8ar1_A 8 15 1 1 0 5 0 5 3 4 7 1 1 3 6 17 20 1 0 3 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" S->T:LB/B:rs5743318: -; 738 V H e 34.0 8ar1_A 7 0 4 1 1 4 4 5 5 33 3 1 1 3 12 3 6 7 2 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 739 H H e 39.3 8ar1_A 17 3 2 2 14 5 15 2 4 4 1 8 2 6 7 2 2 2 0 1 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 740 R H e 87.0 8ar1_A 11 4 1 1 1 4 3 1 11 9 0 1 1 6 40 1 1 1 2 1 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 741 V H e 74.0 8ar1_A 13 0 0 0 2 0 0 10 0 25 4 0 0 0 7 0 3 18 12 3 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 742 L H e 61.2 8ar1_A 12 0 0 0 4 0 0 7 12 32 4 0 1 0 10 0 0 6 10 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 743 G e 29.0 3j0a_A 3 0 0 0 0 39 0 0 4 8 0 7 17 9 1 0 0 3 4 3 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 744 F e 39.3 3j0a_A 12 14 0 0 22 2 1 0 0 17 0 0 4 0 7 0 4 0 3 11 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 745 K e 45.0 3j0a_A 2 0 0 10 0 4 0 0 41 3 0 0 0 4 22 3 7 4 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 746 E G e 30.6 3j0a_A 5 3 8 13 4 8 2 0 17 1 0 0 3 8 14 6 6 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 747 I 4 0 1 8 0 1 2 8 18 19 0 1 2 2 5 3 1 7 4 14 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 748 D G e 90.5 3j0a_A 1 4 14 8 0 13 3 1 13 1 0 2 11 13 5 7 1 3 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 749 R G e 63.0 3j0a_A 3 0 8 5 0 1 0 1 6 1 0 0 1 11 47 3 6 1 3 3 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 750 Q S b 7.5 3j0a_A 1 0 3 5 0 26 0 3 18 14 0 5 3 6 1 9 6 1 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 751 T S e 92.2 3j0a_A 17 3 9 21 1 5 0 1 5 4 0 1 1 1 4 15 11 2 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 752 E S e 60.5 3j0a_A 1 0 10 19 1 4 0 1 18 1 2 1 10 2 12 15 1 1 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 753 Q e 85.5 3j0a_A 9 0 12 18 0 0 0 8 7 1 3 8 0 14 9 3 6 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 754 F b 14.8 3j0a_A 1 2 1 1 15 1 0 7 8 24 0 4 1 0 12 5 5 6 0 9 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 755 E e 53.8 3j0a_A 2 12 8 9 6 1 0 2 7 13 0 4 9 12 5 2 5 2 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 756 Y b 18.7 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[135 aa]:TOLL-LIKE RECEPTOR 2[141 aa] 0 0 0 0 27 0 0 0 0 0 0 4 0 0 0 0 0 0 0 68 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 757 A S b 4.3 3j0a_A 3 0 80 0 0 2 13 0 0 0 0 0 0 0 0 0 2 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 758 A E b 0.0 3j0a_A 91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 759 Y E b 0.4 3j0a_A E5L3Q3_CHICK:H2D5F4_CHICK:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 0 0 0 0 76 0 0 0 0 0 0 0 0 0 0 0 0 6 0 18 MOD_RES:/note="Phosphotyrosine":MUTAGEN:/note="Y->F: Reduced activation of NF-kappa-B in response to ds-RNA. Reduced induction of IL-8 in response to ds-RNA. Loss of interaction with WDFY1." ECO:0000269|PubMed:25736436":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphotyrosine":MUTAGEN:/note="Y->F: Reduced activation of NF-kappa-B in response to ds-RNA. Reduced induction of IL-8 in response to ds-RNA. Loss of interaction with WDFY1." ECO:0000269|PubMed:25736436":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 760 I E b 0.0 3j0a_A 0 0 0 0 7 0 0 34 0 7 0 0 0 0 0 0 0 52 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 761 I E b 2.0 3j0a_A 4 5 0 0 0 0 0 20 0 4 0 0 0 0 0 52 0 14 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 762 H b 6.2 3j0a_A GSH 0 0 0 0 18 0 13 0 0 0 0 0 0 0 0 0 0 0 0 70 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 763 A b 2.3 3j0a_A GSH 8 7 19 0 0 0 0 0 0 0 0 0 0 0 0 66 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 764 Y S e 82.8 3j0a_A GSH 7 0 4 27 0 4 6 0 10 4 0 0 0 0 4 23 8 0 0 3 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 765 K T e 68.9 3j0a_A 7 0 0 7 0 0 14 0 29 0 0 3 0 27 7 0 4 1 0 0 CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 766 D T e 23.5 3j0a_A 0 0 85 0 0 0 0 0 0 0 0 5 0 10 0 0 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 767 K H e 42.6 3j0a_A 15 0 0 25 5 0 0 0 1 0 0 0 0 11 7 33 2 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 768 D H e 71.4 3j0a_A 16 0 34 11 1 4 5 0 0 5 0 3 0 4 0 4 2 0 0 11 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 769 W H b 15.1 3j0a_A 0 0 0 0 19 0 0 0 0 0 0 0 0 0 0 0 0 0 81 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 770 V H b 1.3 3j0a_A 4 0 0 0 0 0 0 4 0 3 0 0 0 0 0 0 0 90 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 771 W H b 14.0 3j0a_A 1 4 0 11 0 1 0 8 9 17 0 8 0 0 16 2 2 1 5 15 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 772 E H e 57.5 3j0a_A 2 0 4 52 0 0 4 0 7 0 0 21 0 11 0 0 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 773 H H e 45.5 3j0a_A 0 0 4 24 0 0 14 4 0 31 7 8 0 0 4 0 0 0 0 4 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 774 F H b 3.9 3j0a_A 0 0 0 0 5 0 0 6 0 56 4 0 0 0 0 0 0 26 0 4 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 775 S H e 40.7 3j0a_A 11 0 5 0 0 0 4 0 15 0 11 0 24 7 10 5 0 8 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 776 S S e 63.0 3j0a_A 17 0 0 2 0 1 0 0 4 4 0 25 10 13 0 4 2 16 0 1 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 777 M T e 46.4 3j0a_A 0 0 0 4 0 0 3 0 4 54 8 4 0 15 5 0 4 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 778 E T e 50.0 3j0a_A 0 0 4 73 0 0 0 0 0 14 0 0 0 0 0 0 0 4 0 5 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 779 K T e 38.3 3j0a_A 0 0 0 37 0 0 5 0 18 7 3 2 8 7 0 9 4 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 780 E T e 80.2 3j0a_A 6 0 6 36 2 29 0 0 0 0 0 4 0 2 10 5 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 781 D T e 55.1 3j0a_A 0 4 27 12 0 7 0 0 0 0 0 9 4 3 16 3 0 15 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 782 Q T e 59.4 3j0a_A 1 0 0 4 0 9 5 5 9 4 0 5 34 10 11 1 1 1 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 783 S e 39.1 3j0a_A 11 0 0 0 0 13 4 0 5 1 0 6 31 0 11 10 5 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 784 L S b 1.4 3j0a_A 0 0 0 0 43 0 0 10 0 32 1 0 0 0 0 0 0 6 0 7 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 785 K e 24.2 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[135 aa]:TOLL-LIKE RECEPTOR 2[141 aa] 0 0 0 0 0 0 3 0 24 8 0 7 0 22 36 0 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 786 F E b 6.7 3j0a_A 0 0 0 0 5 0 0 12 0 78 0 0 0 0 0 0 0 6 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 787 C E b 4.0 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[141 aa] 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 788 L b 4.8 3j0a_A 0 0 0 0 9 0 0 0 0 87 0 0 0 0 0 0 0 4 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 789 E S e 29.1 3j0a_A GSH TLR10_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 0 0 0 28 0 0 58 0 0 0 0 0 7 4 0 0 0 0 0 2 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 790 E S e 42.2 3j0a_A GSH TLR10_HUMAN:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa] 3 0 1 48 0 0 4 0 15 0 0 4 0 5 0 0 0 0 0 19 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 791 R S e 58.9 3j0a_A 0 0 0 0 0 2 0 0 0 0 0 0 0 0 96 2 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 792 D S e 47.5 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[141 aa] 0 0 87 0 0 0 0 0 0 0 0 11 0 0 0 0 0 0 0 2 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 793 F e 53.1 3j0a_A TLR2_HUMAN:TLR10_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[141 aa]:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 0 0 0 0 67 0 0 0 0 4 0 0 0 0 0 2 0 4 23 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 794 E e 49.3 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[135 aa]:TOLL-LIKE RECEPTOR 2[141 aa] 4 0 8 11 0 3 0 29 0 18 0 4 3 0 0 0 0 20 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 795 A S e 89.9 3j0a_A TLR10_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 7 0 0 0 0 0 4 8 0 0 0 0 74 0 0 0 0 7 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 796 G S e 82.1 3j0a_A E5L3Q3_CHICK:H2D5F4_CHICK:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 0 0 4 0 0 92 0 0 0 0 0 4 0 0 0 0 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 797 V S e 40.2 3j0a_A TLR10_HUMAN:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa] 8 0 0 5 4 7 0 3 40 4 0 3 0 6 0 0 0 20 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 798 F e 69.1 3j0a_A TLR2_HUMAN:TLR10_HUMAN:TLR6_HUMAN:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL-LIKE RECEPTOR 2[141 aa]:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 6[143 aa] 17 0 13 0 1 0 4 0 0 3 0 5 6 0 0 13 14 0 15 7 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 799 E H e 60.9 3j0a_A TLR2_HUMAN:TLR10_HUMAN:TLR6_HUMAN:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 6[143 aa] 0 0 0 1 0 2 7 59 2 13 2 0 0 0 6 0 0 8 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 800 L H e 48.5 3j0a_A TLR2_HUMAN:TLR10_HUMAN:TLR6_HUMAN:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL-LIKE RECEPTOR 2[135 aa]:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 6[143 aa] 19 0 0 0 13 0 0 22 0 9 3 0 7 0 0 2 6 14 0 4 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 801 E H b 15.2 3j0a_A TLR2_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL-LIKE RECEPTOR 2[141 aa]:TOLL-LIKE RECEPTOR 2[135 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 18 0 26 46 0 0 0 0 0 0 0 0 0 4 0 3 0 4 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 802 A H b 11.5 3j0a_A TLR2_HUMAN:TLR10_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[141 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 9 0 2 0 0 0 0 0 0 0 0 78 0 0 0 4 3 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 803 I H b 8.8 3j0a_A E5L3Q3_CHICK:H2D5F4_CHICK:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 0 0 0 0 0 0 0 64 0 27 3 0 0 0 0 0 2 4 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 804 V H e 60.2 3j0a_A TLR2_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL-LIKE RECEPTOR 2[135 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 0 0 0 0 0 0 0 49 0 4 8 0 0 8 0 4 4 13 10 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 805 N H e 49.4 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL-LIKE RECEPTOR 2[135 aa]:TOLL-LIKE RECEPTOR 2[141 aa] 16 0 21 8 0 0 3 0 0 0 0 21 0 23 4 2 1 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 806 S H b 3.6 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[141 aa] 22 7 0 0 7 15 0 0 0 0 0 0 0 0 0 49 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 807 I H b 19.9 3j0a_A 4 0 0 0 15 0 0 54 0 0 7 0 0 0 0 0 4 15 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 808 K H e 70.9 3j0a_A E5L3Q3_CHICK:H2D5F4_CHICK:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 4 0 3 32 0 3 15 0 3 4 0 10 0 4 6 0 0 0 5 10 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 809 R H b 13.9 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[135 aa]:TOLL-LIKE RECEPTOR 2[141 aa] 0 0 4 0 0 5 0 0 47 4 0 6 0 4 5 18 3 4 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 810 S S b 1.6 3j0a_A 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 96 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 811 R S b 11.5 3j0a_A SO4 0 0 0 0 0 0 12 0 13 0 0 0 0 0 62 0 0 0 0 13 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 812 K E b 1.4 3j0a_A 3 0 0 0 0 0 0 0 77 0 0 0 0 4 11 0 4 0 0 0 CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":MUTAGEN:/note="K->R: Loss of ubiquitination by ZNRF1.":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":MUTAGEN:/note="K->R: Loss of ubiquitination by ZNRF1.":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 813 I E b 4.7 3j0a_A 2 0 0 0 4 0 0 7 0 0 2 0 0 0 0 12 53 19 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 814 I E b 0.0 3j0a_A 0 0 0 0 0 0 0 53 0 21 3 0 0 0 0 0 0 24 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 815 F E b 6.0 3j0a_A 0 18 0 0 51 0 0 8 0 4 3 0 0 0 0 0 0 15 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 816 V E b 3.4 3j0a_A 0 0 0 0 0 0 0 0 0 9 0 0 0 0 0 0 0 91 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 817 I E b 6.7 3j0a_A 0 0 0 0 0 0 0 8 0 62 4 0 0 0 0 0 0 26 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 818 T b 3.1 3j0a_A 8 0 3 0 0 0 0 0 0 0 0 0 0 0 0 69 21 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 819 H T e 39.9 3j0a_A 0 0 2 17 0 7 12 0 8 0 0 3 13 19 15 4 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 820 H T e 22.0 3j0a_A 0 0 0 0 0 0 32 0 9 0 0 40 0 7 0 3 7 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 821 L H b 1.0 3j0a_A GSH 7 0 7 0 64 0 0 0 0 5 0 0 0 0 0 0 0 0 0 15 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 822 L H b 1.7 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[149 aa] 9 0 0 0 0 0 0 26 0 32 0 0 0 0 7 0 0 25 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 823 K H e 57.3 3j0a_A TLR2_HUMAN:TLR6_HUMAN:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[149 aa]:Toll-like receptor 6[143 aa]:Toll-like receptor 2[142 aa] 3 4 0 0 0 0 3 0 30 0 0 4 0 35 7 0 4 6 0 4 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 824 D H e 55.6 3j0a_A GSH TLR10_HUMAN:E5L3Q3_CHICK:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 15[143 aa] 0 0 14 0 0 0 0 0 0 0 0 10 0 0 0 66 11 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 825 P T b 14.3 3j0a_A TLR10_HUMAN:H2D5F4_CHICK:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 2[142 aa] 0 0 0 48 0 12 0 0 0 0 0 0 12 1 18 0 0 0 2 4 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 826 L S b 3.2 3j0a_A GSH E5L3Q3_CHICK:H2D5F4_CHICK:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 0 0 0 0 0 0 0 0 0 12 0 2 0 0 4 2 0 4 73 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 827 C T e 34.0 3j0a_A GSH TLR2_HUMAN:TLR10_HUMAN:TLR6_HUMAN:E5L3Q3_CHICK:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL-LIKE RECEPTOR 2[135 aa]:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 6[143 aa]:Toll-like receptor 15[143 aa] 9 69 0 1 5 1 0 0 0 7 0 0 0 0 0 4 0 1 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 828 K T e 35.4 3j0a_A TLR2_HUMAN:E5L3Q3_CHICK:TOLL-LIKE RECEPTOR 2[135 aa]:Toll-like receptor 15[143 aa] 3 1 2 5 1 7 1 14 25 6 5 5 2 2 8 7 2 2 3 1 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 829 R H b 8.0 3j0a_A TLR10_HUMAN:TLR6_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL LIKE RECEPTOR 10[134 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 6[143 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 5 1 2 5 1 2 14 2 2 7 1 6 2 1 39 2 4 2 0 1 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 830 F H b 1.7 7nuw_A E5L3Q3_CHICK:H2D5F4_CHICK:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 5 0 0 0 32 0 0 0 0 21 0 0 0 0 5 0 2 0 0 32 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 831 K H b 11.6 3j0a_A GSH TLR2_HUMAN:TLR10_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[141 aa]:TOLL LIKE RECEPTOR 10[141 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 8 0 0 65 0 0 0 0 9 0 0 0 0 0 4 11 0 0 0 2 CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":MUTAGEN:/note="K->R: Loss of ubiquitination by TRIM3.":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":CROSSLNK:/note="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)":MUTAGEN:/note="K->R: Loss of ubiquitination by TRIM3.":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 832 V H e 63.6 3j0a_A TLR2_HUMAN:TLR6_HUMAN:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL-LIKE RECEPTOR 2[135 aa]:TOLL-LIKE RECEPTOR 2[141 aa]:Toll-like receptor 6[143 aa] 7 0 0 0 21 0 0 2 0 34 0 0 2 0 0 0 6 12 0 17 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 833 H H e 33.6 3j0a_A TLR2_HUMAN:TLR6_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL-LIKE RECEPTOR 2[135 aa]:Toll-like receptor 6[143 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] SO4 0 0 15 13 3 0 9 0 7 7 0 4 0 3 8 9 0 0 0 24 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 834 H H b 18.3 3j0a_A TLR2_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL-LIKE RECEPTOR 2[135 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 4 0 4 0 32 0 9 16 0 19 0 0 0 0 4 7 0 0 0 3 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 835 A H e 69.6 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[135 aa] 71 0 0 0 0 4 0 0 0 4 0 0 0 0 0 17 0 0 0 3 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 836 V H e 82.1 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL-LIKE RECEPTOR 2[135 aa] 3 0 0 0 0 0 38 0 0 13 0 0 0 26 4 3 4 9 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 837 Q S e 48.8 3j0a_A E5L3Q3_CHICK:H2D5F4_CHICK:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] SO4 4 0 0 0 15 3 18 0 0 0 6 0 0 30 9 4 13 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 838 Q e 89.3 3j0a_A TLR2_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[135 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] SO4 0 0 0 8 0 4 0 0 3 4 0 14 0 5 40 10 0 0 13 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 839 A e 56.7 3j0a_A 9 3 0 0 0 0 0 0 0 57 3 0 0 13 8 4 0 3 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 840 I b 12.4 3j0a_A 0 0 0 0 45 0 0 9 0 28 7 0 5 0 0 3 0 4 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 841 E e 50.8 3j0a_A 4 0 24 16 0 0 14 0 4 16 0 4 0 5 7 3 0 0 0 3 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 842 Q S e 64.8 3j0a_A 4 0 17 45 0 0 0 0 5 0 0 4 0 5 4 16 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 843 N S e 62.4 3j0a_A 2 0 3 0 0 17 3 0 5 3 0 27 4 0 19 16 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 844 L e 29.7 3j0a_A 1 0 0 4 2 1 2 0 14 11 5 17 0 0 19 16 1 5 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 845 D T e 39.8 3j0a_A 8 0 58 0 0 0 0 0 8 0 0 3 4 0 3 13 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 846 S T b 11.6 3j0a_A 16 0 0 0 0 13 2 0 0 0 0 8 4 0 12 10 0 29 0 2 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 847 I E b 9.6 3j0a_A 13 0 0 0 0 2 0 42 0 20 0 0 0 0 0 0 0 21 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 848 I E b 4.1 3j0a_A 0 0 0 0 4 0 0 72 0 5 0 0 0 0 0 0 0 16 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 849 L E b 1.9 3j0a_A 0 0 0 0 22 0 0 0 0 65 3 0 0 0 0 0 0 10 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 850 V E b 0.0 3j0a_A 0 0 0 0 0 0 0 65 0 0 0 0 0 0 0 0 0 35 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 851 F E b 17.3 3j0a_A 0 0 0 0 17 0 0 24 0 38 0 0 0 0 0 0 0 22 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 852 L S b 20.0 3j0a_A 0 0 0 0 0 0 0 5 0 81 0 0 0 0 0 0 0 6 0 9 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 853 E S e 31.0 3j0a_A 2 0 2 59 0 14 0 0 0 0 0 0 0 9 7 7 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 854 E e 82.8 3j0a_A 1 0 10 16 1 1 0 1 19 1 0 3 37 1 1 7 1 1 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 855 I e 25.3 3j0a_A GOL 1 2 1 1 1 1 0 50 1 18 0 1 1 1 1 1 1 17 0 1 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 856 P e 26.6 3j0a_A GOL 0 0 7 20 0 5 0 0 0 4 0 0 48 3 0 12 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 857 D S e 86.2 3j0a_A GOL 3 0 19 0 2 0 0 0 25 5 0 3 3 28 6 3 0 2 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 858 Y S e 73.0 3j0a_A GOL 10 0 0 0 3 2 5 0 17 2 0 3 0 5 5 10 4 5 0 30 MOD_RES:/note="Phosphotyrosine":MUTAGEN:/note="Y->F: Loss of interaction with WDFY1.":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphotyrosine":MUTAGEN:/note="Y->F: Loss of interaction with WDFY1.":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 859 K S b 11.7 3j0a_A TLR2_HUMAN:TLR6_HUMAN:TOLL-LIKE RECEPTOR 2[149 aa]:Toll-like receptor 6[143 aa] GOL 16 5 5 4 0 0 4 0 16 14 0 2 0 17 3 9 0 0 0 4 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 860 L e 25.3 3j0a_A GOL 0 0 0 0 0 0 3 35 3 43 0 0 0 0 12 0 0 1 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 861 N e 44.9 3j0a_A TLR2_HUMAN:TLR6_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[149 aa]:Toll-like receptor 6[143 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 0 0 13 0 0 0 0 0 2 0 7 6 36 0 11 25 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 862 H S e 95.8 3j0a_A TLR2_HUMAN:TLR6_HUMAN:TOLL-LIKE RECEPTOR 2[135 aa]:TOLL-LIKE RECEPTOR 2[141 aa]:Toll-like receptor 6[143 aa] 0 0 0 5 0 5 6 0 12 0 0 3 4 32 15 9 7 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 863 A e 23.0 3j0a_A TLR2_HUMAN:TLR10_HUMAN:TLR6_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[149 aa]:TOLL-LIKE RECEPTOR 2[135 aa]:TOLL-LIKE RECEPTOR 2[141 aa]:TOLL LIKE RECEPTOR 10[134 aa]:Toll-like receptor 6[143 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 11 0 4 5 5 0 7 0 2 0 0 4 0 14 23 4 0 0 0 20 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 864 L S e 87.2 3j0a_A TLR2_HUMAN:TLR6_HUMAN:E5L3Q3_CHICK:H2D5F4_CHICK:TOLL-LIKE RECEPTOR 2[149 aa]:Toll-like receptor 6[143 aa]:Toll-like receptor 15[143 aa]:Toll-like receptor 2[142 aa] 0 0 0 3 16 0 3 0 0 24 5 0 0 3 5 0 0 25 0 15 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 865 C S b 18.8 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[135 aa]:TOLL-LIKE RECEPTOR 2[141 aa] 1 22 6 14 0 1 13 0 0 5 0 0 3 6 20 4 4 1 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 866 L T b 1.8 3j0a_A TLR2_HUMAN:TOLL-LIKE RECEPTOR 2[135 aa] 1 0 0 3 0 1 0 7 29 50 5 0 0 0 0 1 0 1 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 867 R H b 0.6 7nuw_A 1 0 1 1 1 1 0 1 1 32 0 1 1 1 41 1 1 1 0 14 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" R->Q:LB/B:rs1997689: -; 868 R T e 64.8 3j0a_A 0 0 0 0 0 0 5 0 24 0 0 0 0 17 54 0 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 869 G H e 23.8 3j0a_A 16 0 1 1 1 18 0 1 17 5 0 1 1 1 23 4 3 1 0 6 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 870 M H b 5.7 3j0a_A 0 0 0 0 7 0 0 20 0 54 6 0 0 0 0 0 0 1 0 8 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" M->V:US:-: -; 871 F H e 41.3 3j0a_A GOL 0 22 0 0 6 0 0 5 0 28 27 0 0 0 5 0 0 4 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 872 K H e 85.2 3j0a_A 7 0 0 5 0 3 0 0 19 0 0 19 0 7 15 16 7 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 873 S T b 18.4 3j0a_A SO4 0 0 5 0 0 0 0 0 15 0 5 0 0 16 17 21 20 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 874 H T e 72.4 3j0a_A 1 0 0 0 0 1 6 0 20 1 0 22 0 13 11 12 6 0 0 5 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 875 C e 52.6 3j0a_A 5 16 0 0 0 0 0 0 0 0 0 0 0 7 0 11 51 9 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 876 I e 34.8 3j0a_A 0 0 0 0 3 0 0 16 0 13 0 0 0 0 0 0 0 8 0 59 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 877 L b 10.1 3j0a_A 1 0 1 1 0 1 0 4 1 88 0 0 1 0 1 1 1 1 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 878 N e 69.2 3j0a_A 1 0 1 54 4 1 0 1 5 1 0 6 1 10 7 1 4 1 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 879 W e 28.7 3j0a_A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 880 P b 19.4 3j0a_A 0 0 6 12 0 0 0 0 0 0 0 0 82 0 0 0 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 881 V S e 78.4 3j0a_A 3 0 25 13 0 0 11 0 13 4 4 3 3 2 0 0 12 8 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 882 Q S e 53.1 3j0a_A 0 0 31 16 0 0 0 0 6 0 0 18 0 20 0 9 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 883 K S e 89.0 3j0a_A 5 0 1 22 0 0 0 0 24 8 0 0 26 0 5 0 0 9 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 884 E T e 83.7 3j0a_A 6 0 0 15 0 5 4 0 6 13 0 4 0 14 7 17 7 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 885 R T e 42.0 3j0a_A 12 0 8 0 0 26 1 0 17 1 0 0 0 20 13 0 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 886 I T e 38.7 3j0a_A 0 5 0 6 0 0 12 5 6 1 0 0 0 32 21 0 0 10 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 887 G T e 45.2 3j0a_A 0 0 0 15 0 36 12 0 0 1 0 8 10 3 7 6 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 888 A H e 72.9 3j0a_A 10 0 0 0 0 17 0 7 0 26 3 0 0 0 0 12 0 8 8 6 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 889 F H b 3.8 3j0a_A 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 890 R H e 23.6 3j0a_A 0 0 0 0 0 0 5 0 0 8 0 0 0 0 2 0 0 0 86 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 891 H H e 60.7 3j0a_A 33 0 4 3 0 0 10 0 0 9 0 0 0 17 12 0 5 6 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 892 K H e 38.7 3j0a_A 0 6 0 0 0 0 0 0 20 0 0 38 0 10 16 3 3 0 5 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 893 L H b 1.7 3j0a_A 0 0 0 0 0 0 0 5 0 95 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 894 Q H e 22.9 7nuw_A 0 0 0 0 0 12 0 0 23 0 0 0 0 5 58 2 0 0 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 895 V H e 49.1 7nuw_A 33 0 0 0 0 0 0 2 11 7 5 19 0 0 0 6 11 7 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 896 A H e 24.1 7nuw_A 82 0 0 0 0 0 0 0 0 0 0 0 0 0 6 7 0 6 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 897 L H b 0.0 7nuw_A 0 0 0 0 4 0 0 26 0 63 0 0 0 0 0 0 0 7 0 0 DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic":DOMAIN:/note="TIR":TOPO_DOM:/note="Cytoplasmic" 898 G H e 24.2 7nuw_A 4 0 0 0 0 22 0 3 16 8 0 17 0 0 9 0 21 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 899 S S e 52.0 7nuw_A 0 0 0 0 0 0 0 10 6 0 6 0 0 0 19 39 17 3 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 900 K e 79.7 7nuw_A SO4 0 0 38 21 0 0 0 0 32 0 0 0 0 0 10 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 901 N e 41.2 7ylg_A SO4 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 902 S 0 0 0 0 0 0 52 0 0 0 0 0 0 0 0 48 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 903 V 32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 68 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 904 H 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic"